ISTH 2017 Congress


8-13 July 2017 Berlin
N. Poster
Poster title
Applicant name
  1-PB ErbB Signaling Gene EGFR Centric Network Plays an Important Role in Coronary Artery Disease Madankumar Ghatge Received Received
  2-PB Immunization with Recombinant Atherosclerosis Vaccine Candidate (AHhHmR) Does Not Promote Melanoma Lung Metastasis in B6;129S-Ldlrtm1herApobtm2sgy/J Mice xinjie Lu Received Received
  2-LB A Large-scale Exome-wide Association Study of Venous Thromboembolism: Meta-analysis from the INVENT Consortium Christopher Kabrhel Received Received
  3-PB Pro-inflammatory and Pro-thrombotic Phenotype of Spontaneously Differentiated Human Monocyte-derived Macrophages in Coronary Heart Disease Patients: Implications for Plaque Morphology and Activity Sonia Eligini Received Received
  5-PB The Effect of Factor XIII on the Proliferation and Migration of Vascular Smooth Muscle Cells Réka Bogáti Received Received
  6-LB Prospective Randomized Placebo-controlled Trial of Simvastatin in the Prevention of COPD Exacerbations (STATCOPE) - Effects on Tissue Factor Pathway of Blood Coagulation A Koneti Rao Received Received
  6-PB Insights Into the Genetic Architecture of Coronary Artery Disease in Asian Indians Jiny Nair Received Received
  7-PB Oral Anticoagulants as Modulators of Arterial Calcification Rick H. van Gorp Received Received
  8-LB The Association between Genetic Variants Involved in Immune Response and Inhibitors among Persons with Hemophilia A: A Systematic Review and Meta-analysis Amanda Payne Received Received
  8-PB Involvement of PAR Signaling in Thrombin Generation on Vascular Smooth Muscle Cells from Abdominal Aortic Aneurysms Mélusine Didelot Received Received
  11-LB Platelet Count and Central Venous Catheter-related Thrombosis in Critically Ill Children: An Observational Study Jikke Rutgers Received Received
  12-PB Parameters of Complete Blood Count Do Not Predict On-treatment Platelet Reactivity in Acute Coronary Syndrome Patients Corinne Frere Received Received
  13-PB Impairment of Weight Gain and Lipoprotein Lipase Mediated-triglyceride Clearance in Integrin 3 (CD61) Deficient Mice Xiaodong Xi Received Received
  14-PB Increased Acetyl-CoA Carboxylase phosphorylation state in platelets identify high risk patients with coronary artery disease: ACCTHEROMA trial shakeel kautbally Received Received
  15-PB Recombinant Atherosclerosis Vaccine Candidate Antigen (AHhHmR)-induced Tregs in B6;129S-Ldlrtm1herApobtm2sgy/J Mice Do Not Promote Melanoma Cell (MC) Proliferation xinjie Lu Received Received
  16-PB Peripheral Immune Changes and Persistence of Tolerance to Atherosclerosis by Immune Modulation with Multi-antigenic Construct in Apobtm2Sgy Ldlrtm1Her/J Mice LAKSHMI NARASIMHA RAO THOTA Received Received
  17-PB Association of vWF Antigen/ADAMTS13 Activity Ratio with Gensini Score in Type 2 Diabetes Mellitus SUPAKANYA LASOM Received Received
  20-PB Nanoliposomes for Transfection Of CD39 mRNA: A Step towards Nanotheranostics for Delivery of Anti-inflammatory Therapeutics against Thrombosis Meike-Kristin Abraham Received Received
  21-PB Association of Plasma Soluble Thrombomodulin and HDL-C with Coronary Artery Stenosis Nantarat Komanasin Received Received
  22-PB Protective Auto Antibodies and their Inverse Correlation with Antigen Levels in Indian Patients with Acute Coronary Syndrome Thiruvelselvan Ponnusamy Received Received
  25-PB High Circulatory Level of Inflammatory Cells and their Relation to Recurrent Cardiac Events in Indian Population Thiruvelselvan Ponnusamy Received Received
  26-PB Lipoprotein a Lp(a) and Hemostatic Variables in Young and Post Menopausal Women: Are their Levels Affected by Hormones Use? Fernanda Freire Received Received
  27-PB Selected Factors of Haemostasis and Some Clinical Parameters in Patients with Peripheral Arterial Disease with Regard to Atherosclerosis Danuta Rosc Received Received
  28-PB MicroRNA Target Prioritization to Identify Potential Therapeutic Candidate in Cardiovascular Disease VRUSHALI DESHPANDE Received Received
  34-PB Myocardial Infarction is a Risk Factor for Venous Thromboembolism (VTE) Recurrence in Women with a First VTE Nadia Arshad Received Received
  36-PB Free Ubiquitin Promotes Cardiomyocytes Proliferation and Survival In vitro and In vivo via CXCR4 Pathway Jialu Yao Received Received
  37-PB Development of a Novel Flow Cytometric Immunobead Array to Quantify von Willebrand Factor Antigen and Ristocetin Cofactor Activity and its Application in Acute Myocardial Infarction Yiming Zhao Received Received
  40-PB Platelet-specific p38&945; deficiency improved cardiac function after myocardial infarction in mice panlai shi Received Received
  41-PB Identification of a Plasma microRNAs Profile Related to Arterial Thrombosis Laura Martos Received Received
  42-PB Platelet Serotonin Aggravates Myocardial Reperfusion Injury via Neutrophil Degranulation Maximilian Mauler Received Received
  43-PB Smoking and Fibrinogen Levels Modify the Risk of MI due to FXIII V34L: Results from the MAMI Study Jessica Debattista Received Received
  44-PB Levels of Beta-thromboglobulin and Platelet Factor 4 are different between NSTEMI and STEMI: Results from the MAMI Study Julia Bonaci Received Received
  45-PB CD41 Distribution within Platelet-Monocyte Complexes in Patients with Acute Myocardial Infarction Marina Loguinova Received Received
  46-PB Cardiomyocyte Extracellular Vesicles Increase after Experimental Myocardial Infarction and Promote Endothelial Dysfunction in vitro Carmen Roncal Received Received
  47-PB T Lymphocyte Microparticles Are the Major Determinant of Acute Coronary Syndrome Songpol Haohan Received Received
  50-PB "Soluble P-selectin levels are higher in patients with NSTEMI vs STEMI Christine Agius Received Received
  52-PB Ultrasound Elastography: A New Technique to Distinguish between Acute and Chronic Deep Vein Thrombosis Francesco Dentali Received Received
  53-PB General Practitioner-performed Compression Ultrasound for Deep Vein Thrombosis (Practicus Study): A Prospective, Multicenter Cohort Study Daniela Mastroiacovo Received Received
  54-PB Targeted MiR126 Therapy of Abdominal Aortic Aneurysm Xiaowei Wang Received Received
  56-PB Risk Prediction Model for Peripheral Arterial Disease Patients Undergoing Revascularization within Two Years of Diagnosis Renske Olie Received Received
  57-PB Repetitive Intravenous Thrombin Injections Result in Pulmonary Arterial Endothelial Dysfunction in a Mouse Model of Sublethal Acute Pulmonary Embolism Venkata Subbaiah Garlapati Received Received
  58-PB Lack of Association between Candidate Gene Polymorphisms and Ischemic Events in Patients with Peripheral Arterial Disease Ales Blinc Received Received
  59-PB Restenosis is a Predictor of Poor Outcome in Patients Undergoing Endovascular Intervention for Peripheral Arterial Disease Michelangelo Sartori Received Received
  61-PB Venous Thromboembolism Following Hantaviral Infection Anne-Marie Connolly-Andersen Received Received
  63-PB Thrombophilic and Cardiovascular Risk Factors for Retinal Vein Occlusion Paolo Bucciarelli Received Received
  65-PB Gene-sodium Interaction on the Developing of Hypertension: A Cohort-based Case-control Study Bing-Fang Hwang Received Received
  71-PB The Chimeric Monoclonal Antibody MHCSZ-123 against Human von Willebrand Factor A3 Domain Inhibits High Shear Arterial Thrombosis Model in Rhesus Monkeys shundong Ji Received Received
  72-PB Effects of Two Plant Protein Inhibitors on Haemostasis and Thrombosis Maria Luiza Oliva Received Received
  73-PB Slounase, a Modified Snake Venom Hemocoagulase Combined with FXa, Enhances Hemostasis and Limits Bleeding in Both Normal and Hypocoagulant Conditions Reheman Adili Received Received
  74-PB Platelet Defects Upon Surgical Liver Disease Models iin Mice Friedrich Reusswig Received Received
  77-PB Sickle Cell Red Blood Cells Alter Properties of Mouse and Human Clot FAES Camille Received Received
  78-PB Porcine Model of Methicillin-resistant Staphylococcus Aureus (MRSA) Sepsis-induced Disseminated Intravascular Coagulation (DIC) and Multiple Organ Dysfunction Syndrome (MODS) Trung Nguyen Received Received
  79-PB Role of bone morphogenetic protein receptor type II in vascular remodeling during thrombosis Smriti Sharma Received Received
  80-PB In Vivo Neutralization of Unfractionated Heparin (UFH) and a Bioengineered Heparin Dodecasccharide (12-mer) by Protamine Sulfate in a Primate Model Walter Jeske Received Received
  81-PB Hemostatic Profile in Mouse Models of Advanced Chronic Liver Disease Natacha Dewarrat Received Received
  84-PB Thromboelastography in Mice: Impact of Blood Collection Method Maha Othman Received Received
  85-PB Quantitative Proteomics of Plasma-derived Macrovesicles Identifies Early Systemic Protein Markers of a Hemophilic Bleed in Rats Mads Kjelgaard-Hansen Received Received
  86-PB Improved Anticoagulant Effect of Fucosylated Chondroitin Sulfate Orally Administered as Gastro-resistant Tablets ROBERTO JOSE CASTRO FONSECA Received Received
  87-PB Three Point Ligation of Inferior Vena Cava in Rats: Experimental Approach to Study Mechanism of Venous Thrombosis Neha Gupta Received Received
  88-PB Activated (a) factor (F) VII for hemostasis enhancement in FXI and XIa inhibitor-treated primates Michael Wallisch Received Received
  89-PB The Electrolytic IVC Model of Venous Thrombosis (EIM): A Cost-effective, Highly Reproducible, and Easily Controlled Tool to Investigate Venous Thrombosis under Flow Conditions Olivia Palmer Received Received
  90-PB A Functional and Thromboelastometric-based Micromethod for Assessing Crotoxin Anticoagulant Activity and Antiserum Relative Potency against Crotalus Durissus Terrificus Venom Benedito Prezoto Received Received
  92-PB In the Cath Lab - A Novel Rabbit Bleeding Model Imke Meyer Received Received
  93-PB Von Willebrand Factor Effects Vessel Conformation and the Expression of Integrin aV3 and Ang-2 in the Porcine Female Reproductive Tract Carsten Detering Received Received
  96-PB The Anti-factor XIa Antibody BAY 1213790 is a Novel Anticoagulant that Shows Strong Antithrombotic Efficacy without an Increased Risk of Bleeding in Rabbit Models Anja Buchmueller Received Received
  99-PB New Insights into FV-short Function and Interaction with TFPIa Teodolinda Petrillo Received Received
  101-PB Inhibition of Contact Activation by Histidine-Rich Glycoprotein is Mediated by its Histidine-Rich Domain Tammy Truong Received Received
  103-PB Factor VII Activating Protease (FSAP) and Marburg I (G534E) Polymorphism; How One Amino Acid Determines Function Nis Valentin Nielsen Received Received
  106-PB Fusion to Albumin Extends the Circulatory Half-life and Antithrombotic Effects of the Kunitz Protease Inhibitor Domain of Protease Nexin 2 in Mice William Sheffield Received Received
  109-PB The Most Significant Physiological Function of Protein S is Inhibition of Thrombin Generation Ester Goldfeld Received Received
  111-PB Validation of a FVIII Nijmegen Bethesda Assay for the Detection of Inhibitors to Porcine FVIII Mary Robinson Received Received
  112-PB Single-dose Safety and Toxicological Studies of Long-acting FVIIa (MOD-5014) in Rats and Monkeys Support the Initiation of Clinical Phase 1 Subcutaneous (SC) Study in Healthy Volunteers Malka Hoffmann Received Received
  113-PB Low Plasma FVII:C and Activated FVII as Predictive Markers for Overt Disseminated Intravascular Coagulation Surapong Lertthammakiat Received Received
  116-PB Zinc Binds and Regulates the Activity of the Natural Anticoagulant Protein Z Tanusree Sengupta Received Received
  117-PB Effects of SERPINC1, PROC, PROS1 and EPCR Polymorphisms on the Plasma Levels of Natural Anticoagulants in Healthy Individuals Zsuzsanna Bereczky Received Received
  118-PB Identification of a Novel Factor VII Activating Protease (FSAP) Zymogen-activating Peptide by Phage Display sandip kanse Received Received
  120-PB Microplate-based Method for Quantifying Polyphosphate in Biological Samples Stephanie Smith Received Received
  122-PB Clinical Significance of Prothrombin G20210A Mutation in Homozygous Patients Inna Tsoran-rosenthal Received Received
  125-PB Anti-FVIII IgG1 Antibody in Previously Untreated Patients with Hemophilia A Might Be Protective Against Inhibitor Development: Preliminary Results from the Hemfil Cohort Study Daniel Chaves Received Received
  126-PB Cost-effectiveness of Recombinant Porcine Factor VIII (OBIZUR) for Treatment of Hemorrhagic Events in Acquired Hemophilia A (AHA) Mehdi Najafzadeh Received Received
  128-PB APC-Resistance Testing Based on Genetic or Functional Assays: To Be or Not to Be ? Anne C Brisset Received Received
  129-PB Alteration of the Hemostatic System in Cirrothic Patients CRISTINA DUBOSCQ Received Received
  130-PB In vitro Antithrombin is the Main Inhibitor of Thrombin Generation at the Surface of Endothelial Cells Acting Independently to Heparan Sulfates Jean-Luc PLANTIER Received Received
  132-PB Impact of Thrombin (Dabigatran) and FXa Inhibitors (Rivaroxaban, Apixaban, Edoxaban) on Hemostasis Assays Judith Hammelburger Received Received
  134-PB Prolonged Targeted Temperature Management Causes an Impaired Coagulation: A Randomised Clinical Trial Anni Nrgaard Jeppesen Received Received
  135-PB Features of Clinical and Laboratory Diagnostics of Disturbance of Hemostasis System in Patients with Retinal Vein Occlusion on the Background of FV Leiden Mutation and LA Tatyana Shelkovnikova Received Received
  136-PB Causes of Isolated Prolonged Activated Partial Thromboplastin Time in a Haemostasis Reference Hospital Noelia Vilalta Received Received
  141-PB Characterization of Interactive Sites of the Blood Coagulation Factor VIII and the Low-density Lipoprotein Receptor using Macromolecular Docking Prediction Algorithms Andrey Sarafanov Received Received
  142-PB Comparison of Bleeding Efficacy of FIX-Albumin and FIXWT 7 Days Post-infusion Darrel Stafford Received Received
  145-PB Monoclonal Antibodies to Fc?RIIB (CD32) Modulate FVIII-specific Recall Response in vitro Nadine Vollack Received Received
  148-PB Altering FIX Zymogenicity Extends Procoagulant Function and Improves Hemostatic Function in Murine Hemophilia B Lacramioara Ivanciu Received Received
  150-PB Evaluation of Impact of Codon-Optimization on the Functional Activity of the Blood Coagulation Factor VIII by Clotting, Chromogenic and Thrombin Generation Assays Andrey Sarafanov Received Received
  151-PB An In silico and In vitro Approach to Elucidate the Impact of Residues Flanking the Cleavage Scissile Bonds of FVIII Behnaz Pezeshkpoor Received Received
  152-PB In vitro Characterization of the Factor 8 Gene Mutations Associated with Assay Discrepancy Behnaz Pezeshkpoor Received Received
  153-PB Corn Trypsin Inhibitor Mediates Differential Effects on Thrombin Generation Parameters in Hemophilic Patients Compared with Healthy Volunteers Michelle Piot Received Received
  154-PB Influence of Pharmacodynamics of Factor VIII on Bleeding Phenotype of Children under Long-term Prophylactic Regimen Ihosvany Fernandez Bello Received Received
  156-PB Novel F9 Gene Variants in Hemophilia B Patients from Turkey Ergul Berber Received Received
  158-PB Population Pharmacokinetic Analysis of Perioperative Factor IX Dosing in Hemophilia B Tim Preijers Received Received
  159-PB Which Tests Can Better Indicate Clinical Phenotype of Pediatric Patients with Hemophilia on Prophylaxis? Yilmaz Ay Received Received
  160-PB Acquired Haemophilia and Eosinophilic Fasciitis MROUKI MAROUA Received Received
  162-PB A Novel Tick Salivary Protein Modulates Fibrinolysis by Interacting with Plasminogen and Tissue Plasminogen Activator, and Prevents Arterial Thrombosis in vivo Ivo Francischetti Received Received
  164-PB Optimising the Degradation of NETs to Destabilise Fibrin Clot Structure and Promote Fibrinolysis Locke Matthew Received Received
  165-PB Extracellular Histones Enhance Fibrin Degradation by Prourokinase in a Factor Seven Activating Protease (FSAP)-dependent Manner FABRIZIO SEMERARO Received Received
  166-PB Localization of the C-terminal Cleavage Site of Human Alpha-2-antiplasmin Shirley Uitte de Willige Received Received
  167-PB PAI-1 Inhibition with MDI-2001: Towards a Safer and More Effective Treatment for Deep Vein Thrombosis Jose Diaz Received Received
  168-PB A Phase 2/3, Open-label, Repeat-Dose Study of the Pharmacokinetics, Efficacy, and Safety of Prometic Plasminogen Intravenous Infusion in Subjects with Hypoplasminogenemia (HPLG) Joseph Parker Received Received
  169-PB Colistin Dampens Fibrinolysis and Endothelial Activation during Endotoxemia: A Randomized, Double Blind Trial Christian Schoergenhofer Received Received
  171-PB Global Assay of Fibrinolysis in Sickle Cell Disease: Contrasting Results in Plasma and Whole Blood Anton Ilich Received Received
  174-PB Generation and Characterization of Monoclonal Antibodies against the N-terminus of Alpha-2-antiplasmin Shirley Uitte de Willige Received Received
  175-PB Stretching Fibrin Fibers Hampers their Lysis Martin Guthold Received Received
  176-PB Performance and Determinants of whole Blood and Plasma Fibrinolysis Assays in Patients with Mild Bleeding Symptoms Minka Vries Received Received
  177-PB Characterisation of the Different Pathways of Neutrophil Extracellular Trap (NET) Formation Triggered by Treatment with phorbol-12-myristate-13-acetate (PMA) or Calcium Ionophores Matthew Locke Received Received
  178-PB Effect of Alpha-2 Plasmin Inhibitor p.Arg6Trp Polymorphism and Antigen Level on the Risk of Myocardial Infarction in Young Patients Éva Katona Received Received
  180-PB Study of Fibrinolytic Factors along with Thrombophilia Screening Gives a Comprehensive Picture of the Cause of Venous Thrombosis in Indian Patients Aniket Prabhudesai Received Received
  181-PB Impaired Plasminogen Binding in Patients with Venous Thromboembolism: Association with Protein Carbonylation Jakub Siudut Received Received
  182-PB Ligneous Gingivitis due to Severe Plasminogen Deficiency: Results of a Prophylactic Protocol for Dental Care Maria Teresa Sartori Received Received
  184-PB Fibrinolytic Markers in Patients Undergoing Total Hip Replacement with and without Administration of Tranexamic Acid Irina Antropova Received Received
  185-PB Hyperfibrinolysis during Liver Transplantation Detected by Classical Parameters and Thromboelastometry Sara Maggiolo Received Received
  187-PB Application of the CloFAL Assay, a Global Assay which Evaluates Coagulation and Fibrinolysis in a Cohort of Venous Thromboembolism (VTE) Silmara Montalvao Received Received
  188-PB Simultaneous Thrombin Plasmin Generation Assay in Haemorrhagic and Non Haemorrhagic Caesarean Section: Pilot Study Emmanuelle Jeanpierre Received Received
  189-PB Simultaneous Thrombin Plasmin Generation Assay: Effect of Tranexamic Acid Concentration in vitro Emmanuelle Jeanpierre Received Received
  190-PB Association of Fibrinolytic Parameters with Coagulation Activity and Fibrin Clot Permeability in Patients with Hemophilia A Marija Milos Received Received
  191-PB Consequences of Tranexamic Acid on Fibrinolysis in Patients with Hereditary Bleeding Disorders Compared with Healthy Controls Isaac Goncalves Received Received
  192-PB Association of TAFI Polymorphisms and Fibrinolytic Status with Obesity in Subjects Suspected for Coronary Artery Disease Chutima Rattanawan Received Received
  193-PB Nattokinase Easily Hydrolyzed Fish Elastin and Collagen, and Produced Anti-platelet Aggregation Activity Hiroyuki Sumi Received Received
  195-PB A New Functional Food Coix-Natto for Fibrinolysis Chieko Yatagai Received Received
  198-PB Very High Production of Nattokinase by D-amino Acids Yasuhide Yanagisawa Received Received
  199-PB Evaluation of the Ankle Brachial Index in Persons with Hemophilia: Unexpected Findings Hilde Hop Received Received
  201-PB Patient, Regional and Center-level Variation in Utilization of Arthroplasty and Arthrodesis Interventions in Persons with Hemophilia: An Analysis of the American Thrombosis and Hemostasis Network (ATHN) Dataset Tyler Buckner Received Received
  204-PB Compartmental High Resolution 3D Imaging by HR-pQCT Reveals Low Bone Mineral Density in Hemophilia Patients is Attributed to Loss of Trabecular Bone Adrienne Lee Received Received
  205-PB No Association between HFE and HMOX1 Polymorphisms, Important in Iron and Heme Handling, and the Severity of Haemophilic Arthropathy Lize van Vulpen Received Received
  206-PB Factors Associated with Perception of Functional Abilities in US Adults with Hemophilia Beyond Joint Status: Analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study Christine Kempton Received Received
  210-PB Bleeding Phenotype In Non-severe Hemophilia A Has a Better Association with the One-stage Than the Chromogenic Assay Lisette M. Schtte Received Received
  214-PB Assessment of Clot Kinetics of Recombinant Human Factor VIII, Recombinant Porcine Factor VIII, Recombinant Factor VIIa and Activated Prothrombin Complex Concentrate Utilizing Thromboelastography in Patients with Hemophilia Guy Young Received Received
  215-PB Obesity in Patients with Hemophilia: Prevalence by Age, Clinical Correlates and Impact on Joint Bleeding Chia-Yau Chang Received Received
  216-PB Influence of Genetic Polymorphisms of Biological Mediators on the Phenotypic Heterogeneity in Hemophilic Arthropathy Yeu-Chin Chen Received Received
  217-PB Joint Status and Other Factors Associated with Pain Severity and Interference in US Adults with Hemophilia Beyond Joint Status: Analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study David Cooper Received Received
  218-PB Ranges of Risk Associated with Sports/Recreational Activities in People with Hemophilia: Results of the Activity-Intensity-Risk (AIR) Consensus Survey of US Physical Therapists Sheba Mathew Received Received
  219-PB The Impact of Switching Recombinant Factor VIII Product Concentrates on Inhibitor Development among Haemophilia A Patients in Australia Huyen TRAN Received Received
  220-PB Sociodemographic, Clinical and Psychosocial Characteristics of People with Haemophilia (PWH) in Portugal: Preliminary Results of the First National Survey Ana Cristina Paredes Received Received
  221-PB Understanding Burden of Illness of People with Hemophilia A with or without a Current Inhibitor Daniella Babu Received Received
  222-PB The Continued Use of Cryoprecipitate and Plasma to Treat Bleeding Disorders Christine Herr Received Received
  223-PB Anti-CD20 and Sirolimus for Immune Tolerance in Congenital Hemophilia A with Refractory Inhibitors Bhavya Doshi Received Received
  224-PB A Prospective Surveillance Study of Inhibitor Formation in Quebec Hemophilia A Patients Following a Population Switch to a Third-generation B-Domain-deleted Recombinant Factor VIII Evemie Dubé Received Received
  225-PB Evaluation of Reagent Substitutions in the Centers for Disease Control and Prevention Modified Nijmegen-Bethesda Assay (CDC-NBA) for Factor VIII (FVIII) Inhibitors in Hemophilia A Connie Miller Received Received
  226-PB Evaluation of an Optimized Thrombin Generation Assay for Measurement of rFVIIa in Haemophilia A Patient Plasma Nora Viviana Butta Received Received
  229-PB Frozen Autologous Platelet Gel and Fibrin Glue in Hemophilia A, B and von Willebrand Surgical Patients Bernadeta Ceglarek Received Received
  230-PB Safety and Efficacy Of Moroctocog Alfa (AF-CC) in Patients with Hemophilia A: Results of a Post-authorization Study in Usual Care Settings in China Renchi Yang Received Received
  231-PB Post-authorization Study to Evaluate Pharmacokinetics of FVIII after Moroctocog Alfa (AF-CC), as Well as Safety and Efficacy in Previously Treated Pediatric Patients with Severe Hemophilia A Jeremy Rupon Received Received
  232-PB Understanding Care Utilization and Perceptions of People with Hemophilia A with or without a Current Inhibitor Daniella Babu Received Received
  234-PB Retrospective Analysis of Hemostatic Efficacy by Continuous Infusion of Recombinant Factor VIIa: A Single Institution Study Nobuaki Suzuki Received Received
  235-PB An Evaluation of the Pharmacokinetics of Turoctocog Alfa in Relation to Body Mass Index (BMI) in Patients with Haemophilia A (HA) Silva Zupancic-alek Received Received
  236-PB Pharmacokinetic Studies of FVIII in Chinese Boys with Severe Hemophilia A Zhenping Chen Received Received
  237-PB Preliminary Results of a Personalized One-year Program to Individualize the Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Hemophilia A Patients Juan Eduardo Megías Vericat Received Received
  240-PB Validity of Angiography and Therapeutic Embolization in the Treatment of Acute Bleeding in Hemophilia Patients YOUNG SHIL PARK Received Received
  241-PB Postraumatic Anterior and Posterior Thigh Pseudotumor in Young and Adolescent with Hemophilia Ricardo Silva Received Received
  243-PB Severe Haemophilia A Patients Born between 2000- 2015 at a Single Haemophilia Centre: Characteristics and Inhibitor Development Marta Martorell Received Received
  244-PB The Effectiveness of PK-Tailored Tertiary Prophylaxis for Severe Hemophilia A Children: A Pilot Study from BCH Zhenping Chen Received Received
  245-PB Korea Hemophilia Foundation Registry Trends 1991-2015: Patient Registry, Demographics, Health Services Utilization Soon Ki Kim Received Received
  246-PB Safety and Efficacy of Nonacog Alfa in Patients with Hemophilia B: Results of a Post-authorization Study in Usual Care Settings in China Ashley Daset Received Received
  247-PB Spinal & Cranial Neurosurgical Procedures in Patients with Hemophilia Charles Nakar Received Received
  248-PB Pseudotumors in Hemophilia: Effective Surgery with Application of Frozen Autologous Platelet Gel Bernadeta Ceglarek Received Received
  252-PB Sudden Decrease of High-titer Anti-FVIII Antibodies with Anti-inhibitor Coagulant Complex in a Patient with Severe Hemophilia A and Poor Response to Immune Tolerance Induction Inmaculada Soto Received Received
  254-PB Correlation between Pharmacokinetic of Factor VIII and Bleeding Frequency of Children withsevere Hemophilia A in China - A Single Center Data Analysis Zhenping Chen Received Received
  255-PB Assessment of the Quality of Life in Korean Hemophiliacs: Impact of Disease-related Factors, Social Status and Treatment Factors on the Quality of Life of Korean Hemophiliacs Ho-Jin Shin Received Received
  256-PB Relevance of Polypharmacy for the Clinical Outcome of Patients Receiving Oral Anticoagulation Therapy - Results from the thrombEVAL Study Lisa Eggebrecht Received Received
  257-PB Thromboembolic and Bleeding Risk of Patients with Left-sided Mechanical Heart Prosthesis: The FCSA-START-Valvole Study Emilia Antonucci Received Received
  258-PB Warfarin Binds to a Hydrophobic Pocket within the Oxidized Open State Human VKORC1 Conformation Katrin Czogalla Received Received
  260-PB Assessment of the Efficacy of a Novel Tailored Vitamin K Dosing Regimen in Lowering INR in Over-anticoagulated Patients Emmanouela Kampouraki Received Received
  261-PB Clinical Usefulness of the SAMe-TT2R2 Score: A Systematic Review and Meta-analysis Jasper van Miert Received Received
  262-PB Safety of Long Term Warfarin Therapy in Real Clinical Practice: Predictors of Major and Non-Major Clinically Relevant Bleedings Elizaveta Panchenko Received Received
  263-PB Decreased Bone Mineral Density in Fontan Patients Receiving Long-term Warfarin Chantal Attard Received Received
  264-PB Predicting Recurrent Venous Thromboembolism in Patients with Deep-vein Thrombosis: Development and Internal Validation of an Simply Applicable Prediction Model (Continu-8) Michael Nagler Received Received
  266-PB Anticoagulation Control in Premenopausal Women with Mechanical Heart Valves Using Vitamin K Antagonists: Room for Improvement C.S.B. Veen Received Received
  267-PB Involvement of Antithrombotic Therapy in Intracranial Bleeding: A Tertiary Hospital Experience Veronica Pons Received Received
  268-PB One-year Medical Costs and Predictors of Costs of Pulmonary Embolism: A Prospective Study Jean-Philippe Galanaud Received Received
  269-PB The Impact of Antiphospholipid Syndrome and Related Comorbidities in the Quality of Oral Anticoagulation Gabriela Goes Yamaguti-Hayakawa Received Received
  270-PB Predicting Recurrent Venous Thromboembolism in Patients with Deep-vein Thrombosis: External Validation of a Prediction Model Michael Nagler Received Received
  271-PB Clinical Characteristics Associated with Diagnostic Delay of Pulmonary Embolism in Primary Care: A Retrospective Observational Study Janneke Hendriksen Received Received
  272-PB Variability in Calculation of Time in Therapeutic Range for Quality Control Measurement of Warfarin Safia Siddiqui Received Received
  273-PB D-dimer Levels Predict Clinical Outcomes in Patients with Mechanical Heart Valve Replacement during Oral Anticoagulation Therapy Litao Zhang Received Received
  275-PB Has the Introduction of the DOACs Moved Patients with Labile INRs from Warfarin Therapy? Thomas O Halloran Received Received
  276-PB Long-Term Risk of Recurrence After Stopping Anticoagulants for Acute Unprovoked Venous Thromboembolism: Systematic Review and Meta-Analysis Faizan Khan Received Received
  277-PB Outcome of Vitamin K Antagonist Associated Bleeding in Patients Treated with Prothrombin Complex Concentrate Marjolein P.A. Brekelmans Received Received
  278-PB Association of 5-untranslated Region / Exonic VKORC1 Mutations with Vitamin K Antagonist Resistance: Results of the GFHT Cohort Study Elodie Lesteven Received Received
  279-PB Repeated Serial D-Dimer (DD) Measurement after Anticoagulation Therapy (AT) withdrawal to Identify Patients (PTS) at Risk for Venous Thromboembolism (VTE) Recurrence Benilde Cosmi Received Received
  281-PB AF Patients on VKAs: Heart Failure is Associated with Worst Quality of Anticoagulation and Higher Bleeding Risk. Results from the START Register Emilia Antonucci Received Received
  282-PB Thrombotic Complication Rates Following Anticoagulation Reversal: A Retrospective Evaluation of Prothrombin Complex Concentrates Joseph Shaw Received Received
  287-PB Thrombin Generation Test: A Reliable Tool to Evaluate the Pharmacodynamics of Vitamin K Antagonist Rodenticides in Rats Georges JOURDI Received Received
  288-PB The Efficacy of 3-mg versus 5-mg Warfarin Initiating Dose and Corresponding Dosing Schedule in Thai Patients Diagnosed with Venous Thromboembolism Bundarika Suwanawiboon Received Received
  289-PB Barriers to Implementing an Extended INR Testing Interval Policy for Stable Warfarin Patients: A Mixed Methods Study in Five Anticoagulation Clinics Geoffrey Barnes Received Received
  290-PB Vitamin K Antagonists Compared to Low-molecular-weight Heparins for Treatment of Cancer-associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice Frederikus Albertus Klok Received Received
  291-PB External Quality Assessment of the POCT Prothrombin Time Determination - the 6-Year Experience with the Evaluation of the Postanalytical Phase Petr Kessler Received Received
  292-PB The Incidence of Thromboembolic and hEMorrhagic (ITEM) Complications in Patients on Anticoagulant Therapy. A Dynamic Parallel-group Cohort Study Sophie Testa Received Received
  293-PB Specific Inhibition of Endogenous VKOR Enzymes by Oral Anticoagulants Reveals Lower VKORC1L1 Susceptibility due to Different Binding Site Kerstin Liphardt Received Received
  294-PB A comparison of management strategies for patients with warfarin-induced bleeding Paul Dobesh Received Received
  295-PB Provision of External Quality Assurance for Post Analytical Assessment of Point of Care Haemostasis Tests Ian Jennings Received Received
  296-PB Warfarin Toxicities: Risk Factors and Management - Data from a Developing Country Sidra Asad Ali Received Received
  297-PB Use of a 4-factor Prothrombin Complex Concentrate for Warfarin Reversal prior to Urgent Surgery Brian Trevarrow Received Received
  298-PB Can Results Be Improved on Vitamin K Antagonists (AVKs) Therapy ? ALICIA VILASECA Received Received
  299-PB Genetically Determined Hypersensitivity to Vitamin K Antagonists Caused by a c.109GA (p.Ala37Thr) Mutation in the Factor IX Propeptide: The First Case Identified in Poland Edyta Odnoczko Received Received
  301-PB Prothrombinex-VF versus Vitamin K alone for warfarin reversal prior to emergency surgery in Western Australias Tertiary Orthopaedic Departments. Rachael Stokes Received Received
  303-PB Utility of a new Point of Care system, Coag S, for Vitamin K Antagonist Therapy in a Rural Family Practice József Antal Received Received
  304-PB Duration of anticoagulation, recurrence predictors and treatment pathways in first venous thromboembolism in a tertiary referral centre Laith Tafesh Received Received
  305-PB Out of Range INR Values Increase Healthcare Interaction Time in Four Large Anticoagulation Clinics Geoffrey Barnes Received Received
  309-PB Ex Vivo Haemostatic Capacity of Thawed Plasma Beyond 24 Hours: Comparison between FFP and RTFP24 Ai Leen Ang Received Received
  311-PB Coagulation Parameters and Need for Transfusion in Patients with Veno-arterial Extracorporeal Membrane Oxygenation in Clinical Hospital Center Rijeka Nada Vukelic-Damijani Received Received
  314-PB Knowledge, Attitude and Practice Regarding the Voluntary Blood Donation among the Young Student Population of Karachi Bipin Nepal Received Received
  315-PB Burden of Hemoglobinopathies on the Blood Bank of a Tertiary Care Setting Romana Akbar Received Received
  316-PB Major Blood Groups and A2 Sub-group in Mixed Pakistani Population of Karachi Bipin Nepal Received Received
  321-PB Characterization of a Universal Reversal Agent for Anticoagulants Kamran Bakhtiari Received Received
  323-PB Extracellular Nucleosome Levels in the Etiopathogenesis of Sepsis-associated Coagulopathy Amanda Walborn Received Received
  324-PB Mediators of Inflammation and Infection in Sepsis Associated Disseminated Intravascular Coagulation and Their Prognostic Role Priya Patel Received Received
  326-PB Evaluation of the Diagnostic Utility of Individual Parameters in the Disseminated Intravascular Coagulation (DIC) Panel for Use in Under-resourced Settings Susan Louw Received Received
  327-PB Circulating Nucleosomes and Neutrophil Activation Predict for Disseminated Intravascular Coagulation but Not for Mortality in Patients with Severe Sepsis or Septic Shock Mandy Lauw Received Received
  328-PB A Prospective Observational Study for the Evaluation of New Diagnostic Criteria for Disseminated Intravascular Coagulation by the Japanese Society on Thrombosis and Hemostasis Seiji Madoiwa Received Received
  329-PB A comparison of Disseminated Intravascular Coagulation (DIC) Screening Parameters with and without Human Immunodeficiency Virus Infection in an African Academic Hospital Setting Elizabeth Mayne Received Received
  330-PB International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treated and Those with Disseminated Intravascular Coagulation Debra Hoppensteadt Received Received
  331-PB Epidemiological Evaluation of Patients Presenting with Disseminated Intravascular Coagulation (DIC) at an Academic Hospital in an African Middle-income Country Elizabeth Mayne Received Received
  333-PB Fulminant Disseminated Intravascular Coagulation as Initial Manifestation of Pulmonary Adenocarcinoma Sofia Teixeira Received Received
  334-PB Platelet-mimicking Synthetic Nanoparticles (SynthoPlateTM) Improve Hemostasis and Survival Following Uncontrolled Hemorrhage Matthew Neal Received Received
  338-PB Antifibrinolytic Therapy to Prevent Oral Bleeding in People on Anticoagulants Undergoing Oral or Dental Procedures: A Cochrane Systematic Review Eveline Engelen Received Received
  339-PB Management of Rivaroxaban or Apixaban Associated Major Bleeding with Prothrombin Concentrate: A Prospective Cohort Study Ammar Majeed Received Received
  341-PB Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors Sam Schulman Received Received
  342-PB Reversal of Dabigatran-associated Major Bleeding with Activated Prothrombin Concentrate: A Prospective Cohort Study Sam Schulman Received Received
  343-PB A Randomized Study of 4-factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding, Thrombin Generation, and Pharmacodynamics after Punch Biopsies in Rivaroxaban Treated Subjects with Supratherapeutic Drug Levels Connie Comella Received Received
  344-PB Idarucizumab for Dabigatran Reversal in Daily Practice - First Experiences from Slovenia Nina Vene Received Received
  345-PB The Influence of Histones on the Generation of Factor XIa in Trauma Patient Blood Shannon Prior Received Received
  349-PB Development and Validation of the Warfarin-Aspirin Bleeding Assessment Tool (WA-BAT) Chantal Attard Received Received
  351-PB Chemical Composition of Malian Medicinal Plants Used to Treat Bleeding Events DIALLO Yacouba L. Received Received
  352-PB First Italian Experience of Clinical Use of Obizur, Recombinant Porcine Sequence Factor VIII (RPFVIII), for Acquired Haemophilia A (AHA) Corrado Lodigiani Received Received
  353-PB The Effect of PCC on ROTEM Parameters in Patients with Coagulopathy of Liver Disease Colleen Hamid Received Received
  354-PB Factor VIII and von Willebrand levels at Desmopressin (DDAVP) Challenge Test: A Single Center Results Claudia Casas Received Received
  355-PB Correlation between Platelet Count and Platelet Component in Thromboelastometry Marija Milic Received Received
  357-PB Towards a Clinically Relevant Hybrid Adenovirus-Sleeping Beauty Transposon Vector for Gene Therapy for von Willebrand Disease Irina Portier Received Received
  358-PB Comprehensive Functional and Structural Studies to Characterize von Willebrand Factor Propeptide Novel Missense Variants with Unknown Pathological Significance Hamideh Yadegari Received Received
  359-PB Triggering Receptor Expressed on Myeloid Cells Like Transcript-1 (TLT-1) is a Novel Ligand for von Willebrand Factor Angela Doerr Received Received
  362-PB Axial Structure and Collagen Binding of the von Willebrand Factor Multimer Maria Csilla Csanyi Received Received
  364-PB Recombinant Activated Factor VII-Induced Correction of Bleeding Tendency in Genetically-engineered von Willebrand Disease Type 2B Mice Evaluated Using New Tail Transection Bleeding Models valerie proulle Received Received
  365-PB VWF DD3 Mutations Associated with Type 1 von Willebrand Disease Demonstrate Impaired Gp1B?-VWF Binding under High Shear Stress Christopher Ng Received Received
  366-PB Diagnostic Challenges of Acquired von Willebrand Syndrome Sonja Schneppenheim Received Received
  367-PB Multimer Size Distribution and Multimerization Defects of von Willebrand Factor Investigated at the Single-molecule Level by AFM Imaging Achim Lf Received Received
  368-PB Exploration of Interim Bleeding Scores in VWD Subjects from Irish LoVIC, Canada and the US Zimmerman Program Pamela Christopherson Received Received
  369-PB Does Ageing Modify Hemostatic Parameters in Type 1 von Willebrand Disease (VWD-1)? Giuseppe Guglielmini Received Received
  370-PB Common Single Nucleotide Variants in the von Willebrand Factor Gene Associate with Mutation Negative Type 1 VWD Colleen Notley Received Received
  371-PB Functional Polymorphisms of the von Willebrand Factor Gene in Patients with Mild to Moderate Bleeding Tendency and Low von Willebrand Factor Antigen or von Willebrand Factor Ristocetin Cofactor Stefanie Hofer Received Received
  373-PB Quantitative ELISA Assay for in vivo Proteolysis of von Willebrand Factor and Bleeding: A Pilot Study in Type 2A (IIA) von Willebrand Disease Antoine Rauch Received Received
  374-PB Bleeding Symptoms in Patients Previously Diagnosed as Type 3 von Willebrand Disease: Results from a Multicenter, Multinational Cross-sectional Study Alberto Tosetto Received Received
  375-PB Fluorescence Intensity-based Analysis of the Shear-dependent Internalization of Von Willebrand Factor Mutants by Macrophages Ulrike Klemm Received Received
  376-PB Von Willebrand Factor Multimer Analysis in 255 Patients Previously Diagnosed as VWD Type 3 from the Iranian Republic and Nine European Countries (3WINTERS-IPS Study) Ulrich Budde Received Received
  377-PB Interaction between the A3 and A2 Domains of von Willebrand Factor Reduces the Binding of the A1 Domain to Glycoprotein Iba Miguel Cruz Received Received
  379-PB Perioperative Management of Replacement Therapy in von Willebrand disease: Steps towards Individualization of Treatment? Marjon Cnossen Received Received
  380-PB Deficiency of von Willebrand Factor (VWF) High Molecular Weight Multimers (HMWM) in the Presence of Normal/Increased Activity of both VWF Cofactor Activity (VWF:RCo) and VWF Antigen (VWF:Ag) in Patients with Severe Aortic Stenosis Bernadeta Ceglarek Received Received
  381-PB Usefulness of VWF Propeptide in the Differential Diagnosis between Patients with VWD and AVWS Francesca Stufano Received Received
  384-PB Laboratory Diagnosis of von Willebrand Disease Type 2A versus LVAD-Induced Acquired von Willebrand Syndrome Shannen Deconinck Received Received
  385-PB Elevated Levels of vWF Antigen and Activities, Factor VIII and Fibrinogen Inversely Correlated with the Estimated Glomerular Filtration Rate in Patients with Non-dialysis Chronic Kidney Disease Bundarika Suwanawiboon Received Received
  386-PB Measurement of Platelet von Willebrand Factor (VWF) Antigen Concentration and Activity Using Automated Latex-immunoturbidometric (LIA) Assays Heiko Ruehl Received Received
  389-PB Profile of Mutations Identified in the 3WINTERS-IPS Project on Iranian Patients with Previously Diagnosed Type 3 von Willebrand Disease Luciano Baronciani Received Received
  390-PB Self-reported Experiences with Menorrhagia in Women with von Willebrand Disease: A Patient-oriented Survey Study Ariela Marshall Received Received
  392-PB Ristocetin Cofactor Latex Immunoassay, High Sensibility to Acquired von Willebrand Disease with Subtle Loss of High Molecular Weight Multimers Barbara Montaruli Received Received
  393-PB Von Willebrand Factor Antigen Levels in 255 Patients Previously Diagnosed as VWD Type 3 from the Iranian Republic and Nine European Countries (3WINTERS-IPS Study) Ulrich Budde Received Received
  395-PB Clinical Evaluation of the Sebia Hydragel von Willebrand Factor Assay in Comparison to Electrophoresis and blotting based Multimer Analysis Holger Seidel Received Received
  396-PB Can a One-time von Willebrand Testing Rule out Type 1 von Willebrand Disease in Young Women with Menorrhagia? Shiu-Ki Hui Received Received
  397-PB Screening of von Willebrands Disease in a Region of High Consanguinity YAMINA OUARHLENT Received Received
  398-PB Management of a Spontaneous Ileo-psoas Haematoma in a Girl with Type 3 von Willebrand Disease and Alloantibodies to von Willebrand Factor Chiara Ambaglio Received Received
  400-PB Residual Vein Thrombus Does Not Predict for Recurrent Vein Thrombosis in the ASPIRE Study Timothy Brighton Received Received
  401-PB Utility of Thromboelastometry Analysis in Patients with Mild Bleedings Disorders Anna Wieland Received Received
  402-PB Increased Maximum Lysis of ROTEM in Pregnancy: It Is Not Hyperfibrinolysis Jun Teruya Received Received
  403-PB Significant von Willebrand Disease Can Be Missed if a von Willebrand Factor Activity Assay Is Not Performed Sean Platton Received Received
  404-PB Validation of Flow Cytometric Mepacrine Uptake and CD63 Expression in the Diagnosis of Storage Pool Disease Ivar van Asten Received Received
  405-PB Post-analytical External Quality Assessment - Interpretation of UK NEQAS (Blood Coagulation) Results Ian Jennings Received Received
  406-PB Performance of different D-dimer assays using the age-adjusted threshold for the exclusion of pulmonary embolism Noémie Kraaijpoel Received Received
  407-PB Safety of Multidetector Computed Tomography Pulmonary Angiography to Exclude Pulmonary Embolism in Patients with a Likely Pretest Clinical Probability Helia Robert-Ebadi Received Received
  408-PB Familial Multiple Coagulation Factor Deficiencies - Need for Deeper Clinical and Scientific Assessment Barbara Preisler Received Received
  409-PB Performance of Anti-factor Xa Heparin Assays in External Quality Control Surveys Chantal BON Received Received
  410-PB Ex-vivo Plasma Clot Formation and Lysis as a Universal Measure for Anticoagulation in Patients on Vitamin-K-antagonist, Dabigatran, Rivaroxaban, Apixaban, or Low-molecular-Weight Heparin Oliver Knigsbrgge Received Received
  411-PB Thrombin Generation Response of rFVIIa in Haemophilia A Patient Plasma when Using Different Triggers and Phospholipids Lone Frost Larsen Received Received
  412-PB Performances of the Hydragel 5 von Willebrand Multimers - A New within-Day von Willebrand Factor (VWF) Multimer Screening Method ANNETTE BOWYER Received Received
  413-PB The Selective Use of Computer-assisted Strain Gauge Plethysmography as an Additional Screening Test for Suspected DVT Can Decrease the Need for Compression Ultrasonography: A Validation Study Andrew Hughes Received Received
  414-PB Semi-automated Platelet Aggregometry Employing the Sysmex CS-2x00; Preliminary Findings in a Multi-centre Study Aine McCormick Received Received
  415-PB The Impact of Repeated Freeze-thaw Cycles on Antiphospholipid Antibody Titer Karel Maelegheer Received Received
  416-PB Suitability of a Liquid High-sensitivity Recombinant Human Prothrombin Time Reagent with Two Year Shelf Life on an Automated Coagulation Laboratory Platform Kevin Cawthern Received Received
  417-PB Discrepancy in Optical and Impedance Platelet Count in Platelet Rich Plasma Prepared for Light Transmission Aggregation as a Possible Sample Quality Indicator Ana Mlinaric Received Received
  418-PB Thrombophilia: Women-specific Reference Ranges May Prevent Overdiagnosis C S B Veen Received Received
  420-PB Comparison of Thrombin Generation Profiles among Patients Treated with Three Different Direct Oral Anticoagulants and Warfarin Sophie Testa Received Received
  422-PB Innovative Method for the Description of Human Platelets Population Alena Litvinenko Received Received
  423-PB Thromboelastometry to Detect Anticoagulant Effect of Apixaban in Patients with Non Valvular Atrial Fibrillation Maria Giulia Mosconi Received Received
  424-PB Assessment of Single-factor Deficiency Sensitivty of Three Thromboplastin Reagents Vincent Juif Received Received
  425-PB Genetic Analysis for Investigation of Heritable Bleeding Disorders - Update on the UK NEQAS (Blood Coagulation) Programme Ian Jennings Received Received
  426-PB Platelet Reactivity in Patients on Aspirin and Clopidogrel Therapy Measured by a New Bed-side Whole Blood Assay Carolin Helten Received Received
  429-PB Performance Evaluation of the microINR Point-of-Care INR-testing System Jaco Joubert Received Received
  431-PB Divergence of Normal Ranges Using Thromboelastography as Measured by Clot Viscosity versus Clot Harmonic Resonance Geoffrey Wool Received Received
  432-PB Identification of Triple Positivity Patients with Major Risk for Thromboses Is Dependent of Methodology Applied at the Lab Investigation Silmara Montalvão Received Received
  433-PB Performance Evaluation of the ZL 6000i Cone Plate Viscometer Jayoung Lee Received Received
  435-PB Accurate Recovery of N9-GP in a One-stage Ellagic Acid Based Clot Assay on the ACL Top Analyzer Dr Anuja Khan Received Received
  436-PB A Performance Evaluation of a New Lupus Sensitive APTT Reagent Chris Gardiner Received Received
  438-PB Establishment of Oral Anticoagulant Monitoring Facility at Tertiary Care Teaching Hospital in Western India: Four Years Experience Anjali Kelkar Received Received
  439-PB Do Chinese Patients with Heart Valve Replacement Benefit from Warfarin Pharmacogenetic Test: A Pilot Retrospective Study Litao Zhang Received Received
  440-PB Analytical Performance of an Anti Xa Assay with Rivaroxaban Specific Calibrators CRISTINA DUBOSCQ Received Received
  441-PB Multicenter Study on the Interference of Spontaneous Hemolysis at Blood Sampling on Five Main Hemostasis Tests Chiara Novelli Received Received
  442-PB Performance Evaluation of the Coag-Sense Point-of-Care INR-testing System Jaco Joubert Received Received
  443-PB Thrombin Generation in Patients with Coronary Complications during the First Year after Percutaneous Intervention Tatiana Vavilova Received Received
  444-PB Prediction of Partial Thromboplastin Time (PTT) and Prothrombin Time (PT) on the Basis of Factor Assay Activities Using Data from a Clinical Data Warehouse Amrom Obstfeld Received Received
  445-PB Use of a Synthetic Collagen to Monitor Platelet Function in Patients Receiving Dual Antiplatelet Therapy Walter Jeske Received Received
  448-PB Comparison of Activated Clotting Time Measured by I-STAT, Sonoclot and ACTPlus and Correlation with Anti-Xa during Cardiopulmonary Bypass Procedures Stien Vandendriessche Received Received
  449-PB Presence of Residual Venous Thrombus at Warfarin Withdrawal: A Predictor for Recurrence After a First Episode of Symptomatic Provoked Proximal Deep Venous Thrombosis in an Asian Population? Nuttawut Sermsathanasawadi Received Received
  450-PB Hemolyzed Samples: Should Be Accepted in Hemostasis Laboratories? Dario Jacobsen Received Received
  451-PB Coag S: A Professional INR Monitoring Device. Comparison with the Laboratory INR Testing Zoltan Vajda dr. Received Received
  452-PB Evaluation of the New Tcoag Pre-calibrated TriniLIATM D-Dimer II Assay Jane Needham Received Received
  457-PB Rivaroxaban for Initial Therapy in Patients with Pulmonary Embolism. A Real-life Study Pierpaolo Di Micco Received Received
  459-PB Prothrombin Complex Concentrate for Reversal of XA Inhibitors - Real Life Data Galia Spectre Received Received
  461-PB Rivaroxaban for Scheduled Work-up of Patients with Suspected Deep Venous Thrombosis: A Prospective Interventional Outcome Study - The Ri-Schedule study Synne Fronas Received Received
  464-PB Direct Anticoagulants and Vitamin K-antagonists Exert Differential Effects on Markers of Subclinical Cardiovascular Disease: Results from the MyoVasc Study Lisa Eggebrecht Received Received
  465-PB Lifelong Apixaban Treatment Is Cost-effective for Idiopathic Venous Thromboembolism Lisa de Jong Received Received
  471-PB Plasma Fibrin Clot Properties in the G20210A Prothrombin Mutation Carriers Following Venous Thromboembolism: The Effect of Rivaroxaban Jakub Siudut Received Received
  472-PB A Cross-Sectional, Multinational, Multidisciplinary Survey of Physicians Surrounding the Management of Bleeding Complications in the Setting of Direct Oral Anticoagulant Use Joseph Shaw Received Received
  473-PB Apixaban in Mechanical Circulatory Support - Evaluation in a Mock Circulatory Loop with Human Blood David Connor Received Received
  474-PB Management of Major Bleeding and Outcomes in Patients Treated with DOACs: Results from the START SSC Event Register Emilia Antonucci Received Received
  475-PB High Recanalization Rate in Patients with Proximal-vein Thrombosis Treated with the New Direct Oral Anticoagulants Lucia Sarolo Received Received
  477-PB Concentration Correlation of Direct Oral Anticoagulants as Measured by the TEG 6s Oral Anticoagulant Assay Marc Doubleday Received Received
  478-PB Self-poisoning with Direct Oral Anticoagulants: A Series of Five Cases Admitted to the Intensive Care Unit Alain Stepanian Received Received
  479-PB New Insights in Interindividual Variability of Pharmacodynamic (PD) Response to Rivaroxaban through Thrombin Generation in the Presence of an Active Protein C Pathway: DRIVING Study Results in Healthy Volunteers Virginie SIGURET Received Received
  481-PB No Additional Diagnostic Value of Chest X-ray Prior to the YEARS Algorithm in the Diagnostic Management of Suspected Pulmonary Embolism Liselotte M. van der Pol Received Received
  482-PB Rivaroxaban Levels in Patients Plasmas Are Comparable by Measuring through Two Different Calibrators in Two Different Systems Marta Martinuzzo Received Received
  485-PB Measurement of Apixaban and Rivaroxaban Levels in Real Life Clinical Practice: An Instrument to Improve Anticoagulation Management? CHARALAMPOS KARTSIOS Received Received
  486-PB Comparison of Bleeding and Thromboembolic Event Rates in Atrial Fibrillation Patients with Good and Poor Warfarin Control before and after Switching to Direct Oral Anticoagulants Scott Kaatz Received Received
  487-PB Measurement of Direct Oral Anticoagulant Drug Levels Following Bariatric Surgery Eric Tseng Received Received
  488-PB Use of a 4-factor Prothrombin Complex Concentrate for Management of Direct Xa Inhibitor-induced Major Bleeding Paul Dobesh Received Received
  489-PB Is Rivaroxaban Associated with Headache and Dizziness? A Retrospective Study Siavash Piran Received Received
  492-PB Length of Hospital Stays Following Acute Pulmonary Embolism in England: Observational Cohort Study Using the CPRD-HES Databases Raza Alikhan Received Received
  495-PB Adherence to Rivaroxaban for the Management of Acute Venous Thromboembolism (VTE) - Early Results from the Follow-up in Rivaroxaban Patients in Setting of Thromboembolism (FIRST) Registry Victoria Speed Received Received
  496-PB Level of Fatigue after Initiation of Rivaroxaban for Treatment of Venous Thromboembolism Kristin Kornelia Utne Received Received
  497-PB The Combination of Rivaroxaban and Dabigatran Is Superior to Either Agent Alone in Suppressing Mechanical Heart Valve-induced Thrombin Generation Iqbal Jaffer Received Received
  500-PB Influence of Anthropometric, Hematological and Biochemical Parameters on Plasma Levels of Direct Oral Anticoagulants Monica Sacco Received Received
  501-PB Non Vitamin-k Oral Anticoagulants (NOAC) Dose Reduction and Adverse Outcomes - A Single Center Experience Aaron Lubetsky Received Received
  502-PB Reversal of Rivaroxaban Using Prothromplex Total, a 4-Factor Prothrombin Complex Hartirathpal Kaur Received Received
  503-PB Similar Rivaroxaban Plasma Concentrations Induce Different Anticoagulant Effects in Individual Obese Patients Debora Bertaggia Calderara Received Received
  504-PB Reversal of Dabigatran in Emergency Situations M ANGELES FERNANDEZ Received Received
  505-PB Can we Successfully Reverse a Massive Overdose of Dabigatran? Isabel Freire Received Received
  506-PB Routine Coagulation Tests for Assess Anticoagulant Activity of Direct Oral Anticoagulants Helena Cruz Gomes Received Received
  507-PB Direct Oral Anticoagulants in the Treatment of Deep Vein Thrombosis: The Experience of a Hemostasis Unit Emmanouil Papadakis Received Received
  508-PB Reversal of Dabigatran with Idarucizumab in Five Patients Admitted to the Emergency Department of Centro Hospitalar São João, Porto Luciana Gonalves Received Received
  510-PB Measurement of Direct Factor Inhibitors Concentration in Practice Laboratory Tatiana Vavilova Received Received
  514-PB Long-term Outcome in Children on Anticoagulant Therapy after Extracardiac Conduit Fontan Operation (FO) Mara Agazzoni Received Received
  516-PB e-Health Usefulness in Oral Anticoagulation Therapy in Children: Point of Care Instruments and Mobile APPs Rubén Berrueco Received Received
  518-PB Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical Trials Hugo Maas Received Received
  519-PB Factor Levels in Heparinized Critically Ill Pediatric Patients Jonathan Byrnes Received Received
  522-PB Role of anticoagulation in management of neonatal portal vein thrombosis Suzan Williams Received Received
  523-PB The Incidence, Assessment and Management of Mental Health Issues in Young People on Anticoagulation Therapy Secondary to Idiopathic Venous Thromboembolism Fiona Newall Received Received
  524-PB Investigating the Experience of Parents who Have Given their Children Enoxaparin at Home Fiona Newall Received Received
  526-PB Secondary Antithrombotic Prophylaxis in Children with Right Atrium Thrombosis Pavel Zharkov Received Received
  527-PB Thrombotic Storm in an 11 Year Old Boy Surjit Singh Received Received
  528-PB Variation in Practice in Relation to Antithrombotic Therapy and Monitoring After Paediatric Cardiac Surgery: Results of a United Kingdom Survey Tina Biss Received Received
  530-PB Management of Henoch-Shnlein Purpura in Children with Heparin. Russian Long-term Experience Nadezda Vaynyunskaya Received Received
  531-PB Inherited Antithrombin Deficiency in Children: Treatment of Massive Cerebral Sinus Venous Thrombosis in a Neonate with a Mutation in Gene SERPINC1 (Exon 3 C481ct) Antonio Moscardó Received Received
  532-PB Venous Thromboembolism Prevention in Children Attilia Maria Pizzini Received Received
  533-PB Development of a Thrombus in Giant Coronary Aneurysm of a Child with Kawasaki Disease - An Unusual Clinical Manifestation Surjit Singh Received Received
  534-PB Management of Anticoagulation Therapy in Patients with Thromboembolism in The Context of Renal Diseases: Case Series and Practical Suggestions Mihir Bhatt Received Received
  536-PB Petechial Rash and Thrombocytopenia with Unfractionated Heparin (UFH) Use: Heparin Induced Thrombocytopenia (HIT) in a Child with Non-vegetative Infective Endocarditis Joanna Chan Received Received
  538-PB Selected Expression and Functional Importance of alpha4a-Tubulin in Platelet Biogenesis catherine strassel Received Received
  540-PB PDK1 is Crucial to Proplatelets Formation and Thrombopoiesis Britta Walker-Allgaier Received Received
  541-PB Inhibition of MAP Kinase-interacting Kinase-1 (Mnk1) Regulates Platelet Functional Responses and Protein Synthesis in Megakaryocytes Manne Bhanu Kanth Received Received
  542-PB On-track to Producing Commercially-Feasible cGMP-Compliant Human Platelets from induced Pluripotent Stem Cells at Clinical Scale Whitney Berry Received Received
  546-PB Calcium/calmodulin-dependent Protein Kinase II (CamKII) Regulates Platelet Formation ROBERT CAMPBELL Received Received
  548-PB Platelet Factor 4 (PF4) Levels Correlate with Platelet Count and Ability to Inhibit Megakaryopoiesis in Pediatric Patients with ITP Michele Lambert Received Received
  549-PB Role of NOD-like receptors (NLRs) in Megakaryo/thrombopoiesis Lina Paola DAtri Received Received
  550-PB In vitro Generation of Functional Megakaryocytes Derived from Induced Pluripotent Stem Cells of Parahaemophilia Patients Claudia Radu Received Received
  553-PB The Application of High throughput Sequencing to the Diagnosis of Thrombocytopenia Ruth Wheeler Received Received
  556-PB Uncovering GEnetic NEtworks Underlying Platelet Response to Thienopyridines by EXome Sequencing of Extreme Phenotype Patients: Discovery and Validation Results Jean-Luc Reny Received Received
  557-PB Poorly Controlled Diabetes Mellitus Is Associated with Decreased Aspirin-mediated Acetylation of Platelet Cyclooxygenase-1 (COX-1) at Serine 529 Francesco Finamore Received Received
  562-PB Platelets in Severe Aortic Stenosis Have an Altered Protein Profile and Are More Vulnerable upon Activation Compared to Coronary Artery Disease Christina Christersson Received Received
  564-PB TREM-like transcript-1: a more sensitive marker of platelet activation than P-in Christopher W. Smith Received Received
  566-PB Mechanisms of Platelet Adhesive-receptor Shedding in Platelet Populations in Thrombus Formation Constance Baaten Received Received
  568-PB Gradient-dependent Modulation of Platelet Stimulatory G-protein Coupled Receptors (GPCR) Signaling Ankit Macwan Received Received
  569-PB Activation of aIIb3 Integrin Involves the Cys608-Cys655 Disulfide Bond and the Electrostatic Network of the -tail Domain Ronit Mor-Cohen Received Received
  570-PB Clathrin Mediated aIIb3 Endocytosis Plays an Important Role in Platelet Activation Xuemei Fan Received Received
  571-PB An Inhibitory Mutant of Snake Venom Rhodocytin Blocks CLEC-2/Podoplanin Interaction-dependent Platelet Aggregation and Experimental Lung Metastasis Shimon Otake Received Received
  572-PB Human and Murine Neonatal Platelets Display Reduced CLEC-2 and GPVI Expression and Function Profiles Compared with Adult Platelets Verónica Palma-Barqueros Received Received
  573-PB DCBLD2 but Not GARP Has A Minor Role in Thrombus Formation in Mice which is Not in Line with the Findings in Zebrafish Elien Vermeersch Received Received
  575-PB Engineering scFvs (Single Chain Variable Fragments) to Platelet Glycoprotein VI Samir Hamaia Received Received
  577-PB Decompensated Heart Failure Patients Demonstrate Shedding of Platelet Receptors Glycoprotein (GP) Iba and GPVI in Contrast to Stable Heart Failure Patients Joshua Casan Received Received
  579-PB C-Type Lectin-like Receptor 2 Promotes Hematogenous Tumor Metastasis and Prothrombotic State in Tumor-bearing Mice Toshiaki Shirai Received Received
  582-PB The Effect of Short Chained Polyphosphates on Complement Activation in Plasma and Human Whole Blood Ina Hiland Received Received
  583-PB Extracellular Histones Can Inhibit Complement Activation through C4 Binding YASIR QADDOORI Received Received
  585-PB C5B9 Deposits on Endothelial Cells for the Evaluation of Complement Function in Thrombotic Microangiopathies of Different Origin and Therapy Monitorization Marta Palomo Received Received
  587-PB The Effect of Platelets and Extracellular Vesicles on Complement Activation in Human Plasma Robin Amanda Liang Received Received
  589-PB Hemocompatibility Analysis of Silk Nanoparticles Leads to Different Results under Static and Flow Conditions Manfred Maitz Received Received
  591-PB Role of Protease-activated Receptor-1 in Poly I:C Induction of Tissue Factor Expression in Endothelial Cells and in the Activation of Coagulation in Mice Saravanan Subramaniam Received Received
  592-PB Role of Helicobacter Pylori Eradication Therapy in Platelet Recovery in Chronic Immune Thrombocytopenic Purpura Arshi Naz Received Received
  593-PB Intravascular Parasitic Worms and Hemostasis Patrick Skelly Received Received
  594-PB Comparative Functional Studies of Thrombin and Staphylocoagulase in Terms of Clotting Kinetics and Properties of the Resultant Fibrin Craig Thelwell Received Received
  595-PB Liver Fibrosis and Thrombophilia: Is There a Real Connection? Preliminary Results among HIV/HCV Co-infection Silvia Perés Received Received
  597-PB Comparison of Fibrin Generation Markers in Septic Shock Jean-Christophe GRIS Received Received
  598-PB Thoracic Manifestations in Behcets Disease Leila Belhadj Received Received
  600-PB A Systems Biology Approach to Elucidate the Post-translational Regulome of Coronary Artery Disease Ankit Sharma Received Received
  602-PB Electronic Alerts, Comparative Practitioner Metrics, and Education Effect on Thromboprophylaxis and Thrombosis in Community Hospitals Scott Woller Received Received
  603-PB Efficiency of Bayesian Logic in Reagent Batch Change Management: Application to aPTT Frederic Sobas Received Received
  604-PB aPTT as an Independent Risk Factor for 30-day Survival for Patients on Extracorporeal Membrane Oxygenation (ECMO): 8-year Experience at Albert Einstein College of Medicine, Montefiore Medical Center Ivo Francischetti Received Received
  605-PB Sensitivity of Spatial Thrombin Generation and Fibrin Clot Growth to Clotting Factors Deficiency Anna Balandina Received Received
  606-PB In-cardiome: A Knowledgebase Integrating Molecular and Clinical Worlds for Translational Research and Drug Development in Coronary Artery Disease Ankit Sharma Received Received
  607-PB Addressing Reproducibility Concerns for Mechanistic Models of Clot Formation MOHAN ANAND Received Received
  608-PB Epigenetic Regulation of PAR-4-mediated Platelet Activation Underlies Smoking-related Cardiovascular Disease Christopher Williams Received Received
  609-PB Polymorphic Variation in Glutathione-S-transferase Genes among Chronic Myeloid Leukemia Patients in Pakistan Aneeta Shahni Received Received
  611-PB Nanoscale Measurement of Force Generation during Platelet-driven Clot Formation in Platelet Rich Plasma Timea Feller Received Received
  612-PB Analysis of Platelet Activation by Stable Isotope-resolved Metabolomics (SIRM) Qingjun Wang Received Received
  613-PB Metabolites Associated with Massive versus Submassive Pulmonary Embolism - A Pilot Study Christopher Kabrhel Received Received
  614-PB Efficacy of Dabigatran Etexilate in a Cancer Associated Thrombosis Murine Model Catherine Lemarie Received Received
  615-PB Incidence of Venous Thromboembolism in Cancer Survivors: The Scandinavian Thrombosis and Cancer (STAC) Cohort Inger Lise Gade Received Received
  618-PB Impact of Tumor Grade on the Risk of Venous Thromboembolism in Cancer; the Scandinavian Thrombosis and Cancer (STAC) Cohort Inger Lise Gade Received Received
  619-PB Thromboembolic Events in Cancer Patients on Active Treatment with Cisplatin-based Chemotherapy; Another Look Hikmat Abdel-Razeq Received Received
  620-PB Low Discriminating Power of the Modified Ottawa VTE Risk Score in a Cohort of Patients with Cancer from The RIETE Registry Adriano Alatri Received Received
  622-PB Outcomes of Extended Anticoagulant Treatment of Venous Thromboembolism in Patients with Cancer Monika Stalc Received Received
  623-PB Joint Effects of Body Height and Cancer on the Risk of Incident Venous Thromboembolism: The Troms Study Hanne Skille Received Received
  624-PB Patients with Cancer-associated Thrombosis Benefit from Anticoagulant Treatment Beyond 6 Months Ineke Wilts Received Received
  625-PB Impact of Time Since Diagnosis and Mortality Rate on Cancer-associated Venous Thromboembolism in a General Population - The Scandinavian Thrombosis and Cancer (STAC) Cohort Sigrid Braekkan Received Received
  626-PB Quality of Life Related to Health in Cancer Associated Thrombosis. Pilot of Qca Study Luis Jara-Palomares Received Received
  627-PB Differential Impact of Triggers on the Risk of Venous Thromboembolism in Subjects with and without Cancer - Results from a Population-based Case-crossover Study Olga Vikhammer Gran Received Received
  628-PB Venous Thromboembolism in Patients with Lymphoma Sithakom Phusanti Received Received
  629-PB Cancer Associated Thrombosis in Cancer Patients Receiving Chemotherapy or Hormonal Therapy in an Ambulatory Setting Sue Rhodes Received Received
  630-PB Long-term Impact on Mortality of Isolated Superficial Vein Thrombosis in Patients with Active Cancer Jean-Philippe Galanaud Received Received
  631-PB Prediction of Venous Thromboembolism in Newly Diagnosed Patients Treated for Lymphoid Malignancies - Validation of the Khorana Risk Score among Patients with Diffuse Large B-cell Lymphoma and Hodgkin Lymphoma Joanna Rupa-Matysek Received Received
  634-PB Joint Effect between Smoking Status and Cancer on the Risk of Venous Thromboembolism: The Scandinavian Thrombosis and Cancer Cohort Benedikte Paulsen Received Received
  635-PB The Impact of Traditional Triggers on the Risk of Venous Thromboembolism in Cancer - Results from a Population-based Case-crossover Study Olga Vikhammer Gran Received Received
  636-PB Impact of a Novel Version 2.0 of an Electronic Alert System for Venous Thromboembolism (VTE) Prevention in Hospitalised Cancer Patients Rocío Figueroa Received Received
  637-PB Platelet-related Thrombin Generation in Adult Survivors of Childhood Cancer Marina Panova-Noeva Received Received
  639-PB Clinical History of Thrombosis before Diagnosis of Overt Myeloproliferative Neoplasms in Triple Negative Patients mariasanta napolitano Received Received
  641-PB Variability of Khorana Score and its Validity after First Chemotherapy in Patients with Gastric Cancer Harry Fuentes Received Received
  642-PB Venous Thromboembolism in Patients Undergoing Allogeneic Stem Cell Transplantation with Umbilical Cord Blood Genevieve Moyer Received Received
  643-PB The Impact of FGG rs2066865 and Pre-cancer Plasma Fibrinogen Concentration on Cancer-related Venous Thromboembolism Benedikte Paulsen Received Received
  644-PB Performance of Current Risk Assessment Models for Prediction of Venous Thromboembolism in Patients with Gastric Cancer Harry Fuentes Received Received
  645-PB Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry Corinne Frere Received Received
  646-PB Mean Platelet Volume (MPV) and MPV/Platelet (plt) Identify Essential Thrombocythemia (ET) Patients at High Thrombotic Risk Cristina Verzeroli Received Received
  647-PB Interleukin Profile in Polycythemia Vera and its Correlation with the Risk of Thrombosis DEO PRATEEK Received Received
  648-PB Joint Modeling of Longitudinal Haemostatic and Inflammatory Biomarker Trajectories and Mortality in Patients with Cancer Florian Posch Received Received
  649-PB ClotAssist Program to treat Cancer-associated Thrombosis in an Outpatient Pharmacy Setting Easaw Jacob Received Received
  650-PB Biomarkers for Venous Thromboembolism (VTE) in Newly Diagnosed Multiple Myeloma (NDMM): Early Results from the Thromboprophylaxis in Multiple Myeloma (TiMM) Trial at Kings College Hospital Zara Sayar Received Received
  651-PB The CATs out of the Bag: Alternatives to Low Molecular Weight Heparin (LMWH) in Patients with Cancer Associated Thrombosis (CAT) Maeve Crowley Received Received
  654-PB Predictors of Prolonged Hospitalization Deep Vein Thrombosis Patients Andree Kurniawan Received Received
  655-PB Incidence of Central Venous Catheter-related Venous Thrombosis in Japanese Inpatients with Hematological Malignancies: Single Center Experience KOJI MIYAZAKI Received Received
  656-PB Inaugural Thrombotic Events in Myeloproliferative Neoplasms Héla Baccouche Received Received
  657-PB Biological Pro-coagulant and Pro-inflammatory Effect of Interferon Alpha in Myeloproliferative Neoplasms Nadine Ajzenberg Received Received
  659-PB Audit: Use of Khorana Score in Oncology Patients in Belfast Trust Carrie Carson Received Received
  661-PB Venous Thrombosis and Thromboembolic Risk Factors in Outpatients with Lymphoma on Chemotherapy María Eva Mingot-Castellano Received Received
  664-PB Effects of Low- and High-dose Doxorubicin and Paclitaxel on Tumorigenic, Thrombogenic and Angiogenic Properties of Extracellular Vesicles Derived from Breast Cancer Cell Lines Anat Aharon Received Received
  665-PB Functional Tissue Factor Activity on Endothelial Cells Conveyed by Blood-cell Microparticles Anna Brandtner Received Received
  668-PB P2Y1 and P2Y12 Receptors Mediate the Release and Composition of Platelet Extracellular Vesicles Aleksandra Gasecka Received Received
  669-PB Characterization of Plasma Microvesicles in Patients with Diabetic Nephropathy Melissa Uil Received Received
  672-PB Increase in Microparticles TF/TFPI Procoagulant Ratio in Carriers of Inherited Bleeding Disorders Elena Campello Received Received
  673-PB Factor Xa Inhibitors Apixaban and Rivaroxaban Suppress the Release of TF-bearing Microvesicles from Cancer Cell Lines Sophie Featherby Received Received
  674-PB Endothelial Nitric Oxide Synthase Gene Polymorphisms Influence on Endothelial Microparticles Levels in Renal Transplantation SUELLEN RODRIGUES MARTINS Received Received
  676-PB The Impact of Eculizumab on the Thrombogenicity Induced by Extracellular Vesicles in Paroxysmal Nocturnal Hemoglobinuria Patients Adeline Wannez Received Received
  678-PB Procoagulant Extracellular Vesicles in Amniotic Fluid Johannes Thaler Received Received
  680-PB Enumeration of Circulating Microparticles in Healthy Medical Workers Occupationally Exposed to Low Doses of Ionizing Radiation Ghassan Al Massarani Received Received
  681-PB A High Throughput Flow Cytometry Assay for the Detection of Platelet Microparticles Caroline Reddel Received Received
  682-PB Visualization of Tissue Factor-positive Microvesicles from Pancreatic Cancer Patients Using Laser Scanning Confocal Microscopy Yohei Hisada Received Received
  684-PB Circulating Microparticles in Women with Polycystic Ovary Syndrome: Preliminary Results Elena Campello Received Received
  686-PB Endothelial and Platelet Microparticles in Kidney Transplanted Recipients: Influence of Time Post Transplantation and Donor Type SUELLEN RODRIGUES MARTINS Received Received
  687-PB The Relation between Circulating Endothelial Microparticles and Asymetric Dimethylarginine in Vitamin B12 Deficient Yasemin Altuner Torun Received Received
  688-PB Circulating Microparticles as Predictive Biomarkers for Tumor Progression in Advanced Non-small Cell Lung Cancer Fadi Najjar Received Received
  689-PB Microparticles with Platelet Pro-aggregation Potential Are Present in Patients with Acute Coronary Syndrome and No Perfusion (TIMI-0) Aurora de la Peña Díaz Received Received
  690-PB Obesity and ADAMTS13 Deficiency as Risk Factors for TTP Elien Roose Received Received
  691-PB Acute Thrombotic Thrombocytopenic Purpura (TTP) - Diagnostic and Prognostic Implications of Highly Sensitive Troponin Assays, ECG and ECHO Indrani Karpha Received Received
  692-PB Plasmin Cleavage of ADAMTS-13 Enhances its Activity Coen Maas Received Received
  694-PB Unraveling Immunoprofiles of Acquired TTP Patients Using Anti-idiotypic Antibodies An-Sofie Schelpe Received Received
  695-PB The in vitro and in vivo Effects of Streptokinase in a Papio ursinus Baboon Model of Acquired Thrombotic Thrombocytopenic Purpura (TTP) - A Pilot Study Jaco Joubert Received Received
  696-PB mRNA Identification of a Novel Isoform (ISF) and ISF3 from ADAMTS13 in Different Types of Cells Juvenal Paiva Received Received
  699-PB The Incidence of Thrombotic Thrombocytopenic Purpura in Israel, as Determined by ADAMTS-13 Activity and Anti-ADAMTS-13 Antibody Levels Galit Sarig Received Received
  700-PB A Rapid and Simple Assay for the Determination of ADAMTS-13 Activity Nikolaus Binder Received Received
  702-PB Epidemiology of Thrombotic Microangiopathy in Malaysia Yee Yee Yap Received Received
  703-PB Highly Sensitive Fully Automated Chemiluminescent Immunoassay for Rapid Quantification of ADAMTS13 Activity Maribel Mirabet Received Received
  704-PB Clinical Characteristics and Outcome of Patients with Thrombotic Thrombocytopenic Purpura at Siriraj Hospital Yingyong Chinthammitr Received Received
  707-PB Complements are Activated to a Similar Level in both Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Doyeun Oh Received Received
  708-PB Preliminary Report on the Genetic Background and Clinical Course of Upshaw-Schulman Syndrome in Polish Patients Jerzy Windyga Received Received
  709-PB A Murine Anti-ADAMTS13 Monoclonal Antibody against the Disintegrin-like Domain Inhibit the Enzyme Activity Zhenni Ma Received Received
  710-PB Relationship between ADAMTS13 antigen and free IgG anti-ADAMTS13 antibody, functional ADAMTS13 inhibitor and circulating immune complexes (CIC) using two ELISA techniques, in patients with acquired thrombotic thrombocytopenic purpura. Juvenal Paiva Received Received
  711-PB Predisposed Hemophagocytosis in a Patient with Thrombotic Thrombocytopenic Purpura Takeshi Shimomura Received Received
  712-PB Technozym ADAMTS-13 Activity Assay for Determination of Inhibitory Antibodies against ADAMTS-13 Nikolaus Binder Received Received
  713-PB Evolution of ADAMTS13 Activity in Patients with Relapsing Acquired Thrombotic Thrombocytopenic Purpura FAUSTINO GARCÍA-CANDEL Received Received
  714-PB Evaluation of Sample Interferences on ADAMTS-13 Activity Measurement Nikolaus Binder Received Received
  715-PB Early Detection of Refractoriness and Silent Relapse in Acquired Thrombotic Thrombocytopenic Purpura Pablo Manresa Manresa Received Received
  716-PB Upshaw-Schulman Syndrome: The Importance of the Modulating Effect of the Different Genetic Variations Pablo Manresa Manresa Received Received
  719-PB Thrombotic Thrombocytopenic Purpura as an Initial Presentation of Systemic Lupus Erythematosus in a Thai Child: A Case Report Rungrote Natesirinilkul Received Received
  720-PB A Case of SLE developed different types of thrombotic microangiopathy during the course EMIKO TATSUMI Received Received
  721-PB Congenital Thrombotic Thrombocytopenic Purpura without Nephropathy and Neuropathy Canan Albayrak Received Received
  722-PB Thrombotic Microangiopathies (TMA): First Report of 250 Cases from a Single Institution Experience in Latin America Célia Dos Santos Received Received
  723-PB Successful International Standardisation of the ADAMTS13 Assays - Results from the APMAT (Asia Pacific Microangiopathic Thrombocytopenia) Network Jim Tiao Received Received
  724-PB Treatment of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome in Pediatric Patients - A Single Center Experience Olivera Serbic Received Received
  725-PB Successful Treatment of Renal Infiltration Complicated by Atypical Hemolytic Uremic Syndrome in a Child with Acute Leukemia ZHRE KAYA Received Received
  726-PB Transplant/Imunosupressor Related Thrombotic Microangiopathy Filipa Mousinho Received Received
  727-PB A Heterozygous Mutation of G-protein-Coupled Receptor 25 in a Family with inherited Thrombocytopenia and Thrombosis Jun Yamanouchi Received Received
  729-PB Novel RUNX1 Mutations in Families with Inherited Thrombocytopenia Patrizia Noris Received Received
  730-PB A Novel Mutation in TBXA2R Impairs the Expression of the TP Isoform of the Platelet Thromboxane Receptor and Associates with Bleeding Diathesis Loredana Bury Received Received
  732-PB ACTN1 Macrothrombocytopenia: Deleterious Effects of Rod-domain ACTN1 Variants Anne Vincenot Received Received
  734-PB Identification of Two New P2RY12 Heterozygous Mutations Responsible for Hemorrhagic Diathesis in Two Unrelated Families Arnaud Dupuis Received Received
  735-PB Glanzmanns Thrombasthenia in China: New Insights into its Pathogenesis lu zhou Received Received
  736-PB A New Form of Inherited Thrombocytopenia (IT) Due to Monoallelic Loss-of-function Mutation in the Thrombopoietin (THPO) Gene Patrizia Noris Received Received
  737-PB MYH9 Variants Defined by Next-generation Sequencing: Predicting Variants Likely Causing MYH9-related Disorder Loredana Bury Received Received
  739-PB Pseudo-Glanzmann Thrombasthenia due to Mutation in RasGRP2 Gene Encoding for CalDAG-GEFI Nurit Rosenberg Received Received
  741-PB Detection and Analysis of Gene Mutations in Patients with Glanzmann Thrombasthenia by Next Generation Sequencing Donglei Zhang Received Received
  743-PB Refined Detection and Characterization of Delta Storage Pool Disorders: A Cohort Study on Pediatric Patients Georgi Manukjan Received Received
  744-PB Multiplex PCR and Cycle Sequencing for Detection of Mutations in ACTN1, TUBB1 and ANKRD 26 Letian Dai Received Received
  745-PB Delta Storage Pool Deficiency in a Patient with a R216Q Mutation of GATA1 Maaike Blaauwgeers Received Received
  746-PB Genetic Heterogeneity in Familiar Macrothrombocytopenia with Decreased Expression of GpIIbIIIa catarina lau Received Received
  747-PB Pseudodominance in a Family with Bernard-Soulier Syndrome due to a Homozygous Variant in the Platelet Glycoprotein IX (GP9) Gene Catarina Lau Received Received
  748-PB Highly Significant Bleeding Diathesis in Patients with Platelet Dysfunction due to a Novel Mutation in RASGRP2, Encoding CalDAG-GEFI (p.Gly305Asp) Emilse Bermejo Received Received
  749-PB Positive Impact of Social Media as a Support Group for Females with Glanzmann Thrombasthenia in Saudi Arabia - A Mothers Initiative Mahasen Alsaleh Received Received
  750-PB Five New Cases of Hermansky-Pudlak Syndrome: Identification of Novel Genetic Variants in HPS4 and HPS3 Associated to Relevant Clinical Complications Jose M Bastida Received Received
  751-PB Quality of Life Is Reduced in Patients with (Suspected) Congenital Platelet Function Disorders Maaike Blaauwgeers Received Received
  752-PB Screening for platelet function disorders with Multiplate and Platelet Function Analyzer Floor Moenen Received Received
  753-PB Evaluation of the Platelet Function in Different Inherited Thrombocytopenias. Correlation of Platelet Response Measured by Flow Cytometry with Bleeding Scores and Clinical Phenotypes Maria Adele Alberelli Received Received
  754-PB Management of a Patient with Glanzmann Thrombasthenia during a Coronary Artery Bypass Graft Surgery: A Case Study Mohamad Kurdi Received Received
  756-PB Quantitative Evaluation of Bleeding due to Platelet Disorders Associated with Dense Granule Deficiency and/or Impaired Aggregation Responses Janaki Iyer Received Received
  757-PB MYH9 Disorders Are the Most Common Cause of Macrothrombocytopenia in Australia: Importance of Mean Platelet Diameter Measurement and Dhle Body Detection for Improved Diagnosis Marie-Christine Morel-Kopp Received Received
  758-PB Hemorrhagic Diathesis in Four Patients with the Heterozygous Pro258Thr Mutation of the P2RY12 Gene Maaike Blaauwgeers Received Received
  759-PB Nine-year Effective Management of an LAD III Patient with Conventional Pro-hemostatic and Immunological Treatment Paul Saultier Received Received
  762-PB A Study of Comparison of Platelet Aggregation Response Obtained on Sysmex CS-2000i with Chrono-log Light Transmission Aggregometer Ancy Abraham Received Received
  763-PB Minor Dental Surgery in Patients with Glanzmann Thrombasthenia Patients Anna Sikorska Received Received
  764-PB Flow Cytometric Mepacrine Uptake Related to Platelet Size in Patients with Moderate Macrothrombocytopenia Sory Jazmin Rodriguez Moreno Received Received
  765-PB Circumcision in Children with Inherited Bleeding Disorders - A Tertiary Care Centre Experience in Saudi Arabia Mahasen Alsaleh Received Received
  769-PB Successful Management of Severe Bleeding with Combined Platelet Transfusion, rFVIIa and Tranexamic Acid Therapy in Glanzmann Thrombasthenia Patient Bernadeta Ceglarek Received Received
  770-PB Immature Platelets Fraction and its Application in the Differential Diagnosis of Congenital and Acquired Trombocytopenia João Neves Received Received
  771-PB A Case of Acquired, Transient Bleeding Diathesis Associated with Platelet Dysfunction gian marco podda Received Received
  772-PB Regular Physical Activity and Risk of Incident Venous Thromboembolism in the General Population Line Holtet Evensen Received Received
  773-PB Impact of Regular Physical Activity on the Risk of Recurrent Venous Thromboembolism and All-cause Mortality Line Holtet Evensen Received Received
  775-PB Associations between Serum Levels of Calcium, Parathyroid Hormone and Future Risk of Venous Thromboembolism - The Troms Study Sigrid Braekkan Received Received
  776-PB Repeated Measures of Fish Consumption, n-3 PUFA Intake and Future Risk of Incident VTE Trond Isaksen Received Received
  777-PB Residual Vein Thrombosis in Subjects with Proximal DVT: An Association with Subclinical Atherosclerosis. The VERITAS Study Marta Milan Received Received
  778-PB Elevated Circulating CD40-L in Atrial Fibrillation and its Modulation by Ablation Amanda Walborn Received Received
  779-PB Elevated Cellular Fibronectin is a Modifier of Clot Properties in Type 2 Diabetes: Association with Cardiovascular Disease Agata Bryk Received Received
  781-PB The CHA2DS2-VASc Score Predicts Bleeding Risk in a Cohort with Implantable Cardiac Monitoring Devices without Atrial Fibrillation Fadi Shamoun Received Received
  784-PB Effects of HAART on Fibrinogen, D-dimer and Protein C Levels in Patients with HIV at the University of Benin Teaching Hospital Benin City, Nigeria Omolade Awodu Received Received
  787-PB The Novel 2MACE Score Predicts Cardiovascular Events in Atrial Fibrillation Patients José Miguel Rivera-Caravaca Received Received
  788-PB Altered Platelet Lipidome Influences Thrombotic Disposition: Implications in Acute Coronary Syndrome and Modulation by the CXCL12-CXCR4-CXCR7 Axis Madhumita Chatterjee Received Received
  791-PB Up-Regulation of HO-1 by CORM-2 Attenuates Thrombin-Induced COX-2 Expression and Hypertrophy in Human Cardiomyocytes Chuen-Mao Yang Received Received
  792-PB Antithrombin levels are associated with the risk of first and recurrent arterial thromboembolism at a young age. Frederik Nanne Croles Received Received
  795-PB The Value of sPESI for Risk Stratification in Patients with Pulmonary Embolism Elizabeth Benson-Cox Received Received
  796-PB D-Dimer but Not Platelet Function Testing Improves Risk Stratification in Patients Treated with Elective PCI Elena Novikova Received Received
  797-PB Increased Extracellular Nucleosome Levels, Biomarkers of Cell Death, in Atrial Fibrillation Patients Compared to the Normal Population Debra Hoppensteadt Received Received
  799-PB The Incidence and Prognosis of Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE) Associated with Oral Contraceptives by Age Groups in Japan Takao Kobayashi Received Received
  804-PB Extracellular Nucleosomes, Markers of Cell Death, are Elevated in End-Stage Renal Disease Independent of Circulating Microparticle-associated Tissue Factor Debra Hoppensteadt Received Received
  805-PB Stroke Prevalence in Patients with Different Patterns of Atrial Fibrillation: Cross-sectional Study of Moscow Registry Alexander Melekhov Received Received
  806-PB Validation of a Patient-completed Caprini Risk Assessment Tool in a Spanish-speaking Population Luis Paz Received Received
  808-PB Patients with Multiple Cardiovascular Risk Factors Show a Characteristic Decrease in Circulating MAIT Cells Satoshi Fujii Received Received
  809-PB Protein Z Deficiency: A Reliable Risk Factor for Acute Coronary Syndrome Deena Samir Eissa Received Received
  810-PB Cardiac and Inflammatory Biomarkers and their Role in the Pathogenesis of Heart Failure in End-Stage Renal Disease Jawed Fareed Received Received
  812-PB Increased von Willebrand Factor Platelet Interactions in Patients with Chronic Pain Maren Hoffmann Received Received
  813-PB The effects of misclassification in routine care data on the accuracy of prognostic prediction models Sander van Doorn Received Received
  814-PB Markers of Plasma and Platelet Hemostasis Function as the Risk Factors for Leg Amputation in Patients with Critical Limbs Ischemia Danuta Rosc Received Received
  815-PB Validation of a Patient-completed Caprini Risk Assessment Tool Harry Fuentes Received Received
  816-PB Patients with Diabetes Mellitus 2 on Treatment, with or without Previous Cardiovascular Events, Have Delayed Clot Lysis, but Not Hyperactive Platelets Nor Increased Thrombin Generation Diego Mezzano Received Received
  817-PB Haemorrheologic and Fibrinolytic Activities in Diabetic Patient with Hypertension in Calabar, Nigeria Margaret Solomon Edem Received Received
  821-PB Administration of Dexamethasone during Initial Exposure to Factor VIII Reduces Inhibitor Development in Hemophilia A Mice Via Thymic Tolerance Induction Mechanisms Maria Georgescu Received Received
  822-PB Dual Mode of Interaction of Fibrinogen with the Staphylocoagulase-Prothrombin Complex Ingrid Verhamme Received Received
  823-PB Sensitive, Functional Assay for Detecting Polyphosphate in Plasma Catherine Baker Received Received
  824-PB Combined IV and SC administration of Long-acting FVIIa (MOD-5014) Significantly Improves the Pharmacokinetics (PK), Pharmacodynamics (PD) and Pharmacological Long-term Outcome in Preclinical and Toxicological Models Malka Hoffmann Received Received
  828-PB Selective Inhibition of Protein S Anti-coagulant Functions Restores in vitro Thrombin Generation in Haemophilia A and B Plasma Jacob Lund Received Received
  830-PB Differential Coagulotoxic Effects of Asian Pitviper Snake Venoms: Evolutionary, Pathophysiology and Biodiscovery Implications Jordan Debono Received Received
  831-PB The Effect of Histone H4 on Coagulation Enzymes and Complexes in Purified Systems Shannon Prior Received Received
  832-PB CP-5-001: A Phase 1/2a, Open-Label, Multicenter, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics Profile of a Long-acting Recombinant Factor VIIa (MOD-5014) in Adult Men with Hemophilia A or B Malka Hoffmann Received Received
  833-PB Age-related Variation in the Glycosylation of Alpha-2-Macroglobluin Laura Calvert Received Received
  834-PB First Evaluation of the Safety, Pharmacokinetics and Pharmacodynamics of BAY 1213790, a Full Human IgG1 Antibody Targeting Coagulation Factor XIa, in Healthy Young Men Dirk Thomas Received Received
  835-PB Case Study of Successful Transition to Fc Fusion Factor IX Replacement without Premedication in an Adolescent Male with Severe Hemophilia B, Anaphylactoid Reaction to FIX Replacement, and Previous History of Inhibitor and Nephrotic Syndrom Amber Federizo Received Received
  836-PB Estimates of Within-Subject Biological Variation of Prothrombin time-INR (PT-INR), Activated Partial Thromboplastin Time (APTT), Fibrinogen, Factor VIII clot (FVIII:C) and von Willebrand factor antigen (vWF:Ag) in Pregnant Women. Ann Helen Kristoffersen Received Received
  837-PB A Snake-venom Enzyme (Noscarin)-based Assay for APC-resistance Is Not Influenced by Non-vitamin K Antagonist Oral Anticoagulants (NOAC) Anne Brisset Received Received
  838-PB APC and TFPI Cofactor Activities of Thrombin-cleaved Protein S and C4BP-protein S Complex Tilman Hackeng Received Received
  839-PB Anticoagulants Differentially Affect Procoagulant Platelet Formation Vivien CHEN Received Received
  840-PB A Novel Hypoxia Response Element Regulates Oxygen-related Repression of Tissue Factor Pathway Inhibitor Expression Xue Yan Cui Received Received
  841-PB Impact of Thrombomodulin on Spatial Clot Growth and Fibrin Polymerization in Cirrhotic Patients Aurélien Lebreton Received Received
  842-PB Biomechanisms of a Severe Hypersensitivity Reaction Induced by Factor IX in Hemophilia B Complicated by Factor IX Inhibitor Maria Elisa Mancuso Received Received
  843-PB The Thrombomodulin Resistance in Prothrombin Belgrade Mutation Carriers Valentina Djordjevic Received Received
  846-PB ADP and ATP Inhibit Factor X Activation by Factor VIIa/Tissue Factor Yan Wang Received Received
  847-PB Intracranial Hemorrhage in Neonates and Infants with Congenital Bleeding Disorders: The Experience of ukurova University Hemophilia Center Bulent Antmen Received Received
  848-PB A Novel Mutation in the F7 Gene in a Tunisian Patient with Factor VII Deficiency Gouider emna Received Received
  849-PB A Rat-human Cross-species Compatibility Study: Catalytic Efficiency for Activation of Rat FX Is Decreased for Human FVIIa Compared to Rat FVIIa Inga Tuneew Received Received
  852-PB Correlation Analysis of Standard Bethesda Method versus Modified Nijmegen Assay in Detecting Factor VIII Inhibitors, and Impact of Marginal Titer Inhibitors on FVIII Pharmacodynamics and Pharmacokinetics in Patients with Hemophilia A Angelika Batorova Received Received
  856-PB Interim Safety of a Long-acting Recombinant Factor VIIa (MOD-5014): A Phase 1 Study in Adult Subjects Following Subcutaneous Administration Malka Hoffmann Received Received
  858-PB Hemarthrosis in Rare Factor Deficiencies Zafer Salcioglu Received Received
  859-PB Amyloidosis Induced Abnormal Coagulopathy Associated with Multiple Coagulation Factor Deficiencies Nilgun Sayinalp Received Received
  863-PB Signal through the Regulatory Subunits of PI3Kinase Endows Coagulation Protease Activated Protein C with Hormone Like Function Madhusudhan Thati Received Received
  864-PB Rivaroxaban Ameliorates Neuroinflammation Monika Merker Received Received
  865-PB Novel Role of Protein S in Clot Retraction: Induction of Apoptosis in Activated Platelets Vijaya Pilli Received Received
  868-PB Biochemical and Pharmacological Differentiation of APC and Recombinant Thrombomodulin with Reference to the Effect on the Hemostatic and Fibrinolytic Processes Jawed Fareed Received Received
  869-PB Plasminogen-deficient Patients Hande KIZILOCAK Received Received
  870-PB Direct Factor Xa Inhibitor Apixaban Prevents Endothelial Activation and Damage Associated with Chronic Kidney Disease Sergi Torramade-Moix Received Received
  871-PB A Factor X Activator from Caterpillar Triggers Cell Survival on Fibroblasts in Response to Serum Deprivation by Inhibition of Apoptosis Miryam Paola Alvarez Flores Received Received
  873-PB A Significant Change in Laboratory Markers of Thrombosis Very Early in the First Trimester of Pregnancy May be Linked to a Concurrent Increase in Estradiol Catherine N Bagot Received Received
  874-PB Analysis of potential microRNAs involved in regulation of TFPI-2 in breast cancer cells Marianne S. Andresen Received Received
  875-PB Comparative Studies on the Inhibition of Thrombin by Recombinant Thrombomodulin in Activated Protein C and Whole Blood Plasma Jawed Fareed Received Received
  876-PB Activation of the Hepatocyte Growth Factor/c-met Pathway during Experimental Envenomation of Rats with Bothrops Jararaca or Crotalus Durissus Terrificus Snake Venoms Benedito Prezoto Received Received
  878-PB Silencing of Anticoagulant Protein C Evokes Spontaneous Atherothrombosis in Apoe-/- Mice Marco Heestermans Received Received
  882-PB Positive Correlation of Plasma Protein S Levels to Apolipoprotein C-II in Middle-aged Obese Women and Non-obese Young Women Hiroko Tsuda Received Received
  884-PB Differential Modulation of Plasminogen Activator Mediated Thrombolysis by Recombinant Thrombomodulin and Activated Protein C Jawed Fareed Received Received
  885-PB G-quadruplex-Directed Aptamer Selection against Activated Protein C (APC) Nasim Shahidi hamedani Received Received
  886-PB The Protective Effect of Activated Protein C as the Baised Agonism in Activation of Protease-activated Receptor 1 Liubov Gorbacheva Received Received
  887-PB Function and Prevalence of Host-derived Coagulation Factors on the Virus Surface Bryan Huanjih Lin Received Received
  888-PB Decryption of Hepatocyte Tissue Factor Procoagulant Activity by Bile Acids Requires Non-apoptotic Phosphatidylserine Externalization Kevin Baker Received Received
  890-PB A First-in-Human Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PF-06741086, an anti-TFPI Monoclonal Antibody, Following Administration of Single Subcutaneous or Intravenous Doses in Healthy Adult Male Volunteers Matthew Cardinal Received Received
  893-PB mTOR Inhibitors Reduce Expression of Tissue Factor Isoforms in Neuroendocrine Tumors of the Pancreas Clayton Lewis Received Received
  895-PB Renin-angiotensin System Blockade Downregulates Tissue Factor Expression Induced by ?-Glutamyltransferase in Human Peripheral Blood Mononuclear Cells Exposed to High Glucose Valentina Scalise Received Received
  896-PB Over-activation of Src1 Mediates Tissue Factor-induced Apoptosis in Endothelial Cells Ali Ethaeb Received Received
  897-PB Indoleamine 2,3-dioxygenase 1 Enhances Tissue Factor Expression in Coronary Atherosclerotic Plaque Atsushi Yamashita Received Received
  901-PB Rutin (quercetin-3-rutinoside) Modulates Hemostatic Disturbances and Reactive Species Levels in Experimental Bothrops jararaca Envenomation Marcelo L. Santoro Received Received
  902-PB Measurement of Tissue Factor Molecules and Factor Xa Generation on Vascular Cells Marcela Rosas Received Received
  903-PB Tissue Factor Pathway Inhibitor Polymorphism 399CT Predisposes to Idiopathic DVT in Young Indians Renu Saxena Received Received
  907-PB Transcriptional Regulation of the Tissue Factor Gene is Mediated by the Androgen Receptor Bastian Hoesel Received Received
  908-PB Factor V Expression in Aggressive Breast Cancer Modifies Patient Survival, Tumor Cell Growth and Response to Treatment Mari Tinholt Received Received
  910-PB Platelet-dependent von Willebrand Factor Activity in Acute Myeloid Leukemia Patients: Role in Haemostatic Alterations Botheina Farweez Received Received
  912-PB Altered Fibrin Clot Properties in Advanced Lung Cancer: Impact of Chemotherapy Michal Zabczyk Received Received
  913-PB The Effect of Neoadjuvant Chemotherapy on the Activated Protein C (aPC) Pathway in High Grade Serous Ovarian Cancer Patients Mark Ward Received Received
  914-PB Inhibition of Tumour Cell-induced Platelet Aggregation by a Novel Stat3 Inhibitor in Podoplanin Positive Cancer Cells Kowit-Yu Chong Received Received
  916-PB A Linkage between ERBB2 Expression and the Pro-coagulant Properties of Breast Cancer Cells is Mediated by the PI3k/Akt Signaling Pathways Yunliang Chen Received Received
  917-PB Exosomes from Heparin-treated Cancer Cells Exhibit Transferable Anti-tumorigenic Activity Yunliang Chen Received Received
  918-PB Sonic Estimation of Elasticity via Resonance (SEER) Sonorheometry to Identify Hypercoagulability in Patients with Cancer Erin McLoughlin Received Received
  922-PB The Role of asTF in Glioblastoma Multiforme Maaike Kapteijn Received Received
  923-PB Tumoral Factor VII Expression Changes TGF--mediated Intercellular Communication in Breast Cancer Madelon Paauwe Received Received
  925-PB Preoperative Panel Scores of CA 19-9, FVIII and D-dimer Predict Postoperative Survival in Pancreatic Ductal Adenocarcinoma Nora Mattila Received Received
  926-PB Expression of Coagulation Proteases from the Activated Protein C Pathway in Ovarian Cancers Catherine Spourquet Received Received
  927-PB Mucin1 Acts as a Potential Mediator of the Pro-coagulant Properties of Breast Cancer Cells by Altering the Activity of Key Phosphokinase Pathways Yunlaing Chen Received Received
  930-PB Dissolution of Platelet-rich Thrombus by Perfusion of N-acetyl Cysteine Susan Hastings Received Received
  931-PB Thrombolysis by rt-PA Combinated with Anticoagulant and Antiaggregant Molecules under Flow Conditions Stéphane LOYAU Received Received
  932-PB Systematic Review and Meta-analysis of Treatments for Massive and Submassive Pulmonary Embolism Lana A. Castellucci Received Received
  933-PB Structure and Function of Trypsin-loaded Fibrinolytic Liposomes Anna Tanka-Salamon Received Received
  934-PB Changes in Treatments and Outcomes after Creation of a Pulmonary Embolism Response Team (PERT) Rachel Rosovsky Received Received
  935-PB Comparing Emergency Department Patients to Inpatients Receiving a Pulmonary Embolism Response Team (PERT) Activation Christopher Kabrhel Received Received
  936-PB Indications and Results of Treatment with Ultrasound Assisted Cathether Thrombolysis in Patients with Pulmonary Embolism Boris Dzudovic Received Received
  938-PB A Case Series of Low Dose Alteplase for Submassive Pulmonary Embolism (PE) Jay Lozier Received Received
  941-PB Sub-massive PE - A Role for Low Dose Thrombolysis? Maeve Crowley Received Received
  943-PB Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A SIPPET Analysis Roberta Palla Received Received
  945-PB Bone Properties in Children with Hemophilia A: Influence of Target Joint and FVIII Inhibitor Panagiota Xafaki Received Received
  947-PB Obesity and Dosing of Replacement Therapy in Hemophilia; How to Optimize? Marjon Cnossen Received Received
  948-PB Safety of Nonacog Beta Pegol (N9-GP): Results from the paradigm? Clinical Trials Peter Collins Received Received
  949-PB Perioperative Replacement Therapy in Hemophilia B: Should We B More Precise? Marjon Cnossen Received Received
  950-PB Identification of Patient and Disease-related Characteristics Influencing the Risk of Bone Fracture in Individuals with Haemophilia Predrag Miljic Received Received
  951-PB Post-partum Bleeding in Women who Are Carriers of and Who Have Bleeding Disorders: A Case-Control Study Sonia Wolf Received Received
  954-PB Factor VIII (FVIII) Inhibitor Testing Using a Validated Chromogenic Bethesda Assay (CBA) in HAVEN 1 (BH29884), a Phase 3 Trial of Emicizumab in Persons with Hemophilia A (PwHA) with Inhibitors Daniella Babu Received Received
  955-PB Recombinant FVIII Product Type and the Risk of Inhibitor Development in Previously Treated Patients with Hemophilia A: Preliminary Results of a Systematic Review and Meta-analysis antonino cannavo Received Received
  956-PB Preliminary Observations from a Prospective, Dose Escalating, Prophylaxis Study in Young Boys with Severe Hemophilia A in China: The China Hemophilia Individualized Prophylaxis Study (CHIPS) Wu Junde Received Received
  959-PB Effects of Acute Moderate Physical Activity on Haemostatic Parameters in Severe Haemophilia A Subjects Using a Third Generation B-Domain Deleted Recombinant Factor VIII CLEMENCE MERLEN Received Received
  962-PB Pressure Pain Thresholds Hint at Structural Findings in Knees of Patients with Haemophilia Steffen Krger Received Received
  963-PB Once-weekly Prophylaxis with GlycoPEGylated Recombinant Factor VIII (N8-GP) in Severe Haemophilia A: Safety and Efficacy Results from a Randomised Phase 3 Trial (pathfinder?2) Steven Lentz Received Received
  964-PB End-of-trial Results from a Large Multinational Extension Trial (guardian?2) Using Turoctocog Alfa for Prophylaxis and Treatment of Bleeding in Patients with Severe Haemophilia A Steven Lentz Received Received
  967-PB Characterisation of the Inhibitor Status of Patients with Haemophilia A in Australia Simon McRAE Received Received
  968-PB Long-term Quality-of-Life Outcomes with rFIXFc in Adults with Hemophilia B: Results from B-LONG and B-YOND Jun Su Received Received
  969-PB Lower Risk of Factor VIII Inhibitors among Severe Hemophilia A Patients with Indigenous Background from Brazil Margareth Ozelo Received Received
  970-PB Surgery with Turoctocog Alfa: Efficacy and Safety in Bleeding Prevention During Surgery in Patients with Severe Haemophilia a - Results from the Guardian? Trials Elena Santagostino Received Received
  974-PB Association of Factor VIII and Factor IX Mutations, HLA Class II, Tumor Necrosis Factor-Alpha and Interleukin-10 on Inhibitor Development among Thai Hemophilia A and B Ampaiwan Chuansumrit Received Received
  975-PB Participation of Clinical Psychologist in a Non-hemophilia Treatment Center Aya Nakao Received Received
  979-PB Factor Utilization and Costs in Patients with Hemophilia B Using Standard and Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan Ashley Daset Received Received
  980-PB Long Term Hemostatic Efficacy of Once a Week Administration with a Combination Medicine of Plasma Derived Factor Viia and Factor X for a Hemophilia B Patient with Inhibitor Takashi Suzuki Received Received
  984-PB Improving the Survival for Life-threatening Hemorrhage with Hemophilia Patient in One Hemophilia Treatment Center for 34 Years Kun Lee Received Received
  988-PB Sports/Recreational Activity-specific Risks and Drivers of Risk in People with Hemophilia: Results of the Activity-intensity-Risk (AIR) Consensus Meeting of US Physical Therapists David Cooper Received Received
  989-PB Preferences of Hemophilic Patients and their Parents on the Characteristics of Replacement Treatment Used in Prophylaxis Maria Elisa Mancuso Received Received
  992-PB The Impact of a Comprehensive Hemophilia Management Programme in Vulnerable Population Cesar Montaño Received Received
  996-PB Prevalence of Adult-onset Medical Comorbidities and Active Intervention via Web-based Monitoring in Korean Hemophliacs Hugh Kim Received Received
  998-PB Pharmacokinetics and Annual Bleeding Rate (ABR) during Prophylaxis with a Full-length Recombinant FVIII: One Center Experience Andrea Cocca Received Received
  999-PB A Unique Case Involving Delivery of Bolus rFVIIa via an Innovative Syringe Pump to a Patient with Haemophilia and Inhibitors Undergoing a Kidney Transplant Jenna Stanley Received Received
  1000-PB The Prevalence of Concomitant Deep Vein Thrombosis, Symptomatic or Asymptomatic, in the Patients with Symptomatic Pulmonary Embolism Jana Hirmerova Received Received
  1001-PB Predicting Post-thrombotic Syndrome with Ultrasonographic Measurements after Proximal Deep Vein Thrombosis Charlotte Dronkers Received Received
  1002-PB Can Ultrasonographic and Laboratory Measurements One Year after Proximal Deep Vein Thrombosis Predict Post-thrombotic Syndrome? Gerben C. Mol Received Received
  1003-PB Patient-reported Reasons for and Predictors of Non-compliance with Elastic Compression Stockings in the SOX Trial Susan Kahn Received Received
  1004-PB External Validation of the Patient Reported Form of the Villalta Scale Kristin Kornelia Utne Received Received
  1005-PB High Accuracy and Reproducibility of CT Right-to-left Ventricular Diameter Measurement by Non-radiologists in Patients with Acute Pulmonary Embolism Yvonne Ende-Verhaar Received Received
  1006-PB Nationwide Study on the Management and Outcomes of Patients with Superficial Vein Thrombosis under Real-life Conditions (INSIGHTS-SVT) Rupert Bauersachs Received Received
  1007-PB Post-Thrombotic Syndrome in Patients Treated with Rivaroxaban or Warfarin for Venous Thromboembolism Kathleen Leonard-Bedwell Received Received
  1009-PB Possible Predictors of Long-term Dyspnea in Patients with Pulmonary Embolism - A Cross Sectional Study Mazdak Tavoly Received Received
  1010-PB Reliability Testing of the CAPTSureTM Pediatric Post-thrombotic Syndrome Tool Maria Laura Avila Received Received
  1011-PB Measuring Limb Edema in Children at Risk of Post Thrombotic Syndrome: Do I See what You Feel? Maria Laura Avila Received Received
  1012-PB Laboratory and Clinical Parameters at Diagnosis of Venous Thromboembolism (VTE) Are Not Associated to the Presence of Residual Vein Thrombosis (RVT) Sandra Martins Silva Soares Received Received
  1013-PB An Innovative Approach to an Age-old Problem: Piloting a Smart Compression Garment Device Maria Laura Avila Received Received
  1014-PB Post-Pulmonary Embolism Syndrome Development among Patients who Needed Pulmonary Embolism Response Team Assessment Alya Ahsan Received Received
  1015-PB Patients Treated with Rivaroxaban Presented Low Prevalence of Post-thrombotic Syndrome Joyce M. Annichino-Bizzachi Received Received
  1016-PB Non-invasive Detection of Fresh Deep Vein Thrombosis with Diffusion Weighted Magnetic Resonance Imaging Yasuyoshi Kuroiwa Received Received
  1017-PB Patients Experience of Post-thrombotic Syndrome: A Qualitative Study with Focus Groups Aiming at a More Accurate Diagnosis Marit Engeseth Received Received
  1018-PB Optimizing Treatment for Post-thrombotic Syndrome (PTS): A Systematic Review Samuel Abegunde Received Received
  1020-PB Comparison of Trans-popliteal Reflux in the Limb with Deep Vein Thrombosis and the Limb without Thrombosis Lucia Sarolo Received Received
  1022-PB Inferior Vena Cava Filters: Experience of 133 Patients in a Tertiary Referral Center Antoni Riera-Mestre Received Received
  1025-PB Comparison of Pulmonary Embolism Severity Index Score and Hestia Criteria to Identify Pulmonary Embolism Patients for Outpatient Treatment Syed Ahsan Received Received
  1026-PB Clinical Courses of Portal Vein Thrombosis (PVT) in Children Patcharee Komvilaisak Received Received
  1027-PB The Incidence of Catheter-related-Thrombosis during Induction Chemotherapy and Follow-up in Chinese Acute Lymphocytic Leukemia Children Yunyun Yunyun Received Received
  1030-PB Pulmonary Thromboembolism in Children: Tuberculosis May Be the Underlying Problem Mualla etin Received Received
  1031-PB Inherited Prothrombotic Risk Factors in Turkish Children with Hereditary Anjioedema. Single Center Experience ALPER OZCAN Received Received
  1033-PB Preoperative Assessment of Bleeding Risk - Implementing Strategies in the Pursuit of Effective Patient Blood Management Joanne Joseph Received Received
  1034-PB Indications for the Use of Fresh Frozen Plasma in Neonatal Intensive Care Unit in a Tertiary Care Hospital Romana Akbar Received Received
  1035-PB Intermittent Intravenous Deferoxamine for the Treatment of Transfusional Iron Overload Mala Varma Received Received
  1036-PB Reasons for Blood Donor Deferral among Voluntary Blood Donors in a Tertiary Care Hospital in Kathmandu, Nepal Bipin Nepal Received Received
  1037-PB Haemovigilance Reports of Adverse Blood Donor Reaction among Voluntary Blood Donors in Tertiary Care Hospital in Kathmandu, Nepal Bipin Nepal Received Received
  1038-PB Re-infusion of Heparinized Shed Blood in Aortic Surgery to Maintain Hemostatic Levels of Fibrinogen Meredith Reyes Received Received
  1041-PB Pseudomyxoma Peritonei Surgery: Potential for Predicting Fibrinogen Use using Thromboelastometry Jane Needham Received Received
  1044-PB Five Years of Hemovigilance Reports of Complications of the Blood Donation Reported at a Tertiary Care Centre in Karachi Bipin Nepal Received Received
  1048-PB Is the Thrombin Generation Test, a Useful Research Tool, Suitable to Characterize Therapeutic Plasmas? Catherine RAVANAT Received Received
  1049-PB Viral Inactivation and Enrichment of Factor VIII, Factor XIII, Fibrinogen and von Willebrand Factor (VWF) Multimers from Fresh Frozen Plasma (FFP)using, VIPS Plasma, Virus Inactivation Treatment System Bipin Nepal Received Received
  1050-PB Prolonged Platelet Storage Associated with Increased Incidence of Platelet Transfusion Adverse Events Jian Chen Received Received
  1051-PB Remote Bridging Clinics Maximise Efficiency and Patient Satisfaction in the Perioperative Management of Anticoagulation Sinead Brookman Received Received
  1052-PB Expanding the Role of the Anticoagulation Nurse Stephanie Rivera Received Received
  1053-PB Nurse-led Clinic Initiative for Patients Commencing Direct Oral Anticoagulants (DOACs) in the National Coagulation Centre, Dublin, Ireland Lidhy Solomon Received Received
  1054-PB Haemorrheologic and Fibrinolytic Activities of Sickle Cell Subjects in Steady and Crisis States in Abuja Metropolis, Nigeria Dorathy Chioma Okpokam Received Received
  1055-PB Social Work Research and Funding Opportunities: The Canadian Experience Claude Bartholomew, St. Pauls Hospital, Vancouver, Canada Neale Smith, University of British Columbia Claude Bartholomew Received Received
  1057-PB Empowering a Link Practitioner Network to Enhance Venous Thromboembolism (VTE) Prevention and Anti-coagulation Care Richard Greenall Received Received
  1059-PB Has the Introduction of the Direct Oral Anticoagulants (DOACs) Made Any Difference to Telephone Calls to A Secondary Care Led Anticoagulant Clinic? Sarah Bond Received Received
  1061-PB When the Absence of Prophylaxis in Patients with Hemophilia, Surgery is Inevitable Ljiljana Rakic Received Received
  1064-PB Abrogating Fibrinolysis Does Not Markedly Affect the Bleeding Phenotype or Response to rFVIII Therapy in Mice with Haemophilia A Rikke Stagaard Received Received
  1065-PB Vascular Remodeling in Hemophilic Joint Bleeding is Associated with Vascular Leak: A Possible Mechanism for Re-Bleeding Esther Cooke Received Received
  1068-PB Identification of Regulatory B Cells in Severe Hemophilia A Patients Davide Matino Received Received
  1069-PB Prophylactic Treatment with Turoctocog Alfa Pegol (N8-GP), a GlycoPEGylated Recombinant Factor VIII, Completely Prevents Development of Arthropathy in a F8 - Knockout Mouse Model of Induced Knee Bleeding Josephine B Hebsgaard Received Received
  1070-PB Two Large F8 Deletions Possibly Related to the Mechanism of Microhomology-mediated Break-induced Replication (MMBIR) as a Cause of Severe Haemophilia a and Inhibitors Miguel Martin Abelleyro Received Received
  1071-PB Measurement of Basal Levels of TF, FVII, FVIIa, Free and Total TFPI and FVIIa.AT Complex Levels in Patients with Haemophilia A and B Emma Fosbury Received Received
  1072-PB F8-deficiency in Mice is Associated with Increased von Willebrand Factor (VWF) Content in the Hepatic Endothelium and with Increased VWF Plasma Levels Klytaimnistra Kiouptsi Received Received
  1074-PB The Bone Disease in Haemophilia: A Possible Role of Coagulation Factors? Stefano Lancellotti Received Received
  1075-PB Determinants of Thrombin Generation in Haemophilia A and B Michelle Piot Received Received
  1076-PB Unusual Genomic Rearrangement Combined with Inv22 and Wild-type X-chromosome in Severe Hemophilia A Patients Shogo Tamura Received Received
  1082-PB Turoctocog AlfaPegol (N8-GP) Is Cleared from Subcutaneous Injection Sites without Local Degradation Maj Petersen Received Received
  1083-PB Thrombin Generation Profiling in Amish Factor IX Carriers and Controls: Plasma Composition and Bleeding Phenotype Maria Cristina Bravo Received Received
  1087-PB Rapid and Cost-effective FVIII Intron Inversion 22 Screening of the Central South African Haemophilia A Population Walter Janse van Rensburg Received Received
  1088-PB Patient Satisfaction of Home Delivery Program in Haemophilia through an Association of Patients Martín Cerezuela Received Received
  1089-PB Contribution to the Molecular Study of Hemophilia B in an Algerian Population yamina ouarhlent Received Received
  1091-PB Induction of FVIII Tolerance by Gene Transfer of IL2 and Factor VIII Plasmids in Hemophilia A Mice Meghan J. Lyle Received Received
  1092-PB Therapeutic Expression of Factor VIII Following Ultrasound-mediated Gene Delivery of High-expressing FVIII Variant Plasmids and Immunomodulation in Hemophilia A Mice Carol H. Miao Received Received
  1095-PB A Novel Strategy for Liver Cell-based Therapy in a Hemophilia B Model Ching-Tzu Yen Received Received
  1100-PB Preliminary Results of SPK-9001 Gene Transfer Demonstrate Statistical Improvements on the Health-related Quality-of-Life in Adults with Haemophilia B Sylvia von Mackensen Received Received
  1106-PB Hyperfibrinolysis in Children. Prevalence of Hyperfibrinolysis in Mucocutaneous Bleeders of Unknown Cause in a Pediatric Cohort Pamela Zuñiga Received Received
  1109-PB Dysprothrombinemia Caused by the Homozygote Mutation Ala563Val in the F2 Gene Was Associated with Reduced Thrombin Generation in a Patient with Bleeding Disorder Heidi Glosli Received Received
  1111-PB A Novel Thrombin-activable Factor X Corrects Acquired Hemophilia A in Rabbit Jean-Luc Plantier Received Received
  1113-PB Treatment of Hemophilia A by Injection of FVIII-encoding mRNA Jules Russick Received Received
  1115-PB Rescue of Multiple Hemophilia B-causing Mutations in F9 Exon 3 by a Unique ExSpeU1 Dario Balestra Received Received
  1116-PB Dose-response and Duration of Effect of a Half-life Extended Recombinant Factor VIIa in the Tail Vein Transection Bleeding Model in Haemophilia A Rats Torben Elm Received Received
  1117-PB Defining extended half-life rFVIII: a critical review of the evidence Johnny Mahlangu Received Received
  1119-PB Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered Marzeptacog Alfa (Activated) in Hemophilia B Mice Howard Levy Received Received
  1120-PB Underestimation of N-glycoPEGylated Factor IX (N9-GP) Activity in One-stage Clotting Assay Owing to Contact Activator Impairment of N9-GP Activation Egon Persson Received Received
  1123-PB Administration of rFVIIa to Concizumab-dosed Monkeys Is Safe and Concizumab Does Not Affect the Potency of rFVIIa in Haemophilic Rabbits Brian Lauritzen Received Received
  1124-PB A Monoclonal Antibody with TFPI Neutralizing Activity, Improves the Coagulation Parameters of Hemostatic Assays Performed with Hemophilic Whole Blood Sunita Hett Received Received
  1125-PB Protein Engineering of Factor X to Restore Coagulation: Building an Alternate Amplification Loop Grant E Blouse Received Received
  1132-PB The Safety and Efficacy of IB1001 in Previously Treated Children 12 Years of Age or Younger with Hemophilia David Schaaf Received Received
  1133-PB A Single Analysis for Simultaneous Measurement of All 4 DOACs Jan Emmerechts Received Received
  1134-PB Interest of PERC Rule (Pulmonary Embolism Rule-out Criteria) to Exclude Pulmonary Embolism in European Patients with Low Implicit Clinical Probability: PERCEPIC Study andrea penaloza Received Received
  1135-PB Validation of STA-Liatest D-Di Assay for Exclusion of Deep Vein Thrombosis According to the Latest Clinical and Laboratory Standard Institute/Food and Drug Administration Guideline. Results of a Multicenter Management Study Francois Depasse Received Received
  1136-PB Variation in Practice for FVIII and FIX Inhibitor Investigations - Results from a UK NEQAS (Blood Coagulation) and UK HCDO Multicentre Exercise Ian Jennings Received Received
  1137-PB Improving aPTT Test and Resource Utilisation in Manitoba, Canada - A Successful Provincial Experience Charles Musuka Received Received
  1138-PB Prediction of Coagulation Testing in Underfilled Patient Samples Jonathan Miller Received Received
  1139-PB Thrombin Generation Based Factor VIII Assay is Sensitive to Low FVIII Levels in Hemophilia Cuicui Bai Received Received
  1140-PB Novel Biochip Detects Drug Effects in Patients with Cardiovascular Disease in a Near Patient Setting Amy Hall Received Received
  1141-PB Microfluidic Systems with Vascular Biomimetic Surfaces for Assessment of Platelets and Fibrin Components of Hemostasis: Comparison with a Classic Annular Device in the Evaluation of the Antithrombotic Effects of Apixaban Irene Lopez-Vilchez Received Received
  1143-PB Prenatal diagnosis for Inherited Bleeding Disorders in India Eunice Edison Received Received
  1145-PB The Use of the ADJUST (Age Adjusted) D-dimer Cut-off in Screening Patients Aged over 50 Years Presenting with Suspected DVTs Can Decrease the Need for Compression Ultrasonography Andrew Hughes Received Received
  1146-PB Is the Application of a Single Conversion Factor Suitable for the Laboratory Monitoring of Single Chain rFVIII by One-stage FVIII:C Assay? ANNETTE BOWYER Received Received
  1147-PB Impact of Pneumatic Tube System Transportation for the Monitoring of Heparin Therapy Aurélien Lebreton Received Received
  1148-PB Comparison of von Willebrand Factor Collagen Binding Activity (VWF:CB) Determined by a Chemiluminescent Assay on AcustarTM to an ELISA Kit Emilie Jousselme Received Received
  1149-PB Validation of a Flow Cytometric Platelet Function Test in a Cohort of Patients with a Suspected Platelet Function Disorder Ivar van Asten Received Received
  1150-PB Comparison of light transmission aggregometry and multiple electrode aggregometry for the evaluation of platelet aggregation in patients with mucocutaneous bleeding Sara Israels Received Received
  1151-PB Clot Waveform Analysis Has the Potential to Detect Fibrinogen Abnormalities Atsuo Suzuki Received Received
  1152-PB Effect of Anticoagulant Adjustment on Prothrombin Time Test Using 2 Different Thromboplastins in Patients with Elevated Hematocrit DENISE CARVALHO REZENDE Received Received
  1154-PB LC-MS/MS Nonradioactive Serotonin Release Assay for Platelet Function Analysis in Whole Blood Jonathan Miller Received Received
  1155-PB Thromboelastometry can Generate Significant Disagreement in the Management of Patients after Cardiopulmonary Bypass due to Analytical Variability Felipe Guerrero Received Received
  1156-PB Establishing of Therapeutic Range for Unfractionated Heparin Therapy: Activated Partial Thromboplastin Time vs. Anti-Xa Measurement Litao Zhang Received Received
  1157-PB Impact of Rivaroxaban and Dabigatran on Clotting Screens as Performed Using the Roche Cobas t 711 Analyser Anna Lowe Received Received
  1158-PB Genotypic Characteristics of Polish Patients with Antithrombin, Protein C and Protein S Deficiency Edyta Odnoczko Received Received
  1159-PB Assessment of Overall Coagulation and Fibrinolytic Activity in Hemophilia A Patients by Using Global Hemostatic Laboratory Methods: Overall Hemostasis Potential, aPTT-waveform Analysis and Endogenous Thrombin Potential Marija Milos Received Received
  1160-PB Thrombin Generation in Patients with Systemic Lupus Erythematosus (SLE) Zsuzsa Bagoly Received Received
  1161-PB Comparison of Three Different Anti-Xa Assays in Major Orthopedic Surgery Patients Treated with Edoxaban Hideo Wada Received Received
  1162-PB Assessment of Two Chromogenic FVIII Assays In Haemophilia A Patients Infused with B-domain Truncated or Deleted Products: Results from a French Multicentric Study Emmanuel De Maistre Received Received
  1163-PB Effects of Interfering Substances on Factor Assays Performed Using Q Smart Analyser and DG-PT RecombiLIQ or DG-APTT Synth Reagents Anita Woolley Received Received
  1164-PB Comparison of Point-of-Care Instruments I-STAT, ACTPlus and Hemochron Signature Plus for Measurement of Activated Clotting Time (ACT) Stien Vandendriessche Received Received
  1166-PB Laboratory Expert System in the Field of Hemostasis and Thrombosis: A Pilot Project for the Diagnosis of von Willebrand Disease Holger Seidel Received Received
  1167-PB A New and Improved Euglobulin Clot Lysis Time Assay (iECLT) Anton Ilich Received Received
  1168-PB Platelet Estimation from Peripheral Blood Smear: Does it Really Works? Ikram Bachiri Received Received
  1169-PB Comparison of Rotational Thromboelastometry Reference Ranges with Normative Ranges across Trimesters in Pregnancy Amir Shamshirsaz Received Received
  1170-PB Enhanced Coagulation Decreases Probability of Positive Outcome during in vitro Fertilization Anna Balandina Received Received
  1171-PB Development and Implementation of a Coagulation Factor Testing Method Utilizing Autoverification in a High Volume Clinical Reference Laboratory Environment Paul Riley Received Received
  1172-PB Factors VII and VIII Assays: Analytical Performance and Reference Ranges for Argentinian Population Maria De Lourdes Herrera Received Received
  1174-PB Standardization of a Cytometry Test to Measure the von Willebrand Factor Collagen Binding Activity Daniel Chaves Received Received
  1177-PB Results of Implemented Postanalytical Quality Indicator - Turnaround Time (TAT) Monitoring for Urgent Coagulation Tests Sandra Margetic Received Received
  1178-PB Is it Helpful for Physicians the Laboratory Post Analytical Comments on a Prolonged APTT? Mirta Del Valle Arias Received Received
  1179-PB Sensitive Method for Determination of Blood Hypercoagulation Olga Petrova Received Received
  1180-PB Variants of FVII Deficiency at an Elderly Care Hospital Rodolfo Emanuel Sueldo Received Received
  1181-PB Towards Harmonization of Critical International Normalized Ratio Values Reporting: The Croatian Survey Ana Bronic Received Received
  1182-PB Improving Laboratory Operational Efficiency with the Implementation of a Specialized Hemostasis Lab Automation Vicente Cortina Received Received
  1183-PB In Search of a Sensitive and Reliable Laboratory Tool to Assess Hypercoagulability Debora Bertaggia Calderara Received Received
  1184-PB HIL Interferences in Coagulation Testing: Evaluation of Automatic Check with the New ACL TOP 550 CTS Analyzer Anna Skibowska-Bielinska Received Received
  1185-PB Comparison of Clot Waveform Analysis from Sepsis Patients and Healthy Control Group Nadjwa Zamalek Received Received
  1186-PB Impact of New Oral Anticoagulants on Routine Coagulation Assays Ana Bronic Received Received
  1189-PB Clinical Outcomes in Fragile Patient with Venous Thromboembolism Farès MOUSTAFA Received Received
  1190-PB Comprehensive Characteristics of the Anticoagulant Activity in Relationship to the Plasma Concentration of Dabigatran Willemijn Comuth Received Received
  1191-PB Menstrual Bleeding Patterns in Women Treated with Rivaroxaban: Data from the EINSTEIN CHOICE Trial Kochawan Boonyawat Received Received
  1193-PB Impact of Evolving ACCP Guidelines on Estimates of Venous Thromboembolism Risk in US Hospitals Frederick Anderson Received Received
  1195-PB Oral Anticoagulation with Direct Thrombin Inhibitors Prevents the Early Events of Atrial Remodeling and the Thrombin-activated ErbB Signaling in a Rat Model of Atrial Dilation Monique David-Dufilho Received Received
  1197-PB Outcomes, Interventions and DOAC Plasma Concentration Assay Utility in DOAC-treated Patients Presenting with Major Haemorrhage or Thrombosis - Results from the Anticoagulant Reversal and Events Study Collaborative (ARES1) DAulerio Giuliana Received Received
  1198-PB Direct Oral Anticoagulants in Patients with Venous Thromboembolism Usually Excluded for Clinical Trials Manuel Monreal Received Received
  1199-PB A New Method for Determining Concentrations of Direct Oral Anticoagulants Saartje Bloemen Received Received
  1200-PB Patients with Dabigatran Circulating Concentration above 200 ng/ml Have a Rebound after Neutralization by a Single Dose of Idarucizumab Nicolas Gendron Received Received
  1202-PB Comparison of Applying TTR Proportion of Tests and TTR Rosendaal to a Sample Population Attending a Warfarin Clinic Thomas O Halloran Received Received
  1205-PB Pulmonary Embolism Rule-out Criteria (PERC) Has No Added Value to the YEARS Algorithm to Rule out Pulmonary Embolism Liselotte M. van der Pol Received Received
  1206-PB Evaluation of Different Coagulation Laboratory Methods to Monitor Apixaban, Rivaroxaban and Dabigatran Treatment Jovan P Antovic Received Received
  1207-PB Effect of Rivaroxaban on Expression of Monocyte Platelet Aggregates and P Selectin in Patients with Atrial Fibrillation Rita Duarte Received Received
  1208-PB Gastrointestinal Bleeding in Patients on Warfarin and Direct Oral Anticoagulant Therapy: An Observational Study in a District General Hospital Andrew Mcsorley Received Received
  1209-PB Select-d Trial Qualitative Sub-study: Patient and Carer Experience of Anticoagulation for Cancer-Associated Thrombosis Sophie Rees Received Received
  1210-PB TRAP-induced Platelet Aggregation is Reduced in Patients Receiving Dabigatran Juraj Sokol Received Received
  1211-PB An Oral Factor Xa Inhibitor Edoxaban Ameliorates Neointima Formation Following Vascular Injury in ApoE KO Mice Yoshiyuki Morishima Received Received
  1213-PB Lower Prevalence of Isolated Subsegmental Pulmonary Embolism in the YEARS Diagnostic Algorithm Compared with the Conventional Algorithm for Suspected Pulmonary Embolism Liselotte M. van der Pol Received Received
  1214-PB Renal Clearance is Able to Predict Drug Discontinuation in Patients with Atrial Fibrilation Treated with Direct Oral Anticogulants Begoña Navarro Almenzar Received Received
  1217-PB Treatment Effect Estimates for Extended Treatment of VTE Using Network Meta-analysis from Clinical Trials with Rivaroxaban, Aspirin or Placebo Kathleen Leonard-Bedwell Received Received
  1218-PB Is LMWH-calibrated Anti-Xa Assay Useful to Estimate Apixaban Concentration in Patients Undergoing Apixaban Treatment? Maria De Lourdes Herrera Received Received
  1219-PB Calibrated Automated Thrombogram II: A New Thrombin Generation Test Able to Measure in the Presence of a Direct Thrombin Inhibitor Anouk Gulpen Received Received
  1222-PB Management of Pulmonary Embolism in a Short Stay Medical Unit: A Cohort Study Marco Donadini Received Received
  1224-PB Performance of a Chromogenic Assay for the Measurement of Edoxaban Concentration in Plasma Aurore Barthod-Malat Received Received
  1227-PB Evaluation of Prescribing Practices and Medication Persistence in Patients Initiated on Direct Oral Anticoagulant Therapy at a Tertiary Care Academic Medical Center Patrick Klem Received Received
  1228-PB Selection of Long-term Anticoagulation Therapy after Acute Pulmonary Embolism in Real Life Valdis Gibietis Received Received
  1229-PB Impact Analysis of Prognostic Stratification for Pulmonary Embolism: The iAPP Study marco donadini Received Received
  1230-PB Do the Direct Oral Anticoagulants (Doacs) Make Managing Anticoagulant Therapy during the Peri-operative Period Easier? Kwesi Kittoe Received Received
  1231-PB Limits of Sensitized Rotational Thromboelastometry for Rivaroxaban and Apixaban Detection Claire PAILLERET RINGUIER Received Received
  1232-PB Choice of Anticoagulation in the Obese Georgia McCaughan Received Received
  1233-PB Antithrombotic Effects of Edoxaban, a Direct Factor Xa Inhibitor, and Antiplatelet Agents and their Combination Effects on Stent Thrombosis in Rats Yoshiyuki Morishima Received Received
  1234-PB Dental Extractions on NOACs withouT Stopping Therapy (DENTST) Study: Interim Analysis Yvonne Brennan Received Received
  1235-PB Patients on a Fixed Dose of DOAC: What Percentage is in the Therapeutic Window? H. Coenraad Hemker Received Received
  1236-PB Comparing the Performance of Different Assays for Monitoring Dabigatran Plasma Concentrations in Real-practice Luciana Gonalves Received Received
  1237-PB Total Thrombus-formation Analysis System (T-TAS) as a Potential Tool for Assessing Comprehensive Hemostatic Function in Patients Taking Dabigatran Takashi Ito Received Received
  1240-PB Measurement of Direct Oral Anticoagulants Levels in Patients Admitted for Bleeding Events: A Prospective Study Anne-Laure Sennesael Received Received
  1242-PB Oral Anticoagulant Associated Bleeding Events - A Single Centre Experience McNeill Susan Received Received
  1243-PB Influence of Direct Oral Anticoagulants in Fibrinolysis Testing Monica Pereira Received Received
  1244-PB The Incidence and Assessment of Post-thrombotic Syndrome in Critically Ill Children Two Years Post-central Venous Catheter Placement Sophie Jones Received Received
  1246-PB Chronic Blood Transfusion Therapy Corrects Abnormalities of Coagulation and Fibrinolysis in Children with Sickle Cell Disease Suzan Williams Received Received
  1247-PB Evaluating the Relationship between von Willebrand Factor, ABO Blood Group and Circulating Lymphoblasts in the Development of ALL-associated Thromboembolism in Children Terry Mizrahi Received Received
  1248-PB Central Venous Catheter Associated Thrombosis in Congenital Heart Disease Patients: A Preliminary Analysis of the Childrens Hospital Acquired Thrombosis (CHAT) Registry Michael Silvey Received Received
  1249-PB Neutrophil Extracelular Traps (NETs) and Inflammatory Biomarkers in Patients with Hereditary Spherocytosis. Influence of Splenectomy Antonio Moscardó Received Received
  1251-PB The Association between Central Venous Catheter Placement and Central Venous Catheter Related Thrombus Sophie Jones Received Received
  1254-PB Venous Thromboembolism in Children with Hodgkins Lymphoma Pavel Zharkov Received Received
  1255-PB Thrombin Generation in Venous Thromboembolism, Arterial Ischaemic Stroke and Bleeding Events in Children Vera Ignjatovic Received Received
  1256-PB Paroxysmal Nocturnal Hemoglobinuria Spectrum among Pediatric Age Group of Patients: Single Center Experience without Any Thrombotic Events Neslihan Kalkan Received Received
  1257-PB Incidence and Risk Factors for Childhood Thrombosis: Ten Years Experience of a Paedatric Hematology Center from Turkey Adalet Meral Gne&351; Received Received
  1258-PB A Default in Acetyl-CoA Carboxylase Phosphorylation Increases Thrombus Growth in vitro and in vivo, and in a Collagen-dependent Manner Sophie Lepropre Received Received
  1260-PB Fibrin Activation and Not GPCR Ligand Activation Induces Shedding of Platelet GPVI: Soluble GPVI is Elevated in Thermal Injury and ICU Patients Samantha Montague Received Received
  1262-PB Patient Derived HLA Monoclonal Antibodies Induce Fc&947;RIIa Dependent Platelet Activation Maaike Rijkers Received Received
  1263-PB Platelet PN-1 Regulates Clot Structure and Retraction stéphane LOYAU Received Received
  1265-PB Cyclophilin D Restricts the Lytic Susceptibility of Fibrin via Modulation of Platelet Functions Veronika Judit Farkas Received Received
  1270-PB Controlled Adhesion of Endothelial Cells and Platelets onto Patterned CoCr Alloy Surfaces by Direct Laser Interference Patterning Technique for Cardiovascular Applications Marc Pino Received Received
  1271-PB Authophagy of Microparticles by Platelets is Partially Mediated through TLR-4 and Enhances Thrombogenicity Irene Lopez-Vilchez Received Received
  1272-PB Analysis of Venous and Arterial Hemostatic Plugs Reveals Strikingly Similar Composition and a Gradient of Platelet Activation Chelsea Matzko Received Received
  1273-PB Platelet Reactivity and Receptor Density in Platelets with Different MPV Anna Sdergren Received Received
  1276-PB A Novel Role for the Membrane Protein G6f in Platelet Activation Induced by Weak Stimulation Ali Amirkhosravi Received Received
  1278-PB Heparin Decreases Thrombin Induced Procoagulant Platelet Formation via a Direct Platelet Effect Vivien CHEN Received Received
  1280-PB Autophagy Inhibitors Reduce Platelet Function by Preventing Granule Exocytosis Dafna Groeneveld Received Received
  1281-PB Kinetics of Prothrombin Interaction with Subpopulations of Activated Platelets Nadezhda Podoplelova Received Received
  1282-PB Inhibition of MRP4 Mediated Transport Reduces Platelet Function in a cAMP-cGMP Independent Manner Laura Alemanno Received Received
  1284-PB Systemic Alteration of Platelet Activity during Each Trimester of Normal Pregnancy Steven Cullen Received Received
  1290-PB Exploration of additional parameters of multiple electrode aggregometry is encouraged Mette Tiedemann Skipper Received Received
  1295-PB Synergistic Inhibitory Effect of Capsaicin and Dihydrocapsaicin on the Arachidonic Acid Pathway of Platelet Aggregation Murray Adams Received Received
  1296-PB The PI3K pathway master kinase PDK1 controls platelet activation by regulating the MAPK pathway via the Raf-1 proto-oncogene, serine/threonine kinase Patrick Mnzer Received Received
  1299-PB ELMO1 Negatively Regulates Glycoprotein VI-mediated Signaling by RhoG in Platelets Akruti Patel Received Received
  1301-PB Kindlin-3 identified as a key negative regulator of the small Rho GTPase, Cdc42 during platelet spreading Dorsaf Ghalloussi Received Received
  1303-PB Arp2/3 is Critical for Platelet Homeostasis but Dispensable for Hemostatic Plug Formation David S. Paul Received Received
  1305-PB RGS Proteins Shape the Hemostatic Response by Regulating the Platelet Signaling Networks Shuchi Gupta Received Received
  1307-PB RhoGAP6 and RhoGEF2 are Novel Regulators of RhoA in Platelets Shane Comer Received Received
  1309-PB Annexin A7 (ANX7) regulates GPVI-dependent platelet activation and Ca2 signaling Sascha Geue Received Received
  1311-PB Disabled-2 Controls Platelet Activation Through a Regulatory Circuit Involving Multiple Interacting Proteins Hui-Ju Tsai Received Received
  1312-PB Sustained Inhibition of Acetyl-CoA Carboxylase Decreases Platelet Dense Granules Secretion and Aggregation Sophie Lepropre Received Received
  1314-PB Changes in Gene Expression Levels in Immune Thrombocytopenia Patients Treated with Eltrombopag Jose M Bastida Received Received
  1315-PB Calcium Homeostasis in Platelets in Pregnancy Women with Preeclampsia Volha Bichan Received Received
  1316-PB PDK1 Regulates Platelet Activation through Phosphorylating of S6K on Thr229 Xue Chen Received Received
  1318-PB Integration of Platelet Agonist Signaling during the Hemostatic Response in vivo Timothy Stalker Received Received
  1320-PB Platelet Proteomic Profiling in a Patient with Severe Platelet Dysfunction Associated to an Anti-aIIb3 Autoantibody Triggering Outside-in Signaling Mathieu FIORE Received Received
  1321-PB STAT3 Phosphorylation Is Regulated by Thromboxane A2 Receptor in Platelets Antonio Moscardó Received Received
  1324-PB Involvement of aIIb3 Integrin on Release of Extracellular Vesicles and Chemokines CXCL4 and CCL5 by Platelets Rory Koenen Received Received
  1329-PB Btk Kinase Activity is Not Critical for Platelet Activation by GPVI Phillip Nicolson Received Received
  1330-PB Extracellular Signal-regulated Kinase 5 Associates with Casein Kinase II to Regulate GPIb-IX-mediated Platelet Activation via PTEN/PI3K/Akt Pathway Yu Hu Received Received
  1331-PB Agonist-induced Protein Disulfide Isomerase Activity in Platelets: Different Effect of Different Agonists Ronit Mor-Cohen Received Received
  1332-PB Dose-dependent Inhibitory and Stimulatory Effects of Sphingosine-1-phosphate on Platelet Adhesion to Endothelium Carolin Helten Received Received
  1334-PB Reelin Modulates PLC?2 Phosphorylation upon Platelet Activation and Integrin Outside-in Signaling Irena Krger Received Received
  1335-PB Calcium Monitoring in Platelets: Tool for Diagnosing Platelet Function Defects Alessandro Aliotta Received Received
  1337-PB Role of Heterotrimeric G Proteins in Platelet Activation and Clot Formation in Platelets Treated with Integrin aIIb3 Inhibitor Naphtali Savion Received Received
  1338-PB In vitro Assessment of Catecholamines to Restore Platelet Aggregation in the Presence of Ticagrelor and Aspirin Anne-Céline Martin Received Received
  1339-PB Emerging Role for TLT-1 at the Interception of Inflammation and Hemostasis Jessica Morales Received Received
  1341-PB Platelets Express and Release Immune-modulatory CXCL14 upon Activation Alexander Witte Received Received
  1342-PB CD8 T Cells Are Important Mediators of Platelet Refractoriness Cheryl Maier Received Received
  1345-PB Renal Denervation Decreases the Platelet Activation Status in Hypertensive Patients Maria Teresa Kristina Zaldivia Received Received
  1346-PB Upregulation of Inflammatory Transcripts in Platelets of Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Role of Platelets in the Inflammatory Network of NAFLD Maria Adele Alberelli Received Received
  1347-PB Characterization of PF4-heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential Jawed Fareed Received Received
  1348-PB Acetylsalicylic Acid Differentially Limits The Activation and Expression of Death Markers in Human Platelets Exposed to Staphylococcus aureus Strains Adrien Chabert Received Received
  1349-PB Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in vitro and in Renal Cell Carcinoma Patients Bibian Tullemans Received Received
  1350-PB Tunable Activation of Therapeutic Platelet-Rich Plasma by Pulse Electric Fields: Differential Effects on Clot Formation, Growth Factor Release and Platelet Morphology Andrew Frelinger Received Received
  1352-PB Ascorbic Acid on Platelet Activation. New Functions for an Old Drug Roberto Pozner Received Received
  1354-PB Intercellular Signalling between Platelets and a Myeloid Leukemic Cell Line Tayyaba Iftikhar Received Received
  1355-PB An Optimized Protocol for Platelet Rich Plasma Preparation to Improve its Angiogenic and Regenerative Properties Julia Etulain Received Received
  1357-PB Treatment of Patients with Autologous Platelet Rich Fibrin is Dependent on the Composition of Peripheral Blood Cells: Dental Implant Stability is Associated with Red Blood Cells and Not with Platelets Jasper Remijn Received Received
  1358-PB Identification of a Novel Regulator Platelet P2Y12 Receptor Function: Tetherin, a Lipid-raft Organizing Protein Negatively Regulates Receptor Activity Xiaojuan Zhao Received Received
  1359-PB Platelet Endocytosis in Immune Responses to Viral Infection Sidney Whiteheart Received Received
  1360-PB Pharmacologic Blockade of Platelets Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis Susann Eichler Received Received
  1362-PB Platelets Enhance Distinct Dynamics of Effector Cell Responses of Nave, Effector, and Central Memory CD4 T Cells Shuai Tan Received Received
  1364-PB Platelets Play a Protective Role in the Host Defense against Burkholderia pseudomallei (Melioidosis) Theodora Claushuis Received Received
  1366-PB Platelets Promote Immunosuppression and Colorectal Tumor Formation: Inhibition by Clopidogrel Laurence Servais Received Received
  1367-PB Interplay between Platelets, Neutrophils and Coagulation in Bleeding in a Mouse Model of Inflammatory Bowel Disease Odile Wéra Received Received
  1369-PB Complete Attenuation of PrP(106-126)-mediated Pathological Responses by Flufenamic Acid in Platelets Ram Lala Mallick Received Received
  1371-PB Contributions of von Willebrand Factor to the Development of Angiotensin II-induced Vascular Inflammation Jérémy Lagrange Received Received
  1372-PB Platelets Are Effectors of Articular Degradation in Rheumatoid Arthritis Eleonora Petito Received Received
  1374-PB Procoagulant Platelets as a Biomarker in Suspected Sepsis - A Pilot Study Leonardo Pasalic Received Received
  1378-PB Anticoagulant and Anti-inflammatory Properties of the Novel Antimicrobial Peptide Centrocin 1 from Green Sea Urchin Bjarne sterud Received Received
  1379-PB Deficiency of Sirtuin 3 Elevates Mitochondrial ROS in Neutrophils and Platelets but Does not Exacerbate NETosis or Venous Thrombosis Hideki Hayashi Received Received
  1380-PB Nucleosomes and Neutrophil Extracellular Traps in Septic and Burn Patients Mirta Schattner Received Received
  1382-PB Platelets Release Pathogenic Serotonin in Response to Immune Complexes Nathalie Cloutier Received Received
  1383-PB Influence of Intravenous Immunoglobulin and Methylprednisolone on Cytokines Secreted by T Lymphocyte in Children ITP Ma Jingyao Received Received
  1386-PB GDF-15 Alters the expression of Actin Associated Protein, Increases Migration and the Phosphorylation of Smad2 is Mediated via TGFRII Lena Kask Received Received
  1387-PB Validation of Plasma Marker Candidates for VTE Using Affinity and Mass Spectrometry-based Proteomics Indicate a Link to Alternative Complement Pathway Laura Sanchez-Rivera Received Received
  1389-PB Clinical Determinants of Thrombin Generation Measured in Presence and Absence of Platelets - Results from the Gutenberg Health Study Marina Panova-Noeva Received Received
  1390-PB Metabolomic Study in Plasma Samples to Identify a Metabolite Profile Associated to Venous Thromboembolism Álvaro Fernández-Pardo Received Received
  1391-PB Prevalence of Deep Vein Thrombosis and Wells Score Accuracy for Inpatient with Suspected Deep Vein Thrombosis Michelangelo Sartori Received Received
  1392-PB Impact of Chronic Inflammation, Assessed by C-reactive Protein, on the Association between Red Cell Distribution Width and Risk of Incident Venous Thromboembolism Trygve Slberg Ellingsen Received Received
  1394-PB Plasma Leptin is Not a Mediator of the Association between Obesity and Risk of Venous Thromboembolism Lars Daae Horvei Received Received
  1395-PB Identifying a Common Biochemical Background for Thrombotic Events in Patients with Deep Vein Thrombosis (DVT) and Peripheral Artery Disease (PAD) Arina ten Cate-Hoek Received Received
  1396-PB Plasma Levels of miRNAs Are Associated with Risk of Cancer-related Venous Thromboembolism Irina Starikova Received Received
  1397-PB A Global Metabolomic Analysis Comparing Low-risk and High-Risk Pulmonary Embolism Christopher Kabrhel Received Received
  1398-PB Changes in the Fibrinolytic Status and Cardiovascular Profile in Obese Patients Undergoing Bariatric Surgery Ana Marco Received Received
  1399-PB Evaluation of Risk Factors for Postpartum Hemorrhage after Vaginal Delivery in Uncomplicated Pregnancy Kazuhiro Nishioka Received Received
  1400-PB Analysis of the Substrate Specificity of Factor VII Activating Protease (FSAP) and Design of a Specific and Sensitive Peptide Substrate sandipk kanse Received Received
  1401-PB Von Willebrand Factor Propeptide May Identify the Patients Susceptible for Renal Dysfunction in Collagen Disease Noritaka Yada Received Received
  1402-PB Age-related Diagnostic Value of D-dimer Testing and the Role of Inflammation in Patients with Suspected Deep Vein Thrombosis - Results from the VTEval Study Jrgen Prochaska Received Received
  1404-PB Characterization of a Transient Procoagulant Phenotype Induced by Recombinant Activated Factor VII (rFVIIa) Heiko Rhl Received Received
  1405-PB The Effects of Shear Stress on Platelet Activation and Incipient Clot Characteristics: Exploring the Mechanisms of Shear Induced Clot Formation Karl Hawkins Received Received
  1407-PB Changes in Thrombin Generation in Obese Patients Undergoing Bariatric Surgery: Improvement in the Hypercoagulable Status Ana Marco Received Received
  1408-PB Combined Detection of Factor XIII and D-Dimer Is Helpful for Differential Diagnosis in Patients with Suspected Pulmonary Embolism Ning Tang Received Received
  1409-PB Clinical Significance of Circulating Endothelial-derived Microparticles and Coagulation Profiles in Patients with Advanced Solid Tumors DER SHENG SUN Received Received
  1411-PB A Quantitative Clot-based Assay for Antithrombin Activity Walter Calhoon Received Received
  1413-PB Platelet Counts and Plateletcrit are Associated with an Increased Risk of Venous Thrombosis in Females. Results from the RETROVE Study Miquel Vázquez-Santiago Received Received
  1414-PB Plasma Levels of miRNAs Are Associated with Future Risk of Incident Venous Thromboembolism Irina Starikova Received Received
  1416-PB D-dimer in Acute Medically Ill Adults: A Multicenter Observational Study Evaluating the Prevalence of Elevated D-dimer in Acute Medically Ill, Hospitalized Adults: The DAMIACT Study, Initial Results Iwona Bucior Received Received
  1417-PB Down-regulation of Protein C Pathway Associated with Increased Inflammation in Patients with Implanted Ventricular Assist Devices as a Potential Cause of Pump Thrombosis Walter Jeske Received Received
  1418-PB The effect of iron status on the relationship between red cell distribution width (RDW) and venous thromboembolism (VTE) Jostein Lappegrd Received Received
  1419-PB Utility of novel biomarkers (TAT, PIC, tPAIc and TM) in evaluating worsening of coagulopathy and mortality in APL and Sepsis induced DIC patients: A Prospective Observational study Anupama Janaki Krishnamoorthi Received Received
  1422-PB Assessment of Endothelial and Inflammatory Markers in Brazilian Renal Transplant Recipients SUELLEN RODRIGUES MARTINS Received Received
  1423-PB Remote Platelet Function Testing Using Platelet-Bound P-in as a Marker of Platelet Activation Stanley Heptinstall Received Received
  1424-PB Endothelial Microparticles, Thrombomodulin and D dimer in Women with Systemic Lupus Erythematosus under treatment Fernanda Freire Received Received
  1425-PB Chronic Lymphocytic Leukemia: Is there a Role for Circulating Microparticles or Trombin Generation in Clinical Heterogeneity? Fernanda Freire Received Received
  1426-PB Determinants of Clot Strength in Polycythemia Vera and Primary Myelofibrosis using Rotational Thromboelastometry Nikolaj Nytofte Received Received
  1427-PB Identification & Characterization of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients with Continuous Flow Left Ventricular Assist Device Implants Walter Jeske Received Received
  1428-PB Haemostasis in Children with Acute Lymphoblastic Leukemia Elena Seregina Received Received
  1429-PB Association between FTO rs9939609 Polymorphism and Risk of Recurrent Venous Thromboembolism Abrar Ahmad Received Received
  1430-PB The protein Z system dynamic in patients undergoing offpump coronary artery bypass surgery Zekanowska Ewa Received Received
  1431-PB Relevance of Co Morbidities, D-Dimer, Red Cell Distribution Width and Factor VIII Levels in Thrombosis Annamma Kurien Received Received
  1432-PB Longitudinal Assessment of Coagulation and Fibrinolysis in Pregnant Women with Risk Factors for Preeclampsia Luci Dusse Received Received
  1433-PB Role of Oxidized High-density Lipoprotein (oxHDL) on Coagulation and Platelet Adhesion Modulation Lorena Perez Received Received
  1434-PB Inter-individual Variability and Normal Ranges of Whole Blood and Plasma Thrombin Generation and Correlation with Clotting Factor Levels in a Large Healthy Control Population Hilde Kelchtermans Received Received
  1435-PB Venous Thromboembolism Events over Five Years Presenting with a Normal D-Dimer Huw Rowswell Received Received
  1436-PB Biomarkers for the Diagnosis of Venous Thromboembolism: D-dimers, Thrombin Generation, and Phospholipid-dependent Clotting Time Alexander Gatt Received Received
  1437-PB Risk Factors and Clinical Characteristics Favoring Pulmonary Embolism Vs DVT in Hormonal Therapy (HT) Associated Thromboembolism. Retrospective Analysis of 73 Cases from a Single Hemostasis Unit Emmanouil Papadakis Received Received
  1439-PB Is Platelets - Bound C4d a Marker for Active Disease and Correlates with Hypercoagulability in Patients with Systemic Eritematosus Lupus? Fernanda Freire Received Received
  1440-PB Profiling of Thrombotic and Inflammatory Mediators in Synovial Fluid from Patients Undergoing Primary Total Joint Arthroplasty Jawed Fareed Received Received
  1442-PB Anti-2-Glycoprotein I Antibodies Cause Lupus Anticoagulant and Activated Protein C Resistance via Coagulation Factor V Rolf T. Urbanus Received Received
  1443-PB Plasma Clot Properties, Disease Phenotype, and Thrombotic Risk in Patients with a Lupus Anticoagulant: Results from the Vienna Lupus Anticoagulant and Thrombosis Study (LATS) Florian Posch Received Received
  1444-PB Biophysical Characterization of Clot Retraction in Platelet Rich Plasma of Patients with Anti-phospholipid Syndrome Jolan Harsfalvi Received Received
  1446-PB Longitudinal Anti-phospholipid-Antibody Trajectories for Dynamic Thrombotic Risk Prediction in Patients with the Lupus Anticoagulant: A Joint Model Florian Posch Received Received
  1447-PB Impact of Adding Antiphosphatidylserine/Prothrombin Antibodies in the Thrombotic Risk of Patients with APS Laboratory Criteria: A Prospective Study Marta Martinuzzo Received Received
  1449-PB The Effect of Treatment with Hydroxychloroquine on Soluble Tissue Factor Levels in Patients with Antiphospholipid Antibodies and Antiphospholipid Syndrome Karen Schreiber Received Received
  1450-PB Increased Plasma Cell-free DNA (cfDNA) and Myeloperoxidase (MPO) and Impaired Fibrinolysis in High-risk Patients with Antiphospholipid Antibodies (aPL) FABRIZIO SEMERARO Received Received
  1453-PB Clinical Impact of Triple Positivity of Antiphospholipid Antibodies in Primary Thrombotic Antiphospholipid Syndrome Sabrina Saraiva Received Received
  1454-PB 2GpI Binds to Fibrinogen and Alters Fibrin Generation and Degradation Daniele Peterle Received Received
  1455-PB Circulating Microparticles in Pregnant Patients with Primary Antiphospholipid Antibody Syndrome: An Explorative Study Elena Campello Received Received
  1456-PB Outcomes of Anticoagulant Therapy in Patients with Antiphospholipid Syndrome Managed in an Anticoagulation Clinic Monika Stalc Received Received
  1457-PB Elevated Oxidized Low Density Lipoprotein Levels in Antiphospholipid Syndrome is Related to the Autoantibodies against High Density Lipoprotein and its Associated Proteins Kenji Oku Received Received
  1458-PB Platelet Activation by Antiphospholipid Antibodies through the IgG Receptor Fc?RIIa: Possible Role in Thrombosis Associated with Antiphospholipid Syndrome? Enriqueta Coll Received Received
  1459-PB Prognostic Impact of Antiphospholipid Antibodies on the Clinical Course of Primary Immune Thrombocytopenia or Autoimmune Hemolytic Anemia Ana Clara Ladeira Cruz Received Received
  1462-PB Are Anti2-glycoprotein I IgG Domain I a Useful Tool to Predict Thrombosis? Ana Marco Received Received
  1463-PB Oral Anticoagulation Cost in Primary Antiphospholipid Syndrome: Comparison between Warfarin and Hypothetical Rivaroxaban Paul Ames Received Received
  1464-PB Comprehensive Characterization of Platelet Parameters for Thrombosis Risk Prediction in Patients with the Lupus Anticoagulant Johanna Gebhart Received Received
  1465-PB Severe Vitamin D Deficiency a Potentially Risk Factor for Recurrent Miscarriages in Women with Positive Antiphospholipid Antibodies STAMATIOS PETOUSIS Received Received
  1466-PB Antibodies against Domain I of Beta2-glycoprotein I Have No Added Value for Prediction of Antiphospholipid Syndrome Compared to Classical Antiphospholipid Antibodies Nathalie Pequeriaux Received Received
  1469-PB Thrombocytopenia is Uncommon in High-risk Patients with Antiphospholipid Syndrome (APS) Alessandra Banzato Received Received
  1470-PB Circulating Neutrophil-Extracellular Traps (NETs) in Patients with the Antiphospholipid Syndrome Joan Carles Reverter Received Received
  1471-PB Catastrophic Antiphospholipid Syndrome: Onset and Outcome Tatiana Reshetnyak Received Received
  1472-PB Effect of Hydroxychloroquine on Circulating Levels of Inflammatory Cytokines in Patients with Primary Antiphospholipid Syndrome Bruna Mazetto Received Received
  1473-PB A High Molecular Weigh Protein Is Responsible of Anticoagulant Activity in Isolated Lupus Anticoagulant Alessandra Banzato Received Received
  1475-PB What Is the Risk of The First Thrombosis in Asymptomatic Antiphospholipid Antibodies Carriers? Lidia Costa Received Received
  1476-PB Clinical Relevance of Anti Phospholipid Antibodies in Deep Venous Thrombosis Doaa Eissa Received Received
  1477-PB Results of Lupus Anticoagulant Investigation in Unive Population of Patients Referred for Testing Sandra Margetic Received Received
  1479-PB Detection of Thrombogenicity Positive Antiphospholipid Antibodies in Antiphospholipid Syndrome Diagnosis Jana Ulehlova Received Received
  1482-PB Plasma Thrombogenic Potential in Patients with Granulomatosis with Polyangiitis in Comparison to Antiphospholipid Syndrome Magdalena Celi&324;ska-Lowenhoff Received Received
  1485-PB Predictors of Thrombotic Events in Patients with Antiphospholipid Antibodies Ghaith Abu Zeinah Received Received
  1486-PB Recurrent Arteriovenous Fistula Thrombosis in Female Patient with Antiphospholipid Syndrome (APS), Factor V Leiden Mutation and MTHFR C677 T Mutation Bernadeta Ceglarek Received Received
  1487-PB Comparison of Genetic Risk Score Models to Predict First Venous Thromboembolism in a Population-based Case-cohort. The Troms Study Sigrid Braekkan Received Received
  1488-PB Next-Generation DNA Sequencing Approach to Study Burden of Rare Variants in Loci Susceptible to Cerebral Vein Thrombosis Paolo Bucciarelli Received Received
  1489-PB Impact of Age and Prothrombotic Genotypes on the Risk of Incident Venous Thromboembolism Birgit Smbrekke Received Received
  1490-PB Joint Effects of Ischemic Stroke and Prothrombotic Genotypes on the Risk of Venous Thromboembolism. The Troms Study Ludvig Balteskard Rinde Received Received
  1491-PB Joint Effects of Myocardial Infarction and Prothrombotic Genotypes on the Risk of Venous Thromboembolism. The Troms Study Ludvig Balteskard Rinde Received Received
  1492-PB Population-based Incidence of Venous Thromboembolism in Oklahoma County, OK April 1, 2012-March 31, 2014 Aaron Wendelboe Received Received
  1493-PB Differential Impact of Surgery as a Trigger Factor for Venous Thromboembolism in Patients with and without Prothrombotic Genotypes Esben Bjri Received Received
  1494-PB Hospitalization as a Trigger for Venous Thromboembolism - Results from a Large Population-based Case-crossover Study Esben Bjri Received Received
  1495-PB The Rare Allele of the K858R Variant of Factor V Protects from the Risk of Venous Thrombosis but Only in Non Carriers of the FV Leiden Mutation Pierre Suchon Received Received
  1496-PB Joint Effects of Prothrombotic Genotypes and Body Height on Risk of Venous Thromboembolism: The Troms Study Lars Horvei Received Received
  1498-PB The effect of prothrombotic genotypes on the relationship between red cell distribution width (RDW) and venous thromboembolism (VTE) Jostein Lappegrd Received Received
  1499-PB Homozygous and Heterozygous Factor V Leiden Mutation (FVL) Is Associated with an Increased Risk for Recurrent Venous Thromboembolism (VTE) after First VTE Rainer B. Zotz Received Received
  1502-PB Genetic Characterization of Antithrombin, Protein C and Protein S Deficiencies in Slavic Thromboembolic Patients Ewa Wypasek Received Received
  1504-PB Molecular Genetic Diagnostics of Protein S and Protein C Deficiency Ole Halfdan Larsen Received Received
  1505-PB GPX1 Pro198LEU Polymorphism as a Risk Factor for Venous Thromboembolism in Young Men from North-Western Russia Zhanna Sidorova Received Received
  1506-PB Genetic Association Study between Candidate SNPs and Brazilian Patients with Venous Thromboembolism (VTE) Anna Virgínia Calazans Romano Received Received
  1507-PB Absolute Quantification of Jak2 V617F in Patients with Splanchnic Venous Thrombosis by Droplet Digital PCR Donatella Colaizzo Received Received
  1508-PB Screening of Deletions in Protein S Deficient Families Tereza Fenclova Received Received
  1511-PB A Novel Splice Site Mutation Leading to AT Deficiency Dana Provaznikova Received Received
  1512-PB Gender Differences in the Incidence of Venous Thromboembolism Among Chronic Lung Diseases and Rheumatoid Arthritis in Korea Won-Il Choi Received Received
  1513-PB Application of Massive Parallel Sequencing Searching for Rare Genetic Variants of Protein C and S Associated with Thrombophilia - Implementation to Clinical Practice Ludek Slavik Received Received
  1514-PB Combined Protein C / Protein S Deficiency: Genotype-Phenotype Relationship in an Italian Family Carrying Two Novel Mutations GIOVANNI FAVUZZI Received Received
  1515-PB Impact of Factor V-Leiden, Prothrombin G20210A and MTHFR C677T Mutations on Egyptian Patients with Sickle Cell Disease Abeer Saad Received Received
  1516-PB Heightened Hypercoagulability in Sickle Cell Anemia Patients with Chronic Leg Ulcers Edeghonghon Olayemi Received Received
  1518-PB Apolipoprotein E Gene Polymorphisms: An Indian Study Showing Lateral Association with Thrombophilic Risk Factors in Patients with Deep Vein Thrombosis PULKIT RASTOGI Received Received
  1521-PB Risk Factors of Cerebral Venous Sinus Thrombosis - Single Center Experience Adela Gwozdowska Received Received
  1523-PB Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thromboembolism Andrea Artoni Received Received
  1524-PB Quantification of the Effect of NET-derived Cell-free DNA on Thrombosis and Haemostasis Phenotypes Sonia Lopez Received Received
  1525-PB Iron Deficiency Alters Red Blood Cell Adhesion and Arterial Thrombosis Lalitha Nayak Received Received
  1526-PB Complete Protein S Deficiency and Pregnancy Outcome in Murine Model Raja Prince Received Received
  1527-PB Thrombophilic Phenotype in a Neonate and Five Young Siblings of a Family with Homozygous Antithrombin Type 2 (Budapest III) Deficiency Hans-Joerg Hertfelder Received Received
  1528-PB Venous Thromboembolism in Women Using Hormonal Contraception and the Risk of Recurrence. Findings from a Single Center ALEJANDRA LATORRE Received Received
  1529-PB Thrombophilia Screening Practices in a Tertiary Care Hospital: An Assessment of Appropriateness and Financial Impact Ninada Ganta Received Received
  1530-PB Retrospective Analysis of the Size of Recurrent Pulmonary Embolus: Single Centre Study Will Thomas Received Received
  1531-PB Hyperaggregability of Platelets with Low Dose of ADP and Epinephrin in Patients with Venous Thrombosis: Preliminary Results from the RETROVE Project (Risk of Enfermedad TROmboembólica VEnosa) Dolors Llobet Received Received
  1532-PB The Association of D-dimer Level with Common Inherited and Acquired Risk Factors of Thrombosis Anatoly Dobrovolsky Received Received
  1533-PB Antithrombin p.Thr147Ala: Not Just Another SNP? Kristin Jochmans Received Received
  1535-PB Risk Factor Stratification for Venous Thromboembolim in Patients with Below Knee Injuries Treated with Immobilisation and the Future Role of Thromboprophylaxis Daniel Mulligan Received Received
  1536-PB Paroxysmal Nocturnal Hemoglobinuria (PNH) in Patients Presenting with Cerebral Vein and Sinus Thrombosis (CVST) - Results of Flow Cytometry Based Screening in Indian Patients Jasmina Ahluwalia Received Received
  1537-PB High Levels of VAMP 8 and Serotonin Transporter Suggest a Tendency of Thrombosis in Spanish Population. Preliminary Results from the RETROVE Project (Risk of Enfermedad TROmboembólica VEnosa) Dolors llobet Received Received
  1538-PB Genetic Heterogeneity of Protein C Deficiency in Hungary; Genotype-phenotype Correlations Marianna Speker Received Received
  1539-PB Elevated Plasma Factor IXa Activity in Women Using Hormonal Contraception Pansakorn Tanratana Received Received
  1540-PB Analysis of Factor V Leiden Paradox from a Large Monocentric Cohort Study: A Role for Distal Thrombosis? Elena Campello Received Received
  1542-PB Results of Thrombophilia Testing in Infertile Women and Women Experienced a Miscarriage Sandra Margetic Received Received
  1544-PB Screening of Thrombophilia in Latin America Cecilia Guillermo Received Received
  1545-PB First Do Not Harm: Questioning Ethics Aspects of Thrombophilia Law in Argentina Beatriz Grand Received Received
  1546-PB Extensive molecular characterization of a family with thrombophilia: implication of multiple genetic alterations of low thrombotic risk profile Marina Carrasco Exposito Received Received
  1549-PB Impact of the Molecular Study of the PROC, PROS1 and SERPINC1 Genes in Patients with Venous Thrombosis Patricia Martinho Received Received
  1551-PB Venous Thromboembolism (VTE) in Homozygous Carriers of Factor V Leiden Mutation Patients (FVL) Bernadeta Ceglarek Received Received
  1552-PB Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in Oman khalid Alhashmi Received Received
  1553-PB Anticoagulant Therapy in Disorders in the Fibrinolysis System among Patients with Primary Infertility Igor Kurtov Received Received
  1554-PB Pattern of Thrombophilia Testing in Patients with Venous Thromboembolism at a Tertiary Care Hospital MANILA GADDH Received Received
  1556-PB Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Patient with Decompensated/Uncontrolled Hypertension, Hyperhomocysteinemia, Hypercholesterolemia and Hyperlipidemia Bernadeta Ceglarek Received Received
  1557-PB Twice-daily Low-dose Aspirin Provides a More Consistent Platelet Inhibition in Patients with Essential Thrombocytosis Mads Lamm Larsen Received Received
  1558-PB Long-term Aspirin (ASA) Use Significantly Attenuates Platelet Interactions with von Willebrand Factor (VWF) in Acute Coronary Syndromes (ACS) Dermot Kenny Received Received
  1559-PB Patients with Coronary Artery Disease Have a Pathological P2Y12 Platelet Response with Heightened Procoagulant Platelet Potential Leonardo Pasalic Received Received
  1560-PB Platelet Inhibition with Ticagrelor Versus Clopidogrel in Patients with Peripheral Artery Disease: The EUCLID Platelet Substudy Jeffrey Berger Received Received
  1561-PB Antiplatelet Agents are the Key Drugs for the Prevention of Recurrent Arterial Thrombosis in Patients with Antiphospholipid Syndrome Naoki Ohnishi Received Received
  1562-PB Cyclic Nucleotide Modulators and P2Y12 Antagonists as Novel Anti-platelet Combination Therapy Paul Armstrong Received Received
  1563-PB Prasugrel vs. Ticagrelor after STEMI: Results from the Dsseldorf STEMI Registry Carolin Helten Received Received
  1565-PB Effect of Aspirin Therapy on Abacavir-associated Platelet Hyperreactivity in HIV-infected Patients: A Randomized, Double-blind, Placebo-controlled, Cross-over Study Giuseppe Guglielmini Received Received
  1566-PB Investigation of the Physiological Mechanisms Leading to the Release of BDNF by Platelets and their Susceptibility to Antiplatelet Agents Marie Lordkipanidze Received Received
  1567-PB Clopidogrel Efficiency in Cerebral Aneurysm Stenting: Are Biological Tests Useful? nadine ajzenberg Received Received
  1568-PB Comparison of Platelet Function Tests in a Trial of Different Aspirin Dose Regimens in Type 2 Diabetes Paul Harrison Received Received
  1569-PB The Offset of Ticagrelor Prior to Coronary Artery Bypass Graft (CABG) Surgery Kok Weng Ow Received Received
  1570-PB Nanoparticle Inhibition of Shear Induced Platelet Aggregation David Ku Received Received
  1571-PB Plasma Fibrinogen Level is an Important Determinant of Platelet Reactivity in the VerifyNow Assay Dobrovolsky Anatoly Received Received
  1573-PB Assessment of Low Platelet Reactivity (LPR) with Multiple Electrode Impedance Aggregometry (MEA) and Risk of Bleeding in Patients Receiving P2Y12 Receptor Inhibitors DOBRINKA DINEVA Received Received
  1574-PB Concomitant Use of Antiplatelet and Direct Oral Anticogulants Increase but Not Significantly the Bleeding Risk in Patients with Atrial Fibrilation Juan Jose Cerezo Received Received
  1576-PB Combined Effect of CYP2C19 G681A Polymorphism and Plateletcrit on Clopidogrel Low-responsiveness in Thai Patients with Acute Coronary Syndrome Sornsith Jirungda Received Received
  1578-PB Platelet (plt) reactivity in patients with essential thrombocythemia (ET) receiving antiplatelets therapy with aspirin (ASA) Sara Gamba Received Received
  1579-PB The Influence of Prostaglandin E1 on the Correlation between the Multiple Electrode Aggregometry ADP and the VerifyNow P2Y12 Test in Patients Using P2Y12 Inhibitors Paul Verhezen Received Received
  1580-PB Could Aspirin Play a Role in Diminishing ADP Induced Platelet Aggregation in Clopidogrel Nave Patients? Theodora Kostelidou Received Received
  1581-PB Obesity Is Associated with Reduced Platelets SERCA3 Isoform Expression and Subsequent Platelet Inhibition, Reversible after Weight Loss Alain STEPANIAN Received Received
  1582-PB Patterns and Levels of Platelet Glycosylation in Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus Chenxue Qu Received Received
  1583-PB Hemostatic Abnormalities in Patients with Ehlers-Danlos Syndrome Maria Abbattista Received Received
  1586-PB Chronic Immune Thrombocytopenic Purpura (ITP) in Egyptian Children: A 10 Year Single Center Retrospective Study Magy Abdelwahab Received Received
  1587-PB Acute Episodes of Atrial Fibrillation Cause Altered Platelet Function and Procoagulant Microparticle Consumption Line Pourtau Received Received
  1588-PB Impaired Platelet Responsiveness in Thrombocytopenic Cancer Patients after Chemotherapy as a Consequence of Mitochondrial Dysfunction Constance Baaten Received Received
  1590-PB Thrombocytopenia and Altered Coagulation as Independent Predictors of the Etiology of Tropical Jaundice in Adults Presenting to Emergency in a Tertiary Care Hospital in North India ashish bhalla Received Received
  1591-PB Plasma microRNAs Characterizing patients with Immune Thrombocytopenia Bin Zuo Received Received
  1592-PB Evaluation of in vitro Effects of Tyrosine-kinase Inhibitors on Primary Haemostasis Falk Eckart Received Received
  1594-PB Further Characterization of Platelets Bearing Mutations in Calreticulin or JAK2 Genes in Essential Thrombocythemia Patients Hagit Hauschner Received Received
  1595-PB Clinical Evaluation of the Revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-Thrombosis) in a Cohort of 746 Chinese Adult Patients Rongfeng Fu Received Received
  1596-PB Variations of Mean Platelet Volume with Time Since Blood Sampling in Different Anticoagulants gian marco podda Received Received
  1597-PB Cytosolic Calcium Concentrations in Platelets from Patients with Pulmonary Embolism and Implications for Therapy Jonathan Pike Received Received
  1598-PB Probable Risks and Benefits of Second Line Therapy Splenctomy versus TPO Mimetics in Chronic Idiopathic Thrombocytopenic Purpura an Experience of a Third World Country, Pakistan Tanzeel Imran Received Received
  1599-PB Sonoclot Signature Analysis In Thrombocytopenic Patients kundan mishra Received Received
  1600-PB High Incidence of Platelet Dysfunction is unmasked in Newly-diagnosed Multiple Myeloma Theera Ruchutrakool Received Received
  1601-PB Effects of Time and Different Anticoagulants on Platelet Count in Blood Donors and in Thrombocytopenic Patients gian marco podda Received Received
  1602-PB In vitro Ibrutinib Effect on Platelets Function. A Single Centre Study Sofia Gkotsi Received Received
  1603-PB The Platelet Function Analyzed by Flow Cytometry in Psoriatic Patients on Reference Therapy Tatiana Vavilova Received Received
  1607-PB Protein Disulfide Isomerase Is Regulated by S-nitrosylation: Implications for Vascular Quiescence and Thrombus Formation Roelof Bekendam Received Received
  1608-PB Ultra-sensitive Molecular Magnetic Resonance Imaging of Blood Cells - Endothelium Interactions In vivo Maxime Gauberti Received Received
  1609-PB Contribution of the P2X1 Receptor Expressed by Lung Macrophages to Experimental TRALI Marie-Belle EL MDAWAR Received Received
  1610-PB The Role of von Willebrand Factor in Experimental Malaria-associated Acute Respiratory Distress Syndrome Sirima Kraisin Received Received
  1611-PB Blood platelets bind A&946; peptides vie Integrin &945;IIb&946;3 and induce amyloid-&946; aggregation in cerebral vessels Lili Donner Received Received
  1612-PB Platelet Extracellular Vesicles Induce a Proinflammatory Smooth Muscle Cell Phenotype Tanja Vajen Received Received
  1613-PB Conditional Knockout of Heme Oxygenase-1 in Lysozyme M Positive Cells Attenuates Angiotensin II Induced Vascular Inflammation Jérémy Lagrange Received Received
  1614-PB Defective Fibrin Accumulation and Thrombus Stability in Endothelial Cell-specific BAMBI Knockout-mice Isabelle I. Salles-Crawley Received Received
  1615-PB FXI Inhibition Protects from Vascular Inflammation and Endothelial Dysfunction in Arterial Hypertension Sabine Kossmann Received Received
  1616-PB Function of an Endothelial-specific GPCR in Thrombosis Leonardo Gottlob Received Received
  1617-PB Factor VII Activating Protease (FSAP) Regulates the Expression of Inflammatory Genes through Protease Activated Receptor (PAR1) in Vascular Smooth Muscle and Endothelial Cells Kristina Byskov Received Received
  1618-PB Regulation of Platelet String Formation on Endothelial Cells in the Presence of Coagulation under Shear Toshiaki Shirai Received Received
  1620-PB A2 Domain of von Willebrand Factor (VWF) Mediates Human Vascular Smooth Muscle Cells (VSMCs) Proliferation and Migration Morel E. Worou Received Received
  1621-PB Dietary Alpha-linolenic Acid Reduces Platelet Activation and ex vivo Thrombus Formation in Sickle Cell Disease Mice Simona Stivala Received Received
  1622-PB Podoplanin Overexpression on Endothelial Cells Promotes Superficial Erosive Injury and Thrombus Formation in Rat Carotid Artery Eiji Furukoji Received Received
  1623-PB Evaluation a Novel Mouse Model of Abdominal Aortic Aneurysm to Study Platelet Mechanisms of the Proinflammatory Thrombus YACINE BOULAFTALI Received Received
  1624-PB Increased Inflammatory Properties of Neutrophils and Endothelial Cells (ECs) in Patients with Venous Thromboembolism (VTE), Long after the Acute Disease Kiara Cristina Senger Zapponi Received Received
  1626-PB Effects of Aspirin and Rivaroxaban on Murine Arterial Vessel Wall Remodelling after Vascular Injury Tom Mastenbroek Received Received
  1627-PB Plasminogen Activator Inhibitor Type 1 in Platelets Evokes Thrombogenicity and Increases Thrombus Size by Elevating Thrombolysis Resistance under Shear Stress Tetsumei Urano Received Received
  1628-PB Tissue Engineered Small Vessel Conduits - The Anti-thrombotic Effect of Re-endothelialisation of Decellularised Baboon Arteries Leana Laker Received Received
  1630-PB Protein Kinase C-Dependent Loss of Tissue Factor by Human Pericytes Results from Altered Synthesis, Trafficking and Degradation Maureane Hoffman Received Received
  1633-PB Endothelial Dysfunction in Idiopathic Thromboembolism Investigated through Gene Expression Profiling of Endothelial Colony Forming Cells Corrado Lodigiani Received Received
  1634-PB Role of Lysozyme M Cells in the Development of Angiotensin II-induced Vascular Inflammation Jeremy Lagrange Received Received
  1638-PB Platelet a-granule Deficiency Protects Local and Distal Organs in Intestinal Ischemia Reperfusion Injury Katrina Ashworth Received Received
  1640-PB Development of a Novel Strategy to Target CD39 Antithrombotic Activity to the Endothelial-platelet Microenvironment in Kidney Ischemia-reperfusion Injury Harshal Nandurkar Received Received
  1642-PB Inhibition of Coagulation Factor Xa Attenuates Myocardial Ischemia Reperfusion Injury in Mice Jens Posma Received Received
  1644-PB Contribution of Neutrophil Extracellular Trap (NET) Components to the Structure of Thrombi from Therapeutic Intervention in Ischemic Coronary, Peripheral and Cerebral Artery Disease Ádám Zoltán Farkas Received Received
  1645-PB A Novel Easy-to-Perform Thromboembolic Stroke Model in Mice: Application to the Study of the Thrombolytic Effect of N-acetylcysteine Maxime Gauberti Received Received
  1646-PB Human Platelet Alloantigens and P-Selectin Gene Polymorphisms in Pediatric Arterial Ischemic Stroke Renata Zadro Received Received
  1648-PB Incidence Rates and Case Fatality Rates of Cerebral Vein Thrombosis: A Population-based Study Dentali Francesco Received Received
  1649-PB Biomarkers for the Symptomatic Carotid Atheroma Maria Jesus Iglesias Mareque Received Received
  1650-PB Neutrophil Extracellular Traps (NETs) in Patients with Acute Stroke Are Associated with Stroke Severity and Progression Antonio Moscardó Received Received
  1651-PB Case-fatality after Venous Thromboembolism and Ischemic Stroke in Subjects without and with Atrial Fibrillation. The Troms Study Erin Mathiesen Hald Received Received
  1654-PB Thrombi Retrieved from Patients Suffering Acute Ischemic Stroke Show both Active and Mechanical Interaction between Stent Retrievers and Thrombus, and is Associated with Specific Thrombus Surface Characteristics Heleen van Beusekom Received Received
  1655-PB The Effect of Recanalization on Long-term Neurologic Outcome after Cerebral Vein Thrombosis Francesco Dentali Received Received
  1656-PB Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation Benot Ho-Tin-Noé Received Received
  1658-PB Effects of Phosphodiesterase 3A Modulation on Murine Cerebral Microhemorrhages Mark Fisher Received Received
  1660-PB Long-term Stroke Risk Prediction in Real World Atrial Fibrillation Patients: A Comparison of the ABC-stroke and CHA2DS2-VASc Scores José Miguel Rivera-Caravaca Received Received
  1661-PB Time-restricted Feeding Disturbs Circadian Expression of Thrombomodulin in the Mouse through Peripheral Clock Molecules Shuichi horie Received Received
  1662-PB Reduced ADAMTS13 Levels in Patients with Acute and Chronic Cerebrovascular Disease Frederik Denorme Received Received
  1664-PB Evaluation of the Thrombolytic Potential of N-Acetyl Cysteine in a Mouse Model of Thrombotic Stroke Frederik Denorme Received Received
  1665-PB Is There a Difference in Inherited Prothrombotic Polymorphisms between Arterial Ischemic Stroke and Cerebral Sinus Venous Thrombosis in Children? Renata Zadro Received Received
  1666-PB Alpha-2-antiplasmin Arg407Lys Polymorphism and Cryptogenic Ischemic Cerebrovascular Events: Association with Neurological Deficit Ewa Wypasek Received Received
  1669-PB Early Plasma Fibrinogen Level after Thrombolytic Therapy in Acute Ischemic Stroke Patients Cannot Predict Intracranial Hemorrhage Theera Ruchutrakool Received Received
  1670-PB Prediction of Venous Thromboembolism and Ischemic Stroke by Modified CHA2DS2-VASc Score in Patients with Atrial Fibrillation. The Troms Study Erin Mathiesen Hald Received Received
  1671-PB Safety of Aspirin for Secondary Stroke Prevention: POoled Data Reanalysis of Aspirin for CErebraL InfArction PreventIoN : PORCELAIN Study Takehiko Nagao Received Received
  1672-PB Abnormal Red Cell Indices and the Risk of Arterial Ischemic Stroke in Children Nongnuch Sirachainan Received Received
  1673-PB Remote Platelet Function Testing Using Platelet-bound P-in as a Marker of Platelet Activation. Findings in Patients with Stroke or TIA Treated with Clopidogrel Stan Heptinstall Received Received
  1674-PB Mechanical Endovascular Therapy Plus Intravenous Tissue Plasminogen Activator versus Intravenous Tissue Plasminogen Activator Alone for the Management of Acute Ischemic Stroke: An Adjusted Indirect Treatment Comparison Meta-analysis Jonathan Caranfa Received Received
  1676-PB Unhelpful Use of Hereditary Thrombophilia Tests in Young Patients with Ischemic Stroke. Final Results of the AISYFs Trial José Manuel Ceresetto Received Received
  1679-PB Incidence and Outcome of Childhood Stroke in Thailand Patcharee Komvilaisak Received Received
  1681-PB Another Indication to DOACs Attilia Maria Pizzini Received Received
  1682-PB Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI Ingrid Stroo Received Received
  1683-PB Acute Lowering of Factor XII Induces Accelerated Spontaneous Venous Thrombosis in Mice: New Evidence for the Contact System that Idles? Marco Heestermans Received Received
  1684-PB A Two-step Mechanism for Factor XII Activation in Solution Steven de Maat Received Received
  1686-PB Endothelial Cell Serpins, Including PAI-1, Form a Complex with Fxia Blocking its Activity and Inducing the Clearance, Internalization and Degradation of FXIa Cristina Puy Received Received
  1687-PB Characterization of Polyphosphate in Endothelial Cells under Cellular Stress Rachel Rigg Received Received
  1688-PB Identification of F11 Gene Variations Involved in the Interindividual Variability of Factor XI in Subjects with Congenital Deficiency Caused by Recurrent Mutations Salam Salloum-Asfar Received Received
  1692-PB Activation of The Contact Pathway by Red Blood Cell and Platelet Microvesicles Denis Noubouossie Received Received
  1693-PB Contaminating Silica Particles Contribute Substantially to the Procoagulant Activity of DNA Isolated Using Commercial Kits Stephanie Smith Received Received
  1696-PB Contribution of Intrinsic Coagulation Factors in ex vivo Thrombus Formation and Lysis José Govers-Riemslag Received Received
  1698-PB Haemocompatibility Properties of Polyethersulfone Based Haemodialysis Membrane with Different Amounts of Polyurethane Fatmawati Kamal Received Received
  1699-PB Comparison of Nine Different Blood Collection Tubes for Contact Activation of Coagulation Cornelis Kluft Received Received
  1701-PB Short-term Increase in Factor (F)XIa-dependent Procoagulant Activity in Citrate Blood Shannon Prior Received Received
  1704-PB Mechanism of Growth and Inhibition of Plasma Clots Growing from a Surface with Immobilised Tissue Factor Cornelis Kluft Received Received
  1705-PB Co-operative Binding of VWF to the TSP8 and CUB Domains of ADAMTS13 is Required for its Conformational Activation kieron south Received Received
  1706-PB a-Synuclein Binds to Human a-Thrombin and Inhibits Thrombin-mediated Platelet Aggregation: Possible Implications in Parkinsons Disease Daniele Peterle Received Received
  1707-PB The Effect of Short Chained Polyphosphates on Coagulation Activation in a Whole Blood Model Ina Hiland Received Received
  1709-PB Evidence for Direct and Indirect Modulation of Haemostatic Factors by miR-494 Jasmine Tay Received Received
  1710-PB Situation-adjusted Anticoagulant Release System with Response to Different Coagulation Factors Manfred Maitz Received Received
  1711-PB Liver Hypoxia Regulates Protein S Levels in Obese Patients Vijaya Pilli Received Received
  1712-PB Thrombin is a Selective Inducer of Heparanase Release from Platelets and Granulocytes via Protease-activated Receptor-1 Yona Nadir Received Received
  1714-PB Fibrinogen Polymorphisms Predict Fibrinogen and Clot-related Phenotypes Independently and through Interactions with IL-6 Héléne Toinét Cronjé Received Received
  1717-PB Characterization of GGCX Mutations Identified in the First Clinical Case of a VKCFD Patient Da-Yun Jin Received Received
  1718-PB Comprehensive Identification of miRNA-gene Interactions Reveals Extensive Regulation of the Plasmatic Coagulation Network Jamie Nourse Received Received
  1719-PB Resolving the Roles of Platelets and (Anti)Coagulation Pathways in Whole-blood Fibrin Formation under Flow to Phenotype Hemostatic Disorders Johanna van Geffen Received Received
  1721-PB Thrombin Generation in Schizophrenia Patients Treated with Antipsychotic Medications Karl Egan Received Received
  1723-PB Tissue Factor-dependent Heme-induced Whole Blood Coagulation Activation: A Thromboelastometry Study Bidossessi Wilfried Hounkpe Received Received
  1724-PB Salivary EV: A New Link between Primary and Secondary Hemostasis Yuanjie Yu Received Received
  1726-PB Heparan Sulfate Chains Contribute to an Anticoagulant Milieu in Malignant Pleural Effusion Yona Nadir Received Received
  1728-PB Procoagulant Properties of Microparticles Produced by Monocytes, Granulocytes, Platelets and Endothelial Cells Alexey Mazurov Received Received
  1729-PB Ventricular Assist Devices without Anticoagulation: An Impossible Dream? Phillip Coghill Received Received
  1731-PB The Modification of Thrombin Generation Assay Parameters in Patients with Recurrent Pregnancy Loss Héla Baccouche Received Received
  1736-PB A Polydeoxynucleotide Derived Drug Defibrotide Inhibits Nucleosome Generation in Whole Blood. Implications in the Management of VOD Jawed Fareed Received Received
  1742-PB FXIII and EACA Increase Thrombus Stability and Decrease Pulmonary Embolism in an in vivo Mouse Model of Venous Thromboembolism, but EACA Increases Thrombus Size Shana Shaya Received Received
  1744-PB Fibrin-derived B15-42 Peptide Is a Gatekeeper of Thrombus Resolution Stela Chausheva Received Received
  1745-PB Theoretical Model for Thrombin-FXIII-A2 Complex and the Effect of Ca2 Ions on the Dynamic Behavior of FXIII-A2 Gábor Balogh Received Received
  1747-PB Platelet and Plasma Factor XIII Levels after Replacement Therapy in Severe Congenital Factor XIII Deficiency: Is there a Role for Factor XIII Uptake by Megakaryocytes? Claudia Radu Received Received
  1749-PB Genetic and Clinical Epidemiology of Congenital Fibrinogen Disorders Alessandro Casini Received Received
  1752-PB Congenital FXIII Deficiency in Pakistan: An Update Munira Borhany Received Received
  1754-PB Factor XIII in Tears and its Possible Role in Corneal Wound Healing Zsuzsanna Z. Orosz Received Received
  1755-PB A Role for Factor XIII in Clot Formation and Clot Contraction of Whole Blood Tom Plug Received Received
  1756-PB Structural and Phylogenetic Analysis of Coagulation Factor XIII Explains its Uniqueness in the Transglutaminase Family Arijit Biswas Received Received
  1757-PB In silico Analysis of Extended Promoter Regions of F13A1 and F13B Genes Indicates Putative Sites Might Underlie Regulatory Variation in Factor XIII Levels Muhammad Ahmer Jamil Received Received
  1758-PB Fibrinogen Caracas IX a Novel Fibrinogen Mutation: FGA g. 3057 CT (p. 104 ArgCys) Impair Fibrinogen Secretion Rita Marchi Received Received
  1760-PB Evidence for the Presence of Cross-beta Structures in Fibrin Clots Dick C. Rijken Received Received
  1763-PB Cellular Factor XIII in Human Cornea László Muszbek Received Received
  1764-PB Fibrin-associated ROTEM variables and thrombin generation in patients with congenital fibrinogen defects Timea Szanto Received Received
  1765-PB Studies to Determine Novel Interacting Partners and Functional Roles for Factor XIII B Subunit Sneha Singh Received Received
  1766-PB The Effect of Factor XIII Levels and Factor XIII B Subunit Polymorphisms on the Risk of Venous Thromboembolism Zoltán A Mezei Received Received
  1768-PB Galactosemia Presenting with Afibrinogenemia Inci Yaman Bajin Received Received
  1769-PB Plasma Tromboelastometry (ROTEM) Could be a Complement in Study Fibrinogen Disorders Alicia Beatriz Vilaseca Received Received
  1770-PB A Fibrinogen Activity Method on Photo-optical Coagulation Analyzers without Interference from Hydroxyethyl Starch Zhenghua Cao Received Received
  1771-PB Construct and Known Group Validity of Patient-reported Outcome (PRO) Instruments in US Adults and Caregivers of Children with Hemophilia B: Results from the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) Study Tyler Buckner Received Received
  1775-PB Comparing the One-stage and Chromogenic Assay: Factor VIII Activity Assay Discrepancy at Baseline Does Not Reflect Assay Discrepancy after DDAVP in Non-severe Hemophilia A Lisette M Schtte Received Received
  1776-PB Risk Differential in Inhibitor Development in the First Days of Treatment by Product Class: A SIPPET Analysis Roberta Palla Received Received
  1777-PB Pocket Handheld Ultrasound Has High Accuracy in Identification of Effusions and Major Landmarks in Normal and Hemophilic Joints: Expanding Point of Care for Patients with Hemophilia with Joint Disease Lena Volland Received Received
  1778-PB Influence of Family History on Mode of Delivery in Severe Haemophilia in the UK elizabeth chalmers Received Received
  1781-PB Individualizing Hemophilia Prophylaxis using Thromboelastography (TEG) Guy Young Received Received
  1782-PB Impact of a Product-Specific Reference Standard for the Measurement of a PEGylated rFVIII Activity: The Swiss Multicentre Field Study Pierre Fontana Received Received
  1783-PB Long-term Quality-of-Life Outcomes with rFVIIIFc Prophylaxis in Adult Subjects with Severe Hemophilia A Jun Su Received Received
  1784-PB Bleeding Events and Safety Outcomes in Persons with Hemophilia A (PwHA) with Inhibitors: The First Large, Prospective, Multicenter, Non-interventional Study (NIS) from a Real World Setting Daniella Babu Received Received
  1785-PB Disparities in Age at Diagnosis and Initial Treatment between People with Moderate and Severe Haemophilia A: Evidence from the KAPPA Register Mehdi Osooli Received Received
  1788-PB Intracranial Hemorrhage in Hemophilia Patients: The Status of Ongoing Retrospective-Prospective Italian Registry (2009-2016) Ezio Zanon Received Received
  1790-PB Comparison of the Relationship between Factor IX Activity and Bleeding Risk during Prophylaxis with Nonacog Beta Pegol (N9-GP) Guy Young Received Received
  1792-PB Chronic Liver Disease in People with Hemophilia Aged 40 Years and Older Christian Qvigstad Received Received
  1793-PB Once Weekly rfIX Prophylaxis for Severe-Phenotype Haemophilia B in Normal Clinical Practice: Data from UKHCDO and Finland Martin Scott Received Received
  1795-PB Application of Pharmacokinetic-tailored Approach to Prophylaxis in Routine Hemophilia Care Stacy E Croteau Received Received
  1796-PB Prevalence of Cerebral Microbleeds and Macrobleeds in Neurologically Asymptomatic Patients of Congenital Hemophilia Pankaj Malhotra Received Received
  1798-PB Evaluation of the Impact of Polymorphism/Mutations in Genes Associated to Hemostasis in Clinical Diversity in Patients with Severe Hemophilia Daniel Chaves Received Received
  1799-PB The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort Antonino Cannavò Received Received
  1801-PB Evaluate the Situation Diagnosis and Treatment of Hemophilia in Vietnam in 2015 Mai Nguyen Thi Received Received
  1803-PB Development of the Education Interventions to Enhance Adherence to Prophylactic Treatment in Korean Hemophilia Patients Eun Jin Choi Received Received
  1804-PB Immune Tolerance Induction in Patients with Haemophilia using Fc Fusion Recombinant Factor VIII Azusa Nagao Received Received
  1805-PB Spectrum and Origin of Mutations in Sporadic Cases of Haemophilia A in China yeling lu Received Received
  1806-PB The Utility of Activated Partial Thromboplastin Time Clot Wave Form Analysis in the Investigation of Hemophilia A Patients Using Destiny Max TM Analyzer Ancy Abraham Received Received
  1807-PB Pharmacokinetics of Octocog a in Severe Hemophilia A Boys Aged Less than Six Years on Routine Prophylaxis Tomasz Urasinski Received Received
  1808-PB The World Bleeding Disorders Registry: The Pilot Study Christine Herr Received Received
  1809-PB Data from the Austrian Haemophilia Registry: An Update Judit Rejt Received Received
  1810-PB Application of the Pattern and Parameters of the aPTT Clot Reaction Curve in Patients with Hemophilia A and Acquired HA Rodolfo Emanuel Sueldo Received Received
  1812-PB Personalized Treatment in Hemophilic Patients in Argentina Rodolfo Emanuel Sueldo Received Received
  1813-PB Global Hemostatic Assay at Different Target Procoagulant Activity of Factor VIII and Factor IX Ki-young Yoo Received Received
  1814-PB The Impact of Secondary and Tertiary Prophylaxis in the Reduction of Bleeding Events in Moderate or Severe Hemophilia A or B Karla Bayer Mendonca Received Received
  1815-PB New Methods of Physiotherapy in Patients with Advanced Haemophilic Arthropathy Krystyna Zawilska Received Received
  1819-PB Is Intermediar Intensity Prophylaxis with Factor VIII Sufficient for Improvement of Overall Hemostasis Potential in Hemophilia A Patients? Irena Djunic Received Received
  1820-PB Can Tertiary Prophylaxis Bring about Zero Bleed in Adult Persons with Hemophilia? A Single Center Observation Study in Japan Teruhisa Fujii Received Received
  1823-PB Two Effective Cases of Immune Tolerance Induction Using Turoctocog Alfa Combined with Immunosuppressive Therapy in Non-severe Hemophilia A Chikasawa Yushi Received Received
  1824-PB Tailored Prophylaxis: A Bridge between QoL and Retrenchment. Our Experience with Simoctocog Alfa Jacopo Agnelli Giacchello Received Received
  1825-PB Therapeutic Efficacy of Low-dose Immune Tolerance Inductionin 5 Chinese Severe Hemophilia A Children with Inhibitor in Good Risk Zhenping Chen Received Received
  1826-PB Efficiency of Prophylaxis in an Adult with Hemophilia after Dose Adjustment Using a Bayesian Model FVIII Pharmacokinetics Estimation MARIANA CANARO HIRNYK Received Received
  1828-PB Personalized Approach to Treatment due to Pharmacokinetic Study: Description of One Case of Moderate Haemophilia A with Severe Bleeding Phenotype after Switch to Simoctocog Alfa Chiara Ambaglio Received Received
  1829-PB Haemophilia and Acute Coronary Syndrome (ACS) Attilia Maria Pizzini Received Received
  1830-PB The Diagnostic Value of Rotational Thromboelastometry in Patients with Non-severe Hemophilia A Minoo Ahmadinejad Received Received
  1832-PB Hemophilia Care in Pakistan Munira Borhany Received Received
  1833-PB Risk Management of Pelvic Pseudotumor in a Patient with Inhibitors and Severe Hemophilia Ricardo Silva Received Received
  1834-PB A Study of Home Therapy in Hemophilia Patients Kim Mikyung Received Received
  1835-PB Are we Close to International Standards for Hemophilia Care in Tunisia? Gouider emna Received Received
  1837-PB Screening for heart failure with natriuretic peptides in patients with atrial fibrillation Sander van Doorn Received Received
  1838-PB Direct Oral Anticoagulants (DOAC) vs Low Molecular Weight Heparin (LMWH) as Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation (NVAF) and Concomitant Active Cancer Anna Varela-Magallon Received Received
  1839-PB Thrombin Generation and International Normalized Ratio in Patients with Atrial Fibrillation Using Rivaroxaban or Warfarin Fernanda Freire Received Received
  1840-PB Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation Michela Giustozzi Received Received
  1841-PB Global Public Awareness about Atrial Fibrillation Aaron Wendelboe Received Received
  1842-PB VKA Treatment and Bleeding Rate of Patients Aged Older than 90 Years: Results from a Prospective Multicentre START Register Study Emilia Antonucci Received Received
  1843-PB Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: A systematic review and meta-analysis Sander van Doorn Received Received
  1845-PB Optimisation of Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation Using a Virtual Clinic Model Alison Brown Received Received
  1846-PB Evaluation of Antithrombotic Management in Patients with Atrial Fibrillation at a Tertiary Care Academic Medical Center Snehal Bhatt Received Received
  1847-PB Recent Years Trends in Real-life Antithrombotic Therapy for In- and Out-patients with Atrial Fibrillation in Moscow Alexander Melekhov Received Received
  1848-PB Should we Abandon the APTT for Monitoring the Anticoagulant Effect of Unfractionated Heparin? Deepa Jayakody Arachchillage Received Received
  1849-PB Evaluation of the 4T Score and Rapid Anti PF4/Heparin Antibodies Detection for Heparin Induced Trombocytopenia (HIT) Diagnosis in Clinical Practice. A Multicenter Study Maximiliano Villagra Iturre Received Received
  1850-PB Risk of Thromboembolic Disease in Renal Transplant Patients Veronica Privitera Received Received
  1852-PB In ECMO Patients Anticoagulated with Heparin the Dose-response Relationship Disappears when the Dose is Adjusted by ACT but it is Preserved with Anti-Xa Activity Felipe Guerrero Received Received
  1854-PB A Post Hoc Analysis of Dalteparin versus Vitamin K Antagonist for the Treatment of Cancer-associated Venous Thromboembolism in High-risk Patients with Metastatic Disease and Recent Antineoplastic Treatment Seth Woodruff Received Received
  1855-PB Tinzaparin for the Treatment of Superficial Vein Thrombosis of the Lower Limbs KONSTANTINOS NIKOLAKOPOULOS Received Received
  1856-PB Structural and Haemostatic Features of Pharmaceutical Heparins from Different Animal Sources: Challenges to Define Thresholds Separating Distinct Drugs Mariana Sá Pereira Received Received
  1857-PB The Effect of Prolongation of Initial Enoxaparin Therapy to One Month on the Risk of VTE Recurrences and the Recanalization of Deep Veins Natalya Vorobyeva Received Received
  1858-PB Validation of the Pulmonary Embolism Severity Index (PESI) and Simplified PESI in Asian Patients with Acute Pulmonary Embolism Wei Ying Jen Received Received
  1859-PB Help the Aged? Are we Failing to Protect Patients with Dementia from the Risks of Developing Hospital Associated Venous Thrombo-Embolism? Andrew McSorley Received Received
  1860-PB The Efficacy and Safety of Anticoagulations in Cerebral Vein Thrombosis: A Systematic Review and Meta-analysis Bader Al Rawahi Received Received
  1861-PB Study of Bioaccumulation of Tinzaparin in Renally Impaired Patients when Given at Prophylactic Dose: The STRIP Study denis projean Received Received
  1862-PB Thromboembolic Events Following Splenectomy: Risk Factors, Prevention, Management and Outcomes Yosef Kalish Received Received
  1863-PB Inhibition of thrombin generation distinguishes low and high responders to unfractionated heparin Lisa van der Vorm Received Received
  1864-PB Should Anticoagulation Therapy for Cancer Associated Pulmonary Embolism (PE) Be Modified in Individuals with Brain Metastasis or Thrombocytopenia? Kate Musgrave Received Received
  1865-PB Comparison of the Injection Site Reactions Elicited by Two Subcutaneously Injected Heparins, Nadroparin Calcium and Enoxaparin Sodium Jacob van Tonder Received Received
  1866-PB The Incidence of Adverse Events in Patients Treated with Therapeutic Dose Enoxaparin in Relation to Body Mass Index Riyadh Mustafa Murtadha Al-Shehristani Received Received
  1867-PB Management of Venous Thromboembolism in Patients with Glioma Mosaad Almegren Received Received
  1868-PB Resistance of Liquid Anti-Xa Assay (IL) to Platelet Factor 4 Interference Jagadeesh Gabbeta Received Received
  1869-PB A Matched Case-control Study to Determine Early Post-operative Haematological Complications after Renal Transplantation in Chronic Renal Failure Patients Receiving Therapeutic Anticoagulation EMILY MEEKS Received Received
  1870-PB Factors Associated with Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Yosef Kalish Received Received
  1871-PB Clinical Course of Patients Presenting with Acute Superficial Vein Thrombosis: A Post-hoc Analysis of the ICARO Study on 488 Patients Dentali Francesco Received Received
  1872-PB The Assessment of Safe Prescribing and Cost-effectiveness of Low Molecular Weight Heparin Treatment Jagjot Kaur Chahal Received Received
  1875-PB Efficacy and Safety of Pharmacological Thromboprophylactic Agents for the Prevention of Venous Thromboembolism after Major Abdominal Surgery: A Systematic Review and Meta-Analysis Bader Al Rawahi Received Received
  1876-PB Comparative Anticoagulant Effects of Recombinant Thrombomodulin, Antithrombin, and Unfractionated Heparin, Hematological Implications Debra Hoppensteadt Received Received
  1877-PB Nuts and Bolts of Running a Pulmonary Embolism Response Team: Results from an Organizational Survey of the National PERT? Consortium Members Geoffrey Barnes Received Received
  1878-PB Long Term Anticoagulant Treatment Management in Patients with Portal Vein Thrombosis at High Bleeding Risk mariasanta napolitano Received Received
  1880-PB Establishing the Heparin Therapeutic Range Using aPTT and Anti-Xa Measurements for Monitoring Unfractionated Heparin Therapy Anila Rashid Received Received
  1881-PB Patients Are More Adherent to Treatment with LMWH Nadroparin than Enoxaparin for Cancer Related Venous Thromboembolism Sake van der Wall Received Received
  1882-PB Prevalence of FOXD1 Mutations in Primigravidae with Pregnancy Loss Jean-Christophe GRIS Received Received
  1883-PB Prothrombin Fragment F12 (F1F2) in Pregnancy Is Associated with a History of Venous Thromboembolism (VTE) and Thrombophilia Rainer B. Zotz Received Received
  1885-PB Incidence and Risk Factors of Pregnancy-associated Venous Thromboembolism in Singhealth, a Major Healthcare Cluster in Singapore Sandra Lynn Jaya-Bodestyne Received Received
  1886-PB The Features of Pregnancy Management in Paroxysmal Nocturnal Hemoglobinuria Maria Vinogradova Received Received
  1887-PB High Levels of Complement C3 Increases the Risk for Postnatal Venous Thrombosis Anders Erik Astrup Dahm Received Received
  1888-PB Risk of Venous Thromboembolism in Unsuccessful ART Cycles: An Italian Cohort Study Michela Villani Received Received
  1889-PB M2 Haplotype in Annexin A5 Gene and Antiphospholipid Antibodies: Possible Relationship and Clinical Impact in a General Obstetric Population Michela Villani Received Received
  1891-PB Effect of Blood Loss during Caesarean Section on Coagulation Svetlana Tchaikovski Received Received
  1892-PB Assessment of Peripartum Management in a Population at High Risk for Venous Thromboembolism Heiko Ruehl Received Received
  1893-PB Role of ADAMTS-13 Activity and Inhibitor Monitoring during Pregnancy in Women with History of Severe Preeclampsia Alexander Makatsariya Received Received
  1894-PB Assessment of Annexin A5 and Annexin A2 Levels as Biomarkers for Pre-eclampsia: A Pilot Study Maha Othman Received Received
  1895-PB Attenuated Thrombin Generation and Enhanced Fibrinolytic Activity in Early Onset Preeclampsia Karl Egan Received Received
  1896-PB Management of Venous Thromboembolism in Women during Pregnancy and Puerperium (SAVE): A cross-sectional registry in Africa, Eurasia, Middle East and South Asia Jean-Christophe GRIS Received Received
  1897-PB Genetic Variants Associated with Thrombophilia and Gestational Complications in an Argentinian Cohort Gabriela de Larrañaga Received Received
  1898-PB Risk Factors for Venous Thromboembolism and Pregnancy Outcomes in Women with Pelvic Vein Thrombosis during Pregnancy - A Retrospective Study from a Stockholm Cohort, Ranging from 2000 to 2014 Roza Chaireti Received Received
  1899-PB Maternal Carriage of the Annexin A5 M2 Haplotype is Associated with a Higher Risk of Suffering from Gestational Vascular Complications Federico Aranda Received Received
  1900-PB Pregnancy-associated Hemolytic Uremic Syndrome as a Cause of Maternal Mortality Maria Vinogradova Received Received
  1903-PB Women with Homozygous AT Deficiency Type II Heparin Binding Site (HBS) Are at High Risk of Pregnancy Loss and Pregnancy Complications Julia Kraft Received Received
  1906-PB Venous Thromboembolism in Women Undergoing Assisted Reproduction: Data from RIETE Elvira Grandone Received Received
  1907-PB Outcomes of Threatened Abortions Following Anticoagulation Treatment to Prevent Recurrent Pregnancy Loss Yosef Kalish Received Received
  1908-PB OTTILIA and FIRST: Preliminary Data from Two Ongoing International Registries on Foeto-maternal Prognosis in Women with Recurrent Reproductive Failures after Spontaneous or Assisted Conception Michela Villani Received Received
  1909-PB Efficacy and Safety of Treatment with High Dose Thromboprophylaxis in Pregnant Women - A Retrospective Study from a Stockholm Cohort, Ranging from 2004 to 2014 Roza Chaireti Received Received
  1910-PB Thromboelastography Analysis of Haemostasis in Pre-eclamptic, Hypertensive and Normotensive Pregnant and Non-Pregnant Women Maha Othman Received Received
  1912-PB Obesity and Thromboembolic Risk during Hospitalization in Pregnancy: Preliminary Results VENINA BARROS Received Received
  1913-PB Management of a Pregnant Patient with Antithrombin Deficiency and Acute Venous Thromboembolism Julia Hews-Girard Received Received
  1914-PB Prevalence of FOXD1 Mutations in the Obstetric Antiphospholipid Syndrome Jean-Christophe GRIS Received Received
  1915-PB Management of Pregnancy in Cobalamin C Defect Causing Homocystinuria and Methylmalonic Aciduria Elvira Grandone Received Received
  1919-PB Different Approaches of Thromboprophylaxis during Pregnancy in the Routine Clinical Practice. Results from the TEAM Project Santamaria Amparo Received Received
  1920-PB In the TEAM PROJECT, the Management of Placental-mediated Pregnancy Complication (PMC) Reflects a Real Gap between Evidence-based Guidelines and Routine Clinical Practice Amparo Santamaria Received Received
  1921-PB Risk Assessment of Venous Thromboembolism in Women Furing Pregnancy and Puerperium (SAVE): A Cross-Sectional Registry in Africa, Eurasia, Middle East and South Asia Jean-Christophe GRIS Received Received
  1922-PB Evaluation of Venous Thrombo-embolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in Saudi Arabia (The Saudi Arabian Pregnancy Venous Thromboembolism Registry) Saud Abu-Harbesh Received Received
  1923-PB Ischemic-stroke due to an Embolic Thrombus in Carotid Artery in Recent Postpartum: Case Report and Review of the Literature VENINA BARROS Received Received
  1924-PB Hypodysfibrinogenemia: AChallenge in Maternity Ward - Course of Pregnancy and a Literature Review Justyna Magdalena Teliga-Czajkowska Received Received
  1927-PB Pregnancy Complications in Women with Thrombophilia and their Future Pregnancy Outcome after Anti-coagulant Treatment najib dally Received Received
  1928-PB What is the Actual Role of Antiphospholipid Antibodies in Obstetric Morbidity? Lidia Costa Received Received
  1929-PB Low Molecular Weight Heparin for Women with Pathologic Evidence of Placental Malperfusion Alexandra Gomez-Arteaga Received Received
  1931-PB Intracranial Haemorrhage Associated with during the Course of Extracorporeal Membrane Oxygenation for Severe Respiratory Failure Dee Jayakody Arachchillage Received Received
  1933-PB Soluble Fibrin Causes an Acquired Platelet GPVI-deficiency in Response to Convulxin, Collagen-related Peptide and Collagen: Implications for Trauma Induced Coagulopathy Scott Diamond Received Received